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Abstract 
 
Diiron-cluster-containing oxygenases catalyze a wide range of biological reactions. The chemical 
and biological breadth of the field is still being defined by discovery of new enzymes. The N-
oxygenase CmlI, which plays a role in the biosynthesis of the broad-spectrum antibiotic 
chloramphenicol, is a new entry that brings two significant characteristics to this enzyme class. 
First, the active oxidant of CmlI is a diferric peroxo species (P), in contrast to the high-valent 
intermediates that often serve as oxidants in the cycles of nonheme iron oxygenases. P has unique 
spectroscopic features and a long lifetime in the absence of substrate (t1/2 ~ 3 h at 4 °C, pH 9), 
which facilitated the discovery of its novel η1- η1 or η1- η2 diferric peroxo geometry that 
distinguishes it from the common cis-μ-1,2 geometry and may account for its unique reactivity. 
Characterization of the structure and function of P has led to a new understanding of the role of 
peroxo species in oxygen activation and insertion chemistry. The second novel aspect of CmlI is 
the chemistry that it performs, the six-electron conversion of an aryl-amine precursor to the aryl-
nitro group of the active antibiotic. Utilization of P in single turnover reactions allowed 
spectroscopic and kinetic characterization of each step of this conversion. The six-electron 
transformation begins when P converts the aryl-amine substrate into an aryl-hydroxylamine, 
which acts as a mid-cycle reductant to re-reduce and prime CmlI to regenerate P by reaction with 
O2 while itself being converted to the aryl-nitroso species. The regenerated P species then 
performs the last oxidation to convert the aryl-nitroso into the aryl-nitro group of 
chloramphenicol. Transient kinetic studies show that the substrate is likely to stay in a single 
active site during the entire, multistep reaction. Herein is described a new and highly efficient 
diiron-cluster-mediated N-oxygenase mechanism.  
v 
 
Table of Contents 
 
List of Tables………………………………………………………….………….……………….x 
List of Figures………………………………………………………….………….……………...xi 
List of Schemes……………………………………………………….………….………………xv 
Abbreviations………………………………………………………….………….…………….xvii  
 
Chapter 1: Introduction ................................................................................................................ 1 
Oxygen Activation in Biology ..................................................................................................... 2 
The Role of Dioxygen in Biology ........................................................................................... 2 
The Kinetics and Thermodynamics of O2 Activation ............................................................. 2 
The Role of O2-Activating Enzymes ....................................................................................... 3 
Diiron Oxygenases and Related Proteins .................................................................................. 4 
Iron Containing Oxygenases and Related Proteins ................................................................. 4 
The Biological and Chemical Landscape of Diiron Oxygenases ............................................ 4 
Aims in the Study of Diiron Oxygenases ................................................................................ 9 
Mechanisms of Dioxygen Activation by Diiron Oxygenases .................................................... 9 
Proposed Mechanism for Dioxygen Activation based on sMMO Catalytic Cycle ................. 9 
Peroxo Species Isolated from Diiron Oxygenases ................................................................ 10 
Diferric Peroxo Species Produced by CmlI .......................................................................... 13 
N-oxygenase Enzymes .............................................................................................................. 15 
Nitro-Containing Natural Products ....................................................................................... 15 
Biosynthesis of Chloramphenicol, an Aryl-Nitro-Containing Natural Product .................... 15 
N-oxygenases with Nonheme Iron Co-factors ...................................................................... 16 
Diiron Cluster Containing N-oxygenases.............................................................................. 20 
Structural Characteristics of CmlI and AurF ......................................................................... 21 
Mechanisms of N-oxygenation Mediated by Nonheme Iron Oxygenases .............................. 22 
General Mechanism for Enzymatic N-Oxygenation ............................................................. 22 
vi 
 
Product Analysis-Based Investigations into Biological N-oxygenation ............................... 23 
Role of the Diiron Cluster in Biological N-oxygenation ...................................................... 25 
Aim and Scope of the Thesis .................................................................................................... 27 
 
Chapter 2: Reactivity and Characterization of CmlI-Peroxo Intermediate, the Active 
Oxidant in the Catalytic Cycle of CmlI ...................................................................................... 28 
Introduction .............................................................................................................................. 29 
Results ....................................................................................................................................... 31 
Cloning, Overexpression, and Metal Center of CmlI. ........................................................... 31 
Mössbauer Characterization of CmlI .................................................................................... 33 
A Long-Lived Intermediate is Formed Upon Exposure of Reduced CmlI to Dioxygen. ..... 37 
Reactivity of the CmlI-Peroxo Intermediate. ........................................................................ 38 
CmlI-Peroxo Appears to React Directly with Substrates. ..................................................... 39 
Only Reaction with Native Substrate NH2-CAM Yields the Complete Six-Electron 
Oxidation Product. ................................................................................................................ 42 
Characterization of the Oxygenated Intermediate by Mössbauer Spectroscopy. .................. 43 
Resonance Raman Spectroscopy of the CmlI Oxygenated Intermediate. ............................. 47 
Discussion ................................................................................................................................. 48 
Summary of Findings. ........................................................................................................... 48 
Nature of the CmlI-Peroxo Intermediate. .............................................................................. 49 
Role of CmlI in Chloramphenicol Biosynthesis. ................................................................... 54 
Acknowledgements ................................................................................................................... 55 
 
Chapter 3: Spectroscopic Characterization of Intermediates in the Six-Electron Conversion 
of an Aryl-amine to an Aryl-nitro Product by CmlI ................................................................. 56 
Introduction .............................................................................................................................. 57 
Results ....................................................................................................................................... 59 
vii 
 
Tracking Oxygen Atom Incorporation into Chloramphenicol Product. ................................ 59 
Reaction of CmlI with NO-CAM and Determination of NO-CAM as a Substrate-based 
Intermediate.. ......................................................................................................................... 61 
Reaction of NH(OH)-CAM with CmlI and Determination of NHOH-CAM as a Substrate-
based Intermediate and Catalytically Relevant Reducing Agent. ......................................... 63 
Reaction of CmlI
red
, O2, and NH2-CAM Confirms NH(OH)-CAM and NO-CAM as 
Intermediates. ........................................................................................................................ 69 
CmlI is in the Oxidized State After a Single Turnover. ........................................................ 72 
Exchange of NO-CAM from the CmlI Active Site. .............................................................. 73 
Discussion ................................................................................................................................. 75 
Summary of Findings. ........................................................................................................... 75 
Comparison to a Model Requiring Three Successive Reactions with P. .............................. 75 
Comparison of the Mechanistic Models Employing a Pathway Intermediate as an Electron 
Source. ................................................................................................................................... 76 
Mechanistic Significance. ..................................................................................................... 78 
Conclusions ............................................................................................................................... 79 
Acknowledgements ................................................................................................................... 80 
 
Chapter 4: Kinetic Characterization of P formation and the CmlI Mechanism ................... 81 
Introduction .............................................................................................................................. 82 
Results ....................................................................................................................................... 84 
Kinetic Parameters of P Formation. ...................................................................................... 84 
Kinetic Parameters of P Formation with CAM Present. ....................................................... 86 
Kinetic Parameters of the Reaction of P with NH2-CAM. .................................................... 87 
Kinetic Parameters of the Reaction of CmlI
ox
 with NH(OH)-CAM. .................................... 90 
Reaction of P with NO-CAM…………………………………………………………….....92 
Kinetic Parameters of the Reaction Pathway where NO-CAM and O2 React with CmlI
red
. . 93 
viii 
 
Verification of P as the Active Oxidant that Acts on NO-CAM…………………………...98 
Kinetic Parameters of the Complete Reaction Pathway………...…………………………100 
Discussion ............................................................................................................................... 105 
Applying Kinetic Insight to Evaluate the Proposed Mechanism......................................... 105 
Evaluation of the Single Active Site Hypothesis. ............................................................... 106 
The Formation of Intermediate P. ....................................................................................... 106 
Importance of Binding Order and Hysteretic Effects. ......................................................... 107 
Overall Kinetic Model. ........................................................................................................ 108 
Future Work ........................................................................................................................... 111 
Acknowledgements ................................................................................................................. 111 
 
Chapter 5: Experimental methods ........................................................................................... 112 
Summary ................................................................................................................................. 113 
Reagents .................................................................................................................................. 114 
General Reagents. ............................................................................................................... 114 
Synthesis and Characterization of NO-CAM and NH(OH)-CAM. ..................................... 114 
Preparation of Wild Type CmlI and 
57
Fe CmlI ..................................................................... 115 
Cloning and Heterologous Expression of CmlI. ................................................................. 115 
Expression of CmlI. ............................................................................................................ 115 
Purification of CmlI. ........................................................................................................... 115 
Generation of Diferrous and Peroxo-Diferric CmlI ............................................................. 116 
Preparation of CmlI Diferrous Intermediate (CmlI
red
). ....................................................... 116 
Preparation of CmlI Diferric Peroxo Intermediate (P). ....................................................... 116 
Preparation of P in D2O or H2
18
O. ....................................................................................... 116 
Analytical Methods ................................................................................................................. 117 
Metabolite Analysis. ........................................................................................................... 117 
ix 
 
HPLC................................................................................................................................... 117 
UPLC/MSe and Analysis. ................................................................................................... 117 
Spectroscopic Methods ........................................................................................................... 118 
UV-visible Spectroscopy..................................................................................................... 118 
UV-visible Stopped-Flow. .................................................................................................. 118 
Resonance Raman Studies. ................................................................................................. 119 
EPR Sample Preparation and Analysis. .............................................................................. 119 
Mössbauer Sample Preparation and Analysis. .................................................................... 120 
Obtaining Snapshots of the CmlI Catalytic Cycle ................................................................. 120 
NH2-CAM Catalytic Walk. ................................................................................................. 120 
NH(OH)-CAM and NO-CAM Catalytic Walks. ................................................................. 121 
Capturing the Oxidant in the Reaction of CmlI
red
 with NO-CAM. ..................................... 121 
Determining Kinetic Trends and Constants .......................................................................... 121 
General Procedures. ............................................................................................................ 121 
Trace Fitting and Rate Constant Determination. ................................................................. 122 
Numerical Integration and Simulation of Kinetic Data. ...................................................... 124 
Reactions to Monitor P Formation. ..................................................................................... 124 
Reactions with NH2-CAM. ................................................................................................. 124 
Reactions with NH(OH)-CAM. .......................................................................................... 125 
Reactions with NO-CAM. ................................................................................................... 125 
Oxygen Isotope Tracing Methods .......................................................................................... 125 
Oxygen Isotope Incorporation Experiments........................................................................ 125 
Experiment to Evaluate Exchange of CmlI-peroxo with Atmospheric O2. ......................... 125 
Exchange of Products from the Active Site. ....................................................................... 125 
 
References ................................................................................................................................... 126 
x 
 
List of Tables 
 
Table 1-1: Standard reduction potentials for O2 in aqueous solution, pH 7, 25 °C.. ....................... 3 
 
Table 1-2: Chemical and biological function of known diiron-cluster containing proteins ............ 6 
 
Table 1-3: Spectroscopic parameters and proposed structure of enzymatic  
diiron peroxos and crystallized synthetic peroxos ......................................................................... 14 
 
Table 1-4: Known N-oxygenase enzymes: source organism, function, and redox co-factor ........ 18 
 
Table 2-1. Quadrupole splittings and isomer shifts for as-purified (CmlI
ox
),  
dithionite-reduced (CmlI
red
), and oxygenated forms of CmlI. ....................................................... 36 
 
Table 2-2: Products of the reaction of CmlI-P with aryl-amino substrates .................................... 43 
 
Table 2-3: Spectroscopic parameters of peroxodiiron(III) intermediates observed  
in dinuclear iron enzymes .............................................................................................................. 46 
 
Table 2-4: Spectroscopic parameters of synthetic nonheme high-spin iron-peroxo complexes .... 51 
 
Table 3-1. Oxygen incorporation into CAM products in the reaction of P with NH2-CAM ......... 60 
 
Table 3-2: Mössbauer quantification of CmlI forms during single turnover reactions .................. 66 
 
Table 3-3: Exchange of NO-CAM from the CmlI active site during single turnover ................... 74 
 
Table 4-1: Rate constants and amplitudes for P formation ............................................................ 85 
 
Table 4-2: Rate constants for P formation with CAM present....................................................... 87 
 
Table 4-3: Extinction coefficients for CmlI-P, CmlI
ox
 and CmlI
red
 at four wavelengths ............... 88 
 
Table 4-4: Percentage of P and CmlI
red 
at various time points in the reaction  
of CmlI
red 
with NO-CAM and O2, as determined by Mössbauer spectroscopy ............................. 99 
 
xi 
 
List of Figures 
 
Figure 1-1: Catalytic cycle of soluble methane monooxygenase. .................................................. 10 
 
Figure 1-2: Cis-μ-1,2-diferric peroxo geometry. ........................................................................... 12 
 
Figure 1-3: Chloramphenicol biosynthetic pathway ...................................................................... 16 
 
Figure 1-4: Crystal structure of CmlIΔ33.. .................................................................................... 22 
 
Figure 1-5: Scheme for the six-electron oxidation of an aryl-amine to an aryl-nitro species.. ...... 23 
 
Figure 1-6: Experimental determination of the four-electron oxidized intermediate  
on the pathway to the nitrobenzoate product as catalyzed by AurF .............................................. 26 
 
Figure 1-7: Two proposed mechanisms for the six-electron oxidation of an aryl-amine  
substrate to an aryl-nitro product, mediated by a diiron-cluster-containing oxygenase……..…..28 
 
Figure 2-1:  Optical absorption spectrum of resting CmlI and dithionite reduced CmlI………...34 
 
Figure 2-2: EPR spectra of mixed valent CmlI……………………………………………….35 
 
Figure 2-3: 4.2K Mössbauer spectra of as-isolated CmlI and dithionite reduced CmlI.  . ............. 35 
 
Figure 2-4: Mossbauer spectra of diferric CmlI at pH 6.5, 7.5, and 9.0.. ...................................... 36 
 
Figure 2-5: Comparison of the pH 7.5 Mössbauer spectra of CmlI and AurF  .............................. 37 
 
Figure 2-6: Reaction of CmlI-Peroxo with NH2-CAM.. ................................................................ 38 
 
Figure 2-7: Product from the reaction of 1 mM CmlI-Peroxo with 10 mM NH2-CAM.. .............. 39 
 
Figure 2-8: Single turnover reaction of CmlI-Peroxo with aryl-amine substrates.. ....................... 41 
xii 
 
 
Figure 2-9: Linear dependence of CmlI-Peroxo decay rate ........................................................... 42 
 
Figure 2-10: 4.2K Mössbauer spectra of oxygenated CmlI.. ......................................................... 45 
 
Figure 2-11: Resonance Raman spectra of oxygenated CmlI, pH 9.0 ........................................... 48 
 
Figure 2-12: Proposed structure of CmlI-Peroxo. .......................................................................... 52 
 
Figure 2-13: Role of CmlI in chloramphenicol biosynthesis. ........................................................ 55 
 
Figure 3-1: CmlI-Peroxo exchange test.. ....................................................................................... 61 
 
Figure 3-2: Reaction of CmlI
red
 with NO-CAM.. .......................................................................... 62 
 
Figure 3-3: Reaction of P and CmlI
ox 
with NH(OH)-CAM.. ......................................................... 64 
 
Figure 3-4: Stepwise characterization of the reaction of CmlI
ox
 with NH(OH)-CAM  
by UV-vis and HPLC.. ................................................................................................................... 65 
 
Figure 3-5: Stepwise characterization of the diiron center during NH(OH)-CAM  
oxidation by CmlI
ox
 by Mössbauer spectroscopy. ......................................................................... 66 
 
Figure 3-6: Stepwise characterization of the reaction of P with NH(OH)-CAM  
by UV-vis and HPLC.. ................................................................................................................... 67 
 
Figure 3-7: Stepwise characterization of diiron center during the  
NH(OH)-CAM oxidation by P.. .................................................................................................... 68 
 
Figure 3-8: Spectroscopic snapshots of the CmlI catalytic cycle and HPLC analysis  
of associated products. ................................................................................................................... 70 
 
Figure 3-9: Stepwise characterization of diiron center during NH2-CAM oxidation by P. ........... 72 
xiii 
 
 
Figure 3-10: Single turnover reaction of P with NH2-CAM and NH(OH)-CAM. ........................ 73 
 
Figure 3-11: NO-CAM exchange test. ........................................................................................... 74 
 
Figure 4-1: Proposed mechanistic cycle for N-oxygenation by CmlI. ........................................... 83 
 
Figure 4-2: Optical changes correlated with the formation of species P. ...................................... 84 
 
Figure 4-3: O2 dependence of P formation. ................................................................................... 85 
 
Figure 4-4: P formation in the presence of the product CAM. ...................................................... 86 
 
Figure 4-5: Reaction of a ten-fold excess of NH2-CAM with P, showing P decay. ...................... 88 
 
Figure 4-6: Optical changes at 480 nm correlated with the reaction of P with NH2-CAM. .......... 90 
 
Figure 4-7: NH2-CAM concentration dependence of the RRTs for the reaction  
of P with NH2-CAM. ..................................................................................................................... 90 
 
Figure 4-8: Optical change at 390 nm upon the anaerobic mix of CmlI
ox
 and NH(OH)-CAM ..... 91 
 
Figure 4-9: NH(OH)-CAM concentration dependence of the RRTs for the reaction of  
40 µM CmlI
ox
 and varying concentrations of NH(OH)-CAM in anaerobic buffer. ...................... 92 
 
Figure 4-10: Reaction of CmlI
red
 and NO-CAM in O2-saturated buffer ........................................ 94 
 
Figure 4-11: NO-CAM concentration dependence of trace shape, peak P time,  
and total P accumulation in the reaction of CmlI
red
 with O2 and NO-CAM. ................................. 97 
 
Figure 4-12: Comparison of two models for the reaction of E
red
 with NO-CAM and O2.. ............ 98 
 
 
xiv 
 
Figure 4-13: Optical changes in the reaction of CmlI
red
 with varying NO-CAM  
concentrations and fivefold excess of O2. ...................................................................................... 98 
 
Figure 4-14: Time points chosen for Mössbauer analysis of the reaction of  
CmlI
red
 with O2 and NO-CAM. ...................................................................................................... 99 
 
Figure 4-15: Mössbauer spectra of the 20 ms, 80 ms, 250 ms, and endpoint (30 s) time point 
samples of the reaction of 200 µM CmlI
red
 with 0.9 mM O2 and 2 mM NO-CAM. .................... 100 
 
Figure 4-16: NH2-CAM concentration dependence of P formation and decay. .......................... 101 
 
Figure 4-17: NH2-CAM concentration dependence of RRTs for the reaction of  
CmlI
red
-NH2-CAM and O2.. ......................................................................................................... 102 
 
Figure 4-18: NH2-CAM concentration dependence of RRTs for the reaction of  
CmlI
red
-NH2-CAM and O2 using the sum and product RRT analysis method.. ........................... 103 
 
Figure 4-19: Comparison of maximum P formation achieved by mixing  
200 µM CmlI
red
 with 0.9 mM O2 versus P formation and decay when 200µM CmlI
red
  
is mixed with 180 µM O2 and 2mM NH2-CAM .......................................................................... 105 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xv 
 
List of Schemes 
 
Scheme 2-1: Proposed mechanism for the first step in aryl-amine oxygenation by CmlI ............. 53 
 
Scheme 3-1. Two mechanistic hypotheses for aryl-amine oxygenation mediated  
by diiron cluster enzymes. ............................................................................................................. 58 
 
Scheme 3-2: Production of sample A from the reaction of CmlI
red
, O2, and NO-CAM ................ 61 
 
Scheme 3-3: Production of samples B and C from the reaction of CmlI
ox
 and NH(OH)-CAM .... 64 
 
Scheme 3-4: Production of samples D and E from the reaction of CmlI
red
, O2,  
and NH(OH)-CAM ........................................................................................................................ 67 
 
Scheme 3-5: Production of samples F and G via the reaction of CmlI
red
, O2, and NH2-CAM. ..... 70 
 
Scheme 3-6: Proposed single turnover reaction pathway of CmlI.. ............................................... 75 
 
Scheme 3-7: Comparison of oxygen incorporation into CAM via different pathways. ................ 78 
 
Scheme 4-1: Proposed schemes for the reaction of P with NH2-CAM. . ....................................... 89 
 
Scheme 4-2: Proposed scheme for the reaction of CmlI
red
 with NO-CAM.. ................................. 95 
 
Scheme 4-3: Proposed scheme for the reaction of CmlI
red
 with NO-CAM and O2. ...................... 95 
 
Scheme 4-4: Proposed scheme for the reaction of CmlI
red
 with O2 and NH2-CAM  
to form NH(OH)-CAM ................................................................................................................ 103 
 
Scheme 4-5: Proposed scheme for the reaction of CmlI
red
 with NH2-CAM and O2. ................... 104 
 
Scheme 4-6: Proposed scheme for the full cycle reaction of CmlI
red
 with NH2-CAM and O2 .... 104 
 
xvi 
 
Scheme 4-7: Proposed scheme for the reaction of CmlI
red
 with NH2-CAM and O2 
to form NO2-CAM. ...................................................................................................................... 110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xvii 
 
Abbreviations 
 
Δ9D, stearoyl-ACP Δ9 desaturase 
ADO, aldehyde deformylating oxygenase 
AT-L-pAPA, L-pAPA loaded covalently onto the thiolation domain of a CmlP (the NRPS) 
construct consisting of only the adenylation and thiolation domains 
AurF, N-oxygenase on the aureothin biosynthesis pathway 
BMM, bacterial multicomponent monooxygenases  
CmlI, N-oxygenase on the chloramphenicol biosynthesis pathway 
CAM, chloramphenicol 
CmlI
ox
, diferric CmlI 
CmlI
red
, chemically reduced diferrous CmlI 
EPR, electron paramagnetic resonance 
hDOHH, human deoxyhypusine hydroxylase 
HPLC, high performance liquid chromatography 
LCMS, liquid chromatography mass spectrometry  
L-pAPA, L-para amino phenylalanine 
MMOH, hydroxylase component of methane monooxygenase 
NH2-Ar, aryl-amine moiety  
NH2-CAM, D-threo-1-(4-aminophenyl)-2-dichloroacetylamino-1,3-propanediol 
NH(OH)-Ar, aryl-hydroxylamine moiety  
NH(OH)-CAM, D-threo-1-(4-hydroxylaminophenyl)-2-dichloroacetylamino-1,3-propanediol 
NH(OH)2-Ar, aryl-dihydroxylamine moiety  
NO-Ar, aryl-nitroso moiety  
NO-CAM, D-threo-1-(4-nitrosophenyl)-2-dichloroacetylamino-1,3-propanediol 
xviii 
 
NO2-CAM, chloramphenicol 
NRPS, nonribosomal peptide synthetase  
P, CmlI peroxo species 
pABA, para-aminobenzoate 
pAP, para-aminophenol 
pNA, para-nitroaniline 
Q, MMOH diferryl intermediate  
R2, subunit of RNR that contains a diiron cluster active site  
RNR, ribonucleotide reductase 
RRT, reciprocal relaxation time 
TMO, undefined toluene monooxygenase 
ToMO, toluene/o-xylene monooxygenase 
X, RNR R2 Fe(III)Fe(IV) intermediate 
 
 
 
 
 
 
 
 
1 
 
 
 
 
 
 
 
 
 
 
Chapter 1  
Introduction   
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Oxygen Activation in Biology 
The Role of Dioxygen in Biology 
Approximately 2.2 billion years ago Earth completed its Great Oxidation Event, in which 
ambient O2 levels rose from < 10
-5
 times the current atmospheric level.
1
 This precipitous increase 
in O2 resulted from the rise of photosynthetic organisms and the serendipitous concomitant 
decrease in the presence of reduced organic and inorganic species at the surface of the earth, 
where they could serve as O2 sinks.
2
 Organisms had two options for survival: retreat into anoxic 
environments, or evolve to mitigate oxygen toxicity while taking advantage of the molecule as a 
high potential redox couple. This evolutionary pressure resulted in the development of new 
biological pathways and novel enzymes that allowed for the expansion of the complexity of life.
3
 
In just one example of the awesome power of dioxygen metabolism, aerobic respiration is 
estimated to be sixteen times more efficient at generating ATP than anaerobic fermentation.
4
 
Today, dioxygen is one of the most utilized compounds in the set of chemical reactions that make 
life possible, its use surpassing even that of important biomolecules such as ATP and NAD
+
.
3
 
Dioxygen serves in two main roles, as a substrate to be incorporated into new products, and as an 
electron sink and an oxidizing agent to provide driving force for a chemical reaction. Often, it 
serves both roles at the same time.     
The Kinetics and Thermodynamics of O2 Activation  
 Activation of dioxygen allows the strong O-O bond to be broken, in preparation for 
separating the oxygen atoms and inserting one or both into a product. Moreover, it provides a 
driving force for some of Nature’s most thermodynamically uphill reactions. The potential for the 
complete reduction of dioxygen to two molecules of water is + 0.815 V (Table 1-1), which is 
thermodynamically very favorable. Fortunately, Nature has provided two stopgaps to prevent 
runaway spontaneous reduction of O2 and the concomitant oxidation of all organic molecules in 
its path. First, although the net four-electron reduction is energetically favorable, the first single 
electron reduction of O2 to O2
-
 is thermodynamically uphill at -0.33 V. Second, any attempt at a 
concerted two-electron transfer (thermodynamically downhill at +0.89 V) is kinetically throttled 
by the difference in spin states between dioxygen and organic molecules. Dioxygen has a triplet 
spin state whereas most organic molecules have a singlet spin state. The direct reaction between 
two species of differing spin state requires a spin flip or the conversion of one reactant to an 
3 
 
excited state with a different spin state, both of which are energetically unfavorable and have high 
activation barriers.  
 
Table 1-1: Standard reduction potentials for O2 in aqueous solution, pH 7, 25 °C. Values from ref 
5
. 
Reaction E°(V) vs. NHE 
O2 + e
-
 → O2
-
 -0.33 
O2
- 
+ e
-
 + 2H
+
 → H2O2 + 0.89 
H2O2 + e
-
 + H
+
 → H2O + OH +0.38 
OH + e
-
 + H
+
 → H2O +2.31 
O2
- 
+ 2e
-
 + 2H
+
 → H2O2 +0.281 
H2O2 + 2e
-
 + 2H
+
 → 2 H2O +1.349 
O2
- 
+ 4e
-
 + 4H
+
 → 2 H2O +0.815 
 
 Due to kinetic constraints, uncatalyzed reactions between O2 and organic substrates 
generally occur only via a free radical autoxidation. This process requires an initiator to generate 
the first organic radical species R·, after which the reaction can proceed in a chain reaction as 
long as O2 and the organic substrate are available. No spin inversion is required for the reaction of 
free radical R· and triplet oxygen, resulting in an efficient pathway that is both kinetically and 
thermodynamically feasible. However, free radical oxidation lacks specificity regarding both the 
substrates it oxygenates and the products it yields. Free radical oxidation can wreak havoc in the 
cell and is so damaging that biology has developed a host of defenses that arrest this process 
through trapping and neutralization of free radical species. This process presents the opposite 
problem of the spin state kinetic barrier: it happens too readily and without intention of action.  
The Role of O2-Activating Enzymes 
Oxidation thus poses a conundrum for biology: either the process is too slow for the pace 
of life or too indiscriminate so that it becomes destructive. As a solution, Nature has developed a 
wide variety of enzymes for which the role is to overcome or direct around these thermodynamic 
and kinetic barriers, while at the same time ensuring specificity. One such class of enzymes, 
metalloenzymes, use an active site containing one or more metal atoms to reductively activate 
dioxygen to produce one of the following oxidants: the superoxide (O2
1-
), the peroxide (O2
2-
) or 
the oxide (O
2-
). These enzymes overcome the initial -0.33 V barrier to transfer an electron to O2 
via a variety of strategies, including the use of reducing metal centers, the formation of a complex 
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between the metal center and the substrate(s), and controlling other redox-dependent properties 
such as solvent access and pH. In addition, the design of the enzyme active site ensures that 
oxidizing power of O2 is directed only to a specific site on a specific substrate.  
Diiron Oxygenases and Related Proteins   
Iron Containing Oxygenases and Related Proteins 
Iron is the fourth most abundant element in the earth’s crust, followed by oxygen, silicon, 
and aluminum. Given its high environmental availability and its ability to access a wide range of 
redox states, it is not surprising that Nature chose iron to populate many proteins that facilitate the 
reaction with dioxygen. The iron (II/III) redox couple has a low redox potential that allows it to 
interact with a variety of biological reductants to facilitate electron transfer and redox reactions.   
One way to categorize the increasingly numerous proteins that have an iron co-factor and 
dioxygen as a substrate is by the way the protein uses O2. By this division there are three 
categories: oxygen transport proteins, oxidase enzymes, and oxygenase enzymes. Oxygen 
transport proteins simply reversibly bind O2 for transport to respiring cells. For example, 
hemerythrin (Hr) is a diiron-cluster-containing protein found in invertebrates that binds O2 and 
converts it to the O2
2-
 form for transport.
6
 Oxidase enzymes use O2 as an electron sink to catalyze 
oxidation reactions. One example is stearoyl-ACP Δ9 desaturase (Δ9D), which uses the oxidizing 
power of O2 to desaturate fatty acids. The O2 is incorporated into two molecules of water that are 
produced concomitantly with the desaturation reaction.
7
 Finally, oxygenase enzymes incorporate 
O2 into the final product. Monooxygenase enzymes incorporate one atom of O2 into their product; 
for example, the conversion of methane to methanol is catalyzed by the diiron cluster enzyme 
soluble methane monooxygenase (sMMO).
8
 Dioxygenase enzymes incorporate both atoms of O2 
into the product. Homoprotocatechuate 2,3-dioxygenase, a monoiron containing enzyme, is one 
such example. This enzyme catalyzes the cleavage of the aromatic ring of its catechol substrate 
and inserts both atoms of oxygen into the muconic semialdehyde product.
9
 
The Biological and Chemical Landscape of Diiron Oxygenases 
Iron-containing oxygenases can be further distinguished by the type of iron cofactors 
present: heme monoiron, nonheme monoiron, and nonheme diiron cluster. Diiron-cluster-
containing oxygenases are the least well characterized of the three classes, though their popularity 
is growing as new chemical and biological functions are discovered. As a class, diiron 
5 
 
oxygenases facilitate so many different biological and chemical functions, across the bacterial, 
plant, and animal kingdoms, that functional diversity is almost a class hallmark. These enzymes 
play a role in a wide variety of biological processes, including the primary metabolism of 
methane by sMMO, control of eukaryotic cell proliferation by human deoxyhypusine hydroxylase 
(hDOHH), the biosynthesis of the antibiotic chloramphenicol by CmlA/I, and the generation of 
deoxyribonucleotides by ribonucleotide reductase (RNR). The range of biological functions is 
matched by the variety of chemistries these enzymes carry out, including hydroxylation of C-H 
bonds, the generation of radicals, desaturation, deformylation, and, the focus of this work, N-
oxygenation. A complete list of chemical and biological functions of known diiron-cluster 
containing oxygenases and related proteins is found in Table 1-2.      
Diiron oxygenases are characterized by two aspects: a diiron cluster in a carboxylate and 
histidine rich active site, and the ability to activate oxygen to perform a chemical reaction. Other 
unifying characteristics are increasingly shown to not be universal as more diiron enzymes are 
discovered and characterized. For example, sMMO houses its diiron cluster in a four α-helix-
bundle fold ligated by two histidine and four carboxylate amino acid residues. This fold and 
ligation was thought to be standard as it is shared by several diiron proteins, including the 
oxygenases sMMO and cyanobacterial aldehyde deformylating oxygenase (cADO), the oxidase 
stearoyl-ACP Δ9 desaturate (Δ9D), and the oxygen transport protein hemerythrin. However, the 
diiron oxygenases hDOHH and CmlA do not share the same protein fold or diiron cluster ligation 
as the canonical diiron oxygenases such as sMMO. Structural divergence in the diiron oxygenase 
class is accompanied by mechanistic differences, as is discussed below.  
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Table 1-2: Chemical and biological function of known diiron-cluster-containing proteins 
Protein Transformation Chemical Reaction Biological Function ref 
sMMO hydroxylation O2 + CH4 → CH3OH Central metabolism 
8
 
AlkB hydroxylation alkanes → alcohols Central metabolism 
10
 
TMOs hydroxylation 
 
Central metabolism 
11-13
 
CmlA hydroxylation 
 
Antibiotic biosynthesis 
14
 
hDOHH hydroxylation 
 
Cell proliferation 
15
 
Clk-1 hydroxylation 
 
Ubiquinone 
biosynthesis and 
mediation of the aging 
process 
16
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Protein Transformation Chemical Reaction Biological Function ref 
MiaE hydroxylation 
 
Posttranslational 
modification of tRNA, 
specific function 
unknown 
17
 
CmlI 
and 
AurF 
N-oxygenation 
 
Antibiotic biosynthesis 
18-19
 
RNR R2 
radical 
generation 
 
Synthesis of 
deoxyribonucleotides 
20
 
Δ9D desaturation 
 
Fatty acid metabolism 
7
 
Hr 
reversible O2 
binding 
 
O2 transport 
6
 
8 
 
Protein Transformation Chemical Reaction Biological Function ref 
cADO deformylation 
 
Unknown 
21
 
MIOX 
C-C bond 
cleavage 
 
Inositol metabolism, 
insulin regulation 
22
 
PhnZ 
C-P bond 
cleavage 
 
Phosphate metabolism 
23
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Aims in the Study of Diiron Oxygenases 
 Study of a particular metalloenzyme, diiron oxygenases included, balances two goals: 
one, to understand the chemical and biological function of the specific enzyme, and two, to 
elucidate structure-function correlations and generate mechanistic insight that can be extrapolated 
to the class of diiron enzymes as a whole.  In addition to the particular research goals, diiron 
enzymes are studied with two applications in mind. The first is to understand their biological 
function with an eye to either supplementing or inhibiting that function, as the application 
dictates. For example, the diiron enzyme hDOHH is upregulated in cancer cells and in cells that 
infected with HIV, so work on this enzyme focuses on developing methods of hDOHH 
downregulation to treat these diseases.
24
 A second example is cADO, found in the 
cyanobacterium Prochlorococcus marinus where it deformylates aldehydes into alkanes. The host 
(algae) and the product (drop-in ready alkane fuels) of this enzyme make it an ideal component of 
a biofuels production system.
25
 As such, mechanistic work focuses on optimization and 
upregulation.  
The second application aim is to understand how these enzymes perform their particular 
chemistries so that biomimetic complexes can be synthesized to serve as efficient and 
environmentally friendly catalysts. Most metalloenzymes function under ambient temperature and 
pressures, an ideal goal for synthetic catalysts from both an economics and a safety perspective. 
Furthermore, the reactions they perform are stereospecific and substrate specific, another 
important industrial requirement. This aim requires both understanding how the metal centers 
facilitate electron movement and bond making, as well as how the protein architecture 
surrounding the active site helps ensure specificity and efficiency. For example, sMMO has been 
studied for decades with the ultimate goal of generating complexes that can cheaply oxidize 
methane to methanol on an industrial scale. Similarly, enzymes involved in natural product 
biosynthesis are studied to learn new ways of synthesizing pharmaceuticals, chemical building 
blocks, and other essential molecules.  
 
Mechanisms of Dioxygen Activation by Diiron Oxygenases 
Proposed Mechanism for Dioxygen Activation based on sMMO Catalytic Cycle 
A consensus mechanism for oxygen activation and substrate oxidation by diiron 
oxygenases is based on the cycle of the most studied of the diiron oxygenases, sMMO. As shown 
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in Figure 1-1, activation begins when the diferrous cluster (MMO
red
, I) binds oxygen and forms 
via several steps a diferric peroxo (MMO
P
, II) species. The O-O bond in MMO
P
 is then cleaved 
to form a high valent diferryl closed core species called Q (III), which abstracts a H atom from 
the substrate to initiate the hydroxylation of the substrate C-H bond (IV).
26
 The cluster must be 
reduced by two electrons from the ending diferric state (MMO
ox
, V) to perform another turnover.  
On the cycle of RNR R2, the diiron-cluster-containing subunit of RNR, the high valent active 
oxidant is instead proposed to be a Fe(III)Fe(IV) open core species X.
27
 sMMO and RNR are the 
only two diiron enzymes with an identified high valent species that serves as the active oxidant, 
but the ubiquity of high-valent metal oxo oxidants in mononuclear iron enzymes, both heme and 
nonheme,
28-30
 led to the inaccurate conclusion that such oxidants were the invariable choice of 
oxidation reactions by iron-containing enzymes.  
 
 
Figure 1-1: Catalytic cycle of soluble methane monooxygenase. The diiron cluster is contained in the 
hydroxylase component of MMO. MMO contains two additional components, a reductase MMOR and an 
accessory protein that guides substrate access, MMOB. In vivo the reduction of MMO to prime O2 binding 
is facilitated by NADH2
+
 although in vitro the cycle can be primed by chemical reduction as well. Cycle 
adapted from refs. 
31-32
 
 
Peroxo Species Isolated from Diiron Oxygenases 
 Recent work has shown that the peroxo species, once thought to be exclusively the 
precursor to the real oxidant workhorse, may in fact be the active oxidant in many diiron 
oxygenase cycles. While high valent metal oxo species have been studied in depth over the past 
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two decades, the importance of diferric peroxo species as more than a means to the end has only 
emerged in the past five years. That diferric peroxo (P) species have been overlooked as oxidants 
in their own right is not surprising given the types of P species found in the classical diiron 
oxygen activating enzymes, sMMO, RNR R2, and Δ9D. Due to the short half-life of MMOP, (0.3 
– 11 s, depending on sMMO bacterial source),33,34 characterization is limited to UV-vis and 
Mössbauer spectroscopy (see Table 1-3 for a compilation of known diiron peroxos and their 
spectroscopic parameters). MMO
P
 is overshadowed by interest in Q, which does the impressive 
job of breaking an 104 kcal/mol bond to convert methane into methanol.
35
 MMO
P
 is not capable 
of oxidizing methane or other strong C-H bonds, but can oxidize some electron-rich substrates.
36
 
The structure of MMO
P
, described by the binding mode of O2, is proposed to be cis µ-1,2 (Figure 
1-2) based on theoretical calculations and comparison of spectroscopic parameters to those of 
crystallized synthetic complexes (vide infra).
37
  Peroxo species have also been observed in the 
enzyme toluene/o-xylene monooxygenase (ToMO), which falls into the diiron oxygenase 
subclass bacterial multicomponent monooxygenases (BMM) with MMO. ToMO
P
 isolated from 
wild type ToMO is a short-lived (t1/2 ~ 15 s) diferric species that appears to be active towards 
arene substrates, but is identified only by Mössbauer spectroscopy, with no corroborating 
spectroscopic data (not even UV-vis, curiously ToMO
P
 has no optical signature).
38
 The 
Mössbauer parameters significantly differ from those observed for MMO and other cis µ-1,2-
diferric peroxos, and the structure remains unknown. An inactive mutant form T201S ToMO
P
 has 
also been generated, and the spectroscopic signatures of this species match those of MMO.
39
  
 The peroxo species of RNR R2 (RNR
P
) is also short lived, though a double mutation of 
an iron ligand and a surface residue responsible for electron transfer (W48F/D84E) yielded a 
longer-lived species that has been more extensively characterized. The longer lifetime allowed for 
resonance Raman studies which also characterized this P species as cis µ-1,2 peroxo.
40-42
 A P 
species is isolated in Δ9D when the enzyme is pre-incubated with substrate prior to O2 addition.  
Δ9DP is long lived (half-life ~ 30 min at 25 °C), allowing a suite of spectroscopic techniques to be 
applied in its characterization. UV-vis, Mössbauer, and resonance Raman spectroscopies 
indicated a cis µ-1,2 binding mode. However, Δ9DP  is not active; in the presence of substrate, it 
undergoes autodecay to yield two equivalents of water instead of performing its native desaturase 
reaction. 
43
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Figure 1-2: Cis-μ-1,2-diferric peroxo geometry. 
  
The results of analysis of P species from the three classic diiron enzymes suggested: first, 
that diiron peroxo intermediates universally assume the cis µ-1,2 O2 binding mode, and second, 
with the possible exception of the putative wild type ToMO
P
, they are not oxidants on the native 
catalytic cycles. This paradigm was first definitively broken in 2009, with the discovery of a 
hyperstable (t1/2 > 24 h at room temperature) cis µ-1,2 peroxo species from hDOHH that reacts 
directly with substrate and therefore is presumed to be the active intermediate.
15, 44
 This enzyme 
further broke the mold with a HEAT repeat fold and 4-his 2-carboxylate diiron cluster ligation.
45
 
In 2013, another example of a diferric peroxo serving as the active oxidant was reported. This 
peroxo species, on the cycle of cADO, was spectroscopically characterized as a peroxy-
hemiacetal species, or a diferric peroxo bound to substrate.
46
    
 Geometric assignments of enzymatic P intermediates are largely based on the comparison 
of their spectroscopic parameters to those of crystallized synthetic P species. There are four 
synthetic diferric peroxo species that have been crystallized and spectroscopically characterized 
(Table 1-3). These complexes are built with N and O rich ligands to mimic the histidine and 
carboxylate rich active sites of the enzymes, and all are symmetric with a cis µ-1,2 O2 binding 
mode. These synthetic complexes have been extensively spectroscopically characterized, giving a 
set of spectroscopic parameters to which enzymatic P species can be compared. However, these 
biomimetic synthetic peroxos are fairly stable and unreactive, and therefore do not provide much 
insight into the mechanism of oxidation by a P species.  
In addition to the crystal structures of synthetic diferric peroxo intermediates, three 
crystal structures for enzymatic P species have been published: hDOHH,
45
 T4MO,
47
 and CmlI.
48
 
The hDOHH crystal structure confirms the cis µ-1,2 O2 binding mode earlier determined by 
resonance Raman studies, although the Fe-Fe bond distance in the structure suggests that the 
crystallized enzyme may have been cryoreduced by the x-ray beam, and so the specific distances 
should be viewed with some skepticism. Crystals of T4MO
P
 were prepared by soaking crystals of 
diferric T4MO in H2O2, and the resulting O2 binding mode is cis-µ-1,2. T4MO is active via the 
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peroxide shunt, though the reaction is ~600 times slower than that carried out with the native 
biological reductants and O2. This lower reactivity suggests that the H2O2-generated T4MO
P
 may 
not be a native active species. The crystallized CmlI P also shows a cis µ-1,2 O2 binding mode, 
but the species does not react with substrate and consequently is not thought to be the active or 
native peroxo. Of the three crystallized enzymatic P species, only hDOHH
P
 is shown to be active 
on the native cycle. The high stability and low reactivity of many of the cis µ-1,2 P species, both 
synthetic and enzymatic, combined with new evidence that enzymatic P species are, on some 
cycles, the active oxidant, suggest that this geometry may not be the active species. 
 
Diferric Peroxo Species Produced by CmlI 
 In 2015, Lipscomb and coworkers published the first report of a unique P species from 
the newly discovered diiron enzyme CmlI. CmlI
P
 is the active oxidant on the enzymatic cycle and 
its unique spectroscopic features suggest a completely new O2 binding mode. In addition, CmlI
P
 
can be prepared in way that renders it highly stable in the absence of substrate while maintaining 
reactivity in the presence of substrate, thus enabling spectroscopic and mechanistic 
characterization, respectively. The study of CmlI
P
, and the overall CmlI mechanism, represents a 
unique opportunity to begin to understand the role of diferric peroxos beyond a simple conduit to 
a high valent oxidant. In addition, the novelty of the enzyme CmlI extends beyond its unusual 
oxidant to also include the chemical transformation it directs, as discussed in the next section.   
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Table 1-3: Spectroscopic parameters and proposed structure of enzymatic diiron peroxos and crystallized synthetic peroxos.  
Species λmax, nm 
(ε, mol-1 cm-1) 
δ, mm/s 
(ΔEQ, mm/s) 
ν (O-O) cm-1 Proposed structure Ref(s) 
MMOH
P
 M. capsulatus (Bath) 420 (4000), 725 
(1800) 
0.66 (1.51)  cis μ-1,2 34 
MMOH
P
 M. trichosporium 
(OB3b) 
700 (2500)   cis μ-1,2 33 
ToMO not observed 0.54 (0.67)   
38
 
T201S ToMO 675 (1500) 0.67 (1.51)   
39
 
Δ9DP 700 (1100) 0.68 (1.90), 0.64 (1.06) 898 cis μ-1,2 
43, 49
 
RNR R2
P
 (mouse) 700 (1500) 0.63 (1.74)  cis μ-1,2 
50
 
W48F/D84E RNR R2
P
 (E. coli) 700 (1800) 0.63 (1.58) 870 cis μ-1,2 
41, 51
 
cADO
P
 450 (1200) 0.48 (0.49), 0.55 (1.23)  μ-η
2
-η2 or peroxoyhemiacetal 46 
CmlI
P
 500 (500) 0.62 (-0.23), 0.54 (-0.68) 791 μ-η
1
-η2 or μ-η2 52 and this 
work 
AurF
P
 500 (500) 0.54 (-0.66), 0.61 (0.35)   
53
 
hDOHH
P
 630 (1500) 0.55 (1.16), 0.58 (0.88) 855 cis μ-1,2 
15
 
Fe2(Ph-BIMP)(O2)(O2CPh)
2+
 500 – 800 (1700) 0.58 (0.74), 0.65 (1.70)  cis μ-1,2 
54
 
Fe2(N-Et-hptb)(O2)(OPPh3)2
3+
 588 (1500) 0.52 (0.72) 900 cis μ-1,2 
55-56
 
Fe2(Tp
iPr2
)2(O2)(CO2CH2C6H5)2 694 (2650) 0.66 (1.40)  cis μ-1,2 
57
 
Fe2(6Me2-BPP)2(O2)(O)
2+
 644 (3000) 0.5 (1.31), 0.5 (1.46) 847 cis μ-1,2 
58
 
 
15 
 
N-oxygenase Enzymes  
Nitro-Containing Natural Products 
 There are over 200 known nitro-containing natural products, and those that have been 
functionally characterized show a promising array of antibiotic, antifungal, and cytostatic 
properties.
59
 The correct incorporation of the nitro group is essential for function. In the past 20 
years, the gene clusters aryl-nitro-containing natural products have been mapped, but the method 
by which the aryl-nitro moiety is synthesized is not well understood. The nitro group may be 
incorporated into a natural product either by direct nitration or by oxidation of an amine 
precursor. Enzymes that facilitate the latter transformation are known as N-oxygenase enzymes, 
and known members of this class are shown in Table 1-4. All contain some type of redox active 
co-factor, and several identified employ nonheme iron for that purpose.   
 
Biosynthesis of Chloramphenicol, an Aryl-Nitro-Containing Natural Product 
 Chloramphenicol is perhaps the best studied aryl-nitro-containing natural product, on 
account of its commercial availability as a broad spectrum antibiotic used to treat a wide variety 
of bacterial infections. The mechanism of action is arresting protein synthesis by binding to the 
peptidyl transferase center of the 50S ribosomal subunit.
60
  First prescribed in 1948, its use today 
is restricted to serious cases in which other antibiotics have failed due to toxicity of 
chloramphenicol in the form of aplastic anemia and bone marrow suppression. However, there is 
resurgent interest in chloramphenicol due to its wide efficacy in light of the global antibiotic 
resistance crisis.
61-62
 In addition, the general interest in natural products has brought this and other 
naturally derived antibiotics back into the research sphere. 
 Chloramphenicol is synthesized in Streptomyces venezuelae by the non-ribosomal 
peptide synthetase (NRPS) CmlP and associated tailoring enzymes. A biosynthetic scheme is 
shown in Figure 1-3, although the exact order of the tailoring reactions in the later stages of 
synthesis is not definitively determined.
63-65
 CAM biosynthesis begins with a derivative of the 
shikimate pathway, a metabolic route used by bacteria and fungi for the assembly of aromatic 
metabolites. The resultant p-aminophenylalanine is modified by a non-ribosomal peptide 
synthetase (NRPS) system and several tailoring enzymes, of which CmlI is the last. There are two 
diiron oxygenases present on this pathway; β-hydroxylase CmlA, which is responsible for 
hydroxylating CmlP-bound p-aminophenylalanine midway through the biosynthetic pathway, and 
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CmlI, which is an N-oxygenase that does the last step in chloramphenicol biosynthesis and acts 
on the free, not CmlP-bound, precursor.   
 
Figure 1-3: Chloramphenicol biosynthetic pathway based on refs. 
63, 65
  
 
N-oxygenases with Nonheme Iron Co-factors 
 There are only three N-oxygenases shown to do the full six-electron conversion of an 
amine precursor to the nitro-containing final product, all of which utilize iron cofactors. Two of 
these enzymes employ a diiron cofactor: AurF acts on a precursor of the antimicrobial natural 
product aureothin, catalyzing the oxidation of aminobenzoate to nitrobenzoate,
18
 and CmlI 
performs the last step in the biosynthesis of the antibiotic chloramphenicol (CAM).
63
 The third 
six-electron N-oxygenase is PrnD, which utilizes a monoiron cofactor in conjunction with a 
Rieske cluster, and catalyzes the final step in the biosynthesis of the antifungal natural product 
17 
 
pyrrolnitrin.
66
 Not much is known about how these enzymes catalyze the full six-electron 
oxidation of their respective aryl-amine substrates and the reaction is especially puzzling given 
that these types of enzymes can generate oxidants that can catalyze, at most, a two electron 
oxidation.  
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Table 1-4: Known N-oxygenase enzymes: source organism, function, and redox co-factor.  
Name Organism Reaction Co-factor Ref 
AurF Bacterial:  
Streptomyces thioluteus 
 
diiron 67 
RHAI 
 
Bacterial:  
Rhodococcus jostii 
 
 
diiron 
68
 
PsAAO Bacterial:  
Pseudomonas syringae 
 
diiron 
69
 
CmlI Bacterial: 
 Streptomyces venezuelae 
 
diiron 19 
PrnD Bacterial:  
Pseudomonads 
 
monoiron Rieske 66 
19 
 
Name Organism Reaction Co-factor Ref 
NocL 
Bacterial:  
Nocardia uniformis 
 
P450 
70
 
KijD3 
 
Bacterial:  
Actinomadura kijaniata and 
Micromonospora chalcea 
 
flavin 
71
 
Senecionine    
N-oxygenase 
(SNO) 
Plant:  
Crotalaria scassellatii 
Insect:  
haemolymph of specialized 
insects (i.e. Arctiids, 
Lepidoptera) 
 
flavin 
72
 
Flavin 
monooxygenase 
(hFMO) 
Human 
 
flavin 
73
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Diiron Cluster Containing N-oxygenases 
 In 2004 Hertweck and coworkers discovered an unusual enzyme on the biosynthetic 
pathway of the metabolite aureothin.
18
 Aureothin is a natural product produced by the soil 
bacterium Streptomyces thiolutues, and contains an aryl-nitro moiety.
74
 Analysis of the gene 
cluster did not reveal any genes correlating to enzymes known to do nitro insertion reactions, nor 
standard redox enzymes that might perform an oxidation. Gene deletion mutants and subsequent 
product assays revealed the responsible enzyme, named AurF, was indeed an “N-oxygenase” 
rather than a nitration enzyme.
18
 AurF is part of a polyketide synthetase system in which it 
catalyzes a mid-pathway reaction, the conversion of p-aminobenzoate to p-nitrobenzoate. In 2006 
Zhao and co-workers showed that AurF was metal-cofactor dependent and likely part of the 
diiron oxygenase family.
75
 Although there was for a time a debate in the literature about whether 
AurF was perhaps a dimanganese enzyme,
76-77
 it has been shown since, via both crystal structure 
and activity assays, that AurF contains a diiron cofactor.
78
  
In 2012 Zhao and coworkers isolated a putative oxidase from the chloramphenicol 
biosynthesis pathway called CmlI, and showed that this enzyme too is a diiron N-oxygenase. 
CmlI is the ultimate enzyme on the chloramphenicol biosynthesis pathway found in the soil 
bacterium Streptomyces venezuelae, where it converts D-threo-1-(4-aminophenyl)-2-
dichloroacetylamino-1,3-propanediol (NH2-CAM) to the final chloramphenicol (CAM) product. 
Discovery of CmlI as a diiron enzyme was made possible by the elucidation of the CAM 
biosynthesis pathway, largely undertaken by Vining and co-workers (Figure 1-3).  
 There exist a small handful of additional diiron N-oxygenases that have been isolated for 
initial characterization.  These include RHAI and PsAAO, which were identified in 2011 and 
2015, respectively, by in-silico search for AurF gene homologs.
68-69
 The sequence identity to 
AurF for RHAI and PsAAO are 38% and 25%, respectively, and both are adjacent to the gene for 
a putative NRPS. RHAI was isolated from the soil bacterium Rhodococcus jostii, and PsAAO 
was isolated from the plant pathogenic bacterium Pseudomonas syringae. The absorption 
spectrum of the purified enzymes are consistent with that of the diferric state of a diiron 
oxygenase, but no other structural or spectroscopic data is available. The native substrate for 
RHAI is proposed to be p-aminobenzoate, although in vitro the enzyme shows preference for 
aminophenol substrates. The true substrate for PsAAO is also unknown, although it is presumed 
to be a relatively small substituted aryl-amine, as the enzyme shows preference for 5’-substituted 
aminophenols.  
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 Protein blast searches show that there are likely hundreds of additional AurF and CmlI 
homologs. Those that have been characterized so far are present in soil bacteria and/or plant 
pathogenic bacteria, and are associated with polyketide synthase or non-ribosomal peptide 
synthetase operons. 
18, 68-69
 This finding indicates that diiron enzymes play a significant role in 
natural product biosynthesis. 
 
Structural Characteristics of CmlI and AurF 
 CmlI and AurF are part of the ferritin-like superfamily of diiron proteins, the 
characteristics of which include a diiron cluster located inside a four α-helix bundle, and histidine 
and carboxylate metal center ligands.  CmlI is a homodimer made up of two 10 α-helix 
monomers, and has a 22 Å separation between the diiron clusters housed in each monomer 
(Figure 1-4A). CmlI has been crystallized in the diferric and diferrous forms as CmlIΔ33, an N-
terminally truncated form of CmlI that shows the same activity as the wild-type enzyme. 
Crystallization of wild type CmlI was not successful.
48
 The crystal structures of AurF are quite 
similar with those of CmlI, reflecting the 37% sequence identity between the two proteins and the 
identification of the two as homologs. Wild type AurF has been crystallized in the diferric resting 
state
67, 78
 and in complex with its product p-nitrobenzoic acid.
78
  
 The active sites of AurF and CmlI nearly overlay, both containing a diiron cluster ligated 
by three histidine and four carboxylate residues (Figure 1-4C). Drawing conclusions based on 
structural differences between the two active sites as shown in their respective oxidized crystals is 
not straight forward, as it is likely that the CmlI structure is of a form that is not catalytically 
active. However, the major difference observed in these two structures is the position of 
Glu236/227. In AurF E227 is bound bidentate to a single Fe atom while in CmlI E236 is swung 
out to bridge between the two iron atoms and occupy the space where in AurF there exists a 
single atom bridge. The CmlI crystal structure does not show any oxo bridge between the two 
iron atoms. However, the spectrum of diferric CmlI in solution includes an UV-vis absorption 
band with a shoulder at ~375 nm, a feature characteristic of such a bridge and ascribed to a 
Fe(III)-O charge transfer band in diiron proteins such as Hr and CmlA.
79
 Furthermore, XAS 
analysis of CmlI shows a solvent-derived bridge in the diferric and diferrous forms of the enzyme 
(unpublished data). Thus, the rotation of E236 in CmlI (relative to its corollary’s position in 
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AurF) may be an artifact of crystal packing, or it may represent an alternative conformation 
related to the regulation of oxygen activation in the system.  
 
 
Figure 1-4: Crystal structure of CmlIΔ33. A, structure of one monomer of the homodimer CmlI showing 
the diiron center surrounded by 10 α-helices. The dotted line indicates a disordered set of residues between 
K52 and F62. Protein ligands are located on helices α2, α3, α5, and α6. B, the CmlI dimer with iron atoms 
shown in orange. C, Overlay of the active sites of CmlI (grey) and AurF (green). The solvent-derived 
bridge observed in the AurF structure is shown as a red sphere. The iron atoms are shown as orange spheres 
(CmlI) or green spheres (AurF). Adapted from ref. 
48
 PDB: 5HYH. 
 
Mechanisms of N-oxygenation Mediated by Nonheme Iron 
Oxygenases 
General Mechanism for Enzymatic N-oxygenation  
Synthetic work on the conversion of an amine substituent into a nitro species has focused 
on the reverse reduction reaction carried out by electrochemistry. Early work defined the six 
electron reduction reaction as three successive two-electron transfers to form first a nitroso or 
dihydroxylamine intermediate, followed by a hydroxylamine and finally the amine.
80-82
 The 
proposal for the oxidation mechanism is simply the reduction mechanism in reverse (Figure 1-5).  
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Figure 1-5: Basic scheme for the six electron oxidation of an aryl-amine to an aryl-nitro species. The four 
electron oxidized species may be either a nitroso or a dihydroxylamine species, and the two may be 
interconvertible depending on the reaction conditions.  
 
Product Analysis-Based Investigations into Biological N-oxygenation 
Investigation into the mechanism of N-oxygenase enzymes began in the mid-2000s by 
natural product chemists who were interested in the unusual properties and structures of aryl-nitro 
molecules. As such, the characterization of the cycle began with the identification of the small 
molecule intermediates between the aryl-amine and aryl-nitro species. The first intermediate on 
the cycle, aryl-hydroxylamine, is the logical two electron oxidized postcursor of an aryl-amine. 
Hydroxylamine has been identified as the first intermediate in the cycles of AurF,
75, 83
 CmlI,
19
 and 
PrnD,
84
 both by isolation of the compound from the native reaction and by direct reaction of aryl-
hydroxylamine with the purified enzyme.  
 A second two electron oxidation would yield either an aryl-nitroso or aryl-
dihydroxylamine species, both of which have been proposed as the second intermediate.
75, 84-85
 
Analysis of this step is complicated by the reactivity of both candidates. Dihydroxylamines are 
unstable in aqueous solution and have yet to be isolated in any N-oxygenase reaction. This 
species is proposed based on process of elimination and failure to observe an aryl-nitroso species 
in a particular reaction. Aryl-nitroso species are more stable, but are prone to dimerize to form 
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azoxy species, and are the decay product of aryl-hydroxylamines under acidic conditions.
83, 86
 
Thus, care must be taken with the reaction workup to identify the correct intermediate. Failing to 
isolate the aryl-nitroso intermediate as part of the reaction, as some research groups report, only 
indicates that the intermediate does not accumulate under their specific reaction conditions, not 
that it does not form.  
Analysis of only the small molecules would not eliminate the possibility that both 
proposals are correct, i.e. that aryl-dihydroxylamine is formed first, by oxygenation, followed by 
a dehydration to form the nitroso. A clever study by Zhao and co-workers sought to differentiate 
between these possibilities (Figure 1-6). They added unlabeled NH
16
OH-benzoate to a vial of E. 
coli over-expressing AurF under an 
18
O2 atmosphere.
75
 If the reaction proceeded through a 
dihydroxylamine followed by a dehydration, the resulting product should be a mix of N
18
O2-
benzoate and N
18
O
16
O-benzoate. However, only the latter was observed, indicating the absence of 
a dehydration step to remove the original 
16
O. Thus, simple product analysis supports the 
hypothesis that diiron enzymes convert aryl-amines to aryl-nitros via aryl-hydroxylamine and 
aryl-nitroso intermediates, with no interceding aryl-dihydroxylamine. However, other researchers 
maintained that aryl-nitrosos are not part of the pathway and so the scientific debate as to the 
correct pathway for N-oxygenation continued.
85
  
 
 
Figure 1-6: Experimental determination of the four electron oxidized intermediate on the pathway to the 
nitrobenzoate product as catalyzed by AurF. The reaction begins by adding hydroxylamine benzoate to a 
degassed vial of AurF-expressing E. coli, followed by the addition of 
18
O2. If dihydroxylamine benzoate is 
on the pathway, then the final products should be a mixture of N
18
O2-benzoate and N
18
O
16
O-benzoate (top 
pathway). If no aryl-dihydroxylamine is present, then the product should be only and N
18
O
16
O-benzoate 
(bottom pathway). The latter case was observed experimentally.  
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Role of the Diiron Cluster in Biological N-oxygenation  
 Studying the N-oxygenation mechanism purely from the organic substrate point of view 
is restrictive due to the instability of the intermediates and the limited number of analytical 
methods available. Being able to follow the concurrent changes in the diiron cluster as the 
reaction progresses provides a whole new view into the cycle. In particular, isolating the active 
species in the diiron N-oxygenation reactions opens up many experimental possibilities. 
The explicit role of the diiron center in N-oxygenation was not thoroughly investigated 
until the active oxidant was isolated in the diiron reaction, reported in 2009 for AurF
53
 and in 
2015 for CmlI.
52
 In both cases the active oxidant appears to be a diferric peroxo species for which 
the spectroscopic features differ from the canonical diferric peroxos of MMO, RNR, and 
hDOHH. These unusual intermediates have a broad Fe(III) – O MLCT band extending from the 
UV out to 600 nm, and an orange color when concentrated to the mM regime. The unique 
electronic features translate to a new type of structure for diferric peroxos.  In addition, both 
peroxo intermediates have long half-lives, CmlI
P
 particularly so. At 4 °C the half-life of CmlI
P
 is 
~3 hours (pH 9, 50 mM Bicine) while the half-life of AurF
P
 is 7 min, reported at room 
temperature (20 °C, pH 7.5, 50 mM HEPES). It is presumed the two species might have similar 
half-lives if generated under the same conditions, given the structural similarity of the protein and 
the nearly identical spectroscopic features of the P species.  
A diferric peroxo species is a two electron oxidant, so initial hypotheses proposed a three 
sequential oxidation mechanism, where three consecutive P species facilitate the six-electron 
transfer required for the aryl-amine to aryl-nitro conversion (Figure 1-7, I). In 2011 Bollinger and 
co-workers endeavored to track the diiron cluster by Mössbauer as it proceeded through the N-
oxygenation cycle.
85
 AurF
P
 is relatively long lived and accumulates to detectable concentrations, 
and so at least three states of the diiron cluster can be distinguished by Mössbauer: diferric, 
diferric peroxo, and diferrous. As a result of this study, a new type of mechanism for N-
oxygenation was proposed that invoked an organic substrate-based reductant mid cycle. In 
summary, the reaction proceeds as follows (Figure 1-7, II): the first two steps are identical two 
electron oxidations by AurF
P
 to yield the aryl-hydroxylamine and aryl-dihydroxylamine in 
succession. In the last step, the aryl-dihydroxylamine acts as a reducing agent to reduce the AurF 
diferric cluster to diferrous, while itself being oxidized to the final aryl-nitro product. Thus, the 
cycle ends with the enzyme already primed to accept O2 to form AurF
P
 for the next turnover.  
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This new mechanism provided new insight into the role of the diiron cluster in multi-
electron oxidation reactions, but many questions remained. Does the substrate stay in the active 
site for the entire reaction, or does it leave after the first AurF
P
 is “spent” to find another AurFP 
for the second oxidation? Is dihydroxylamine really the four electron oxidized organic 
intermediate, or is nitroso just not accumulating to detectable levels? Are all of the O2 atoms 
derived from the AurF
P
 species (and therefore from O2) or do one or both come from water? And, 
is this a consensus mechanism for diiron N-oxygenation, or an anomaly specific to AurF?  
 
 
Figure 1-7: Two proposed mechanisms for the six-electron oxidation of an aryl-amine substrate to an aryl-
nitro product, mediated by a diiron-cluster-containing oxygenase. Adapted from ref.
85
 
 
Elucidating the mechanism of N-oxygenation by CmlI provides the opportunity to 
answers all of these questions, and in additional insight into the complex regulatory mechanisms 
utilized by this enzyme. On a surface level, CmlI is an additional data point that allows us to 
determine if substrate-based reduction is anomalous or a characteristic of the class. In addition, 
the long half-life of CmlI
P
 makes possible many experimental procedures and investigations that 
would not be available with a shorter lived intermediate, such as that in AurF, and provide deep 
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mechanistic insight. For example, it has allowed the first steps of the cycle to be performed under 
one isotope of O2, followed by an exchange of the atmosphere to complete the cycle with a 
different type of O2. In this way, the source of each O2 atom incorporated into the product can be 
tracked separately. These results are reported in Chapter 3. It has allowed spectroscopic 
investigation of this species in solution, as seen in the resonance Raman characterization in 
Chapter 2. It has also allowed extensive stopped flow experiments in which the order of addition 
of the various substrates can be varied, as seen in Chapter 4.       
 
Aim and Scope of the Thesis 
 CmlI is a new entry into the diiron cluster-containing oxygenase canon in both the 
transformation it performs and in the type of oxidant it uses to carry out its chemistry. 
Furthermore, the presence of a diiron oxygenase in a natural product biosynthesis pathway 
represents a new role in biology for this class of enzymes. The discovery and isolation of the 
enzyme CmlI has allowed for several avenues of research that can enhance our understanding of 
the chemistry and the biological role of diiron cluster-containing oxygenases.   
 The aim of this thesis is to take advantage of the unique oxidant CmlI
P
 to study various 
aspects of N-oxygenase and diiron oxygenase chemistry, and to broaden the understanding of O2 
activation by iron containing enzymes. One aim was to answer the specific mechanistic questions 
left by the work on AurF, detailed in the previous section, with the goals of understanding 
biological N-oxygenation and multi-step oxidations performed by diiron enzymes. A second goal 
was to characterize the structure and reactivity of CmlI
P
 with an eye towards expanding the 
understanding of the role of diiron peroxo intermediates in diiron oxygenase chemistry.  
This thesis begins in Chapter 2 by characterization of the active oxidant CmlI
P
 as well as 
the diferric and diferrous forms of the enzyme, and of the reactivity of the CmlI enzyme towards 
native and non-native aryl-amine substrates. Chapter 3 undertakes a detailed mechanistic study 
built on spectroscopic characterization of enzyme and substrate based intermediates along the six 
electron oxidation pathway, and proposes a new and highly efficient mechanism for this six 
electron transformation. Chapter 4 expands the mechanistic study with kinetic analysis of each 
section of the CmlI single turn-over cycle, demonstrates the importance of substrate binding order 
on the enzyme function, and proposes a kinetic model that supports and expands on the 
mechanism proposed in Chapter 3. Chapter 5 provides detailed methods for all of the experiments 
performed in the previous chapters, including biological, analytical, and spectroscopic methods.   
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Chapter 2  
 
Reactivity and Characterization of CmlI Peroxo Intermediate, 
the Active Oxidant in the Catalytic Cycle of CmlI 
 
 
 
 
Portions of this chapter are reprinted and adapted with permission from: Thomas M. Makris, Van 
V. Vu, Katlyn K. Meier, Anna J. Komor, Brent S. Rivard, Eckard Münck, Lawrence Que, Jr., and 
John D. Lipscomb. “An Unusual Peroxo Intermediate of the Arylamine Oxygenase of the 
Chloramphenicol Biosynthetic Pathway” J. Am. Chem. Soc., 2015, 137, 1608-1617. Copyright 
2015 American Chemical Society. 
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Introduction 
Carboxylate-bridged diiron cluster-containing monooxygenases catalyze an extraordinary 
array of chemical reactions, including the oxidation of aliphatic C–H bonds for carbon 
utilization,
87
 antibiotic biosynthesis,
78, 88
 the maturation of proteins involved in cell proliferation,
89
 
and the post-translational modification of tRNA,
17
 among many others.  Studies of oxygen 
activation in diiron hydroxylase enzymes and functional mimics have revealed that the most 
common mechanism for dioxygen activation in this class of enzymes involves the initial binding 
of O2 to the reduced diferrous cluster, resulting in the formation of a peroxodiferric metal-oxygen 
adduct.
90-92
  Subsequent to formation of this initial complex, the reactivities of diiron oxygenases 
diverge.  In some cases, the peroxo intermediate is thought to directly participate in the oxidation 
of weak C–H bonds; 93 in others, it is known to undergo O–O bond cleavage to form a high-valent 
metal-oxo adduct that can transfer oxygen to inert hydrocarbons.
94-96
  The peroxo intermediate is 
also the precursor of species involved in radical formation in ribonucleotide reductase (RNR),
97-98
 
and thought to be involved in desaturation reactions by fatty acid desaturases.
99
 Therefore, studies 
of the electronic structures and reactivities of diiron peroxo intermediates are of central 
importance in understanding catalysis by a large number of diverse biological systems.  
The reactive nature of diferric-peroxo intermediates often prohibits accumulation to 
concentration levels that permit structural interrogation.  As a result, a thorough spectroscopic 
and structural study that can successfully address the O2 coordination mode has been limited to a 
handful of diiron enzymes in which the Fe2O2 unit is unusually long-lived.  In each of these cases, 
including the D84E/W48F mutant of RNR,
40, 92, 100
 fatty acid Δ9 desaturase (Δ9D),99, 101 and 
deoxyhypusine hydroxylase (hDOHH), 
89
 dioxygen has been shown to bridge the two iron atoms 
in a -η1:η1 coordination mode. Accordingly, the optical spectrum of the peroxodiferric 
intermediate in these enzymes has been shown to exhibit an intense (ε > 1000 M-1cm-1) charge 
transfer band with λmax between 600 and 700 nm, similar to intermediates observed in transient 
kinetic studies of methane monooxygenase
102
 and biomimetic model complexes. 
54, 56-57, 103-104
 
Despite the uniformity of the dioxygen binding mode observed for the spectroscopically 
characterized peroxodiferric intermediates, the possibility of alternative coordination geometries 
has been raised based on the distinct spectroscopic properties, primarily optical and Mössbauer, 
observed in transient intermediates of toluene/o-xylene monooxygenase (ToMO),
38, 105
 para-
aminobenzoate N-oxygenase (AurF), 
53, 85
 aldehyde deformylating oxygenase (ADO)
46
 and the 
ribonucleotide reductase variant W48A/Y122F.
106
  In contrast to the canonical -η1:η1 peroxo 
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intermediates, these diferric intermediates do not exhibit the optical signature band at ~700 nm, 
and instead show either no apparent optical absorption (e. g. ToMO), or a weaker (ε ≤ 500 M-1 
cm
-1
) feature at shorter wavelength (450-500 nm; e.g. ADO, AurF, and RNR W48A/Y122F).    
Mössbauer spectroscopy similarly suggests that the O2 binding mode of these species may indeed 
deviate from -η1:η1 coordination, as suggested by a significant decrease in quadrupole splitting 
(ΔEQ ≤ 0.7 mm/sec) when compared to corresponding values (ΔEQ > 1 mm/sec) in peroxo 
intermediates that display the 700 nm band.  Despite the marked discrepancy of the spectroscopic 
features of these peroxo intermediates versus those of the structurally characterized -η1:η1 
peroxodiferric complexes, the direct demonstration of an alternative peroxo ligand geometry has 
not been obtained in any dinuclear iron enzyme.  In contrast, a variety of alternative binding 
modes, including the -η2:η2 or -η1:η2, have been observed in dicopper cluster-containing 
enzymes and heteronuclear heme iron:copper model complexes, suggesting that they may also be 
found in diiron cluster-containing systems.
89, 92, 99, 107-116
 
Arylamine oxygenases are a recently characterized class of diiron oxygenases involved in 
the biosynthesis of a nitroaryl moiety in a number of antibiotic pathways, including aureothin 
18, 75
 
and chloramphenicol. 
19, 117
  This enzyme family, exemplified by AurF from the aureothin 
biosynthetic pathway, has been shown to catalyze nitro group formation through the six-electron 
oxidation of an amine precursor.  This process may involve intermediary hydroxylamino-, 
dihydroxylamino-, and nitroso-oxidation products, although only the hydroxylamino derivative 
has been shown to be metabolized when used as an initial substrate in the case of AurF.
75, 85
  
Studies have now firmly established that AurF utilizes a diferrous cofactor to activate O2 in a 
manner reminiscent of the bacterial multicomponent monooxygenase (BMM) superfamily. 
53, 78
 
The diiron active-site of AurF is structurally similar to those of the BMMs, including that of 
methane monooxygenase (MMO). 
118-119
  The most notable deviation in the primary ligation 
environment is the presence of an additional histidine ligand in AurF, which substitutes for a 
water ligand in MMO and other members of the superfamily.   
Recent studies of AurF by Bollinger, Krebs and colleagues have shown that the O2 
activation mechanism of arylamine oxygenases may permit an unprecedented opportunity to 
structurally characterize a diiron-peroxo intermediate with a unique O2 coordination geometry. 
53, 
85
  Exposure of reduced AurF to dioxygen resulted in the accumulation of a diferric intermediate 
with substantial kinetic stability, enabling its spectroscopic characterization by stopped-flow and 
rapid-freeze-quench techniques.  While these approaches did not allow the structural details of the 
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AurF peroxo unit to be fully elucidated, the observed optical and Mössbauer spectroscopic 
properties of the presumptive oxygen-bound intermediate suggest that the coordination geometry 
may significantly differ from the commonly observed -η1:η1 mode.   
CmlI is an arylamine oxygenase from the nonribosomal peptide synthetase (NRPS)-based 
chloramphenicol biosynthetic pathway of Streptomyces venezuelae.
19, 120
 It has a high sequence 
identity (37%) to AurF, and thus it was proposed to contain a diiron cluster.  Accordingly, 
sequence alignments suggest that the diiron clusters of CmlI and AurF have conserved ligand 
structures.  CmlI and a -hydroxylase, CmlA, from the same pathway were recently recognized 
as the first diiron cluster-containing oxygenases to function in an NRPS pathway.
88
 CmlI and 
CmlA serve to tailor the developing antibiotic by adding or converting functional groups. 
Conversion of the arylamine to the nitroaryl group by CmlI is essential for the biocidal activity of 
chloramphenicol.
121
  The similar amino acid sequences and catalyzed reactions of CmlI and AurF 
suggest that they may be able to form similar reactive intermediates. 
19
 Here, we show 
definitively that CmlI contains a diiron cluster and forms a hyperstable peroxo intermediate that 
can be spectroscopically characterized in solution as well as in frozen media.  Using a 
combination of UV/Vis, Mössbauer, and resonance Raman spectroscopies, we demonstrate that 
the diiron arylamine oxygenase generates a peroxodiferric intermediate with a geometry that has 
not been previously described in the nonheme iron family.  Moreover, transient kinetic absorption 
studies and product identification studies suggest that the unique peroxo intermediate is the 
reactive species in the oxygenation of arylamine substrates.  These studies directly demonstrate 
the role of CmlI in chloramphenicol biosynthesis.  
 
Results 
Cloning, Overexpression, and Metal Center of CmlI. The arylamine oxygenase, CmlI, 
catalyzes the reaction shown in the inset of Figure 2-1 to yield chloramphenicol. The enzyme was 
cloned from S. venezuelae genomic DNA of the chloramphenicol biosynthesis cluster, 
overexpressed in E. coli, and purified to homogeneity.  The enzyme as isolated from M9 minimal 
media with exogenously added iron contained 2.1 ± 0.1 irons per monomer.  The optical spectrum 
showed an intense chromophore at 375 nm ( = 2700 M-1 cm-1) (Figure 2-1, black trace). 
Anaerobic reduction of the metal center with sodium dithionite required two reducing equivalents 
and resulted in a weak, featureless spectrum in the visible (Figure 2-1, blue trace).  The resting 
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and fully reduced forms of the enzyme are EPR silent at X band. However, the partially reduced 
enzyme exhibits a pH-dependent EPR spectrum (Figure 2-2), with the principal g-values below g 
= 2, a characteristic feature of an S = ½ ground state species from an antiferromagnetically 
coupled Fe
III
Fe
II
 cluster. The metal quantification and the spectral characteristics of the oxidized 
enzyme are consistent with a dinuclear iron cluster in which the irons are bridged by an oxo 
ligand (see for example 
88
). 
 
 
Figure 2-1:  Optical absorption spectrum of resting CmlI (black trace), and dithionite reduced CmlI (blue 
trace). Buffer: 50 mM Bicine at pH 9.0, 25 °C. Inset: Reaction catalyzed by CmlI.  At least one and 
probably both oxygens in the nitro group derive from O2. The reaction is a net 6 electron oxidation of the 
amine function, but the stoichiometries of O2 utilization and electrons required during the reaction to 
activate O2 are controversial.   
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Figure 2-2: EPR spectra of mixed valent CmlI. Mixed valent CmlI produced by photoreduction at pH 6.5 
(top, black) and pH 9.0 (bottom, red), recorded at 15 K (black) and 45 K, respectively, at a microwave 
power of 10 mW. 
 
 
Mössbauer Characterization of CmlI. Mössbauer spectra of CmlI at pH 6.5, 7.5 and 9.0 
(Figure 2-3 and Figure 2-4) indicate that the protein contains a diiron center, in accord with the 
expectations based on the sequence similarities between CmlI and AurF. The spectra of diferric 
CmlI (CmlI
ox
) depend sensitively on the pH in ways we do not yet understand; the pH 
dependence is more complicated than that of a simple interconversion between two forms of the 
diiron cluster. The studies reported here focus on reduced CmlI (CmlI
red
) and a reaction cycle 
intermediate at pH 9.0 in Bicine buffer, and so the following spectral analysis pertains to the 
enzyme under those conditions.   
  The 4.2 K Mössbauer spectra of as-isolated and dithionite reduced CmlI are shown in 
Figure 2-3, Figure 2-4, and Figure 2-5.  A summary of all fitting parameters is given in Table 2-1.  
The spectrum of as-isolated CmlI
ox
 at pH 9.0 (Figure 2-3A) is best described as a superposition of 
four quadrupole doublets, each having an isomer shift of δ ~ 0.50 - 0.55 mm/sec that is 
characteristic of high-spin Fe
III
. The observation of quadrupole doublets at 4.2 K (rather than 
spectra exhibiting paramagnetic hyperfine structure as typically observed for mononuclear Fe
III
 
complexes) suggests exchange coupled pairs of iron atoms, in accord with the observations 
reported for numerous diiron proteins. The black line in Figure 2-3A represents the sum of the 
four doublets. The red line shows the sum of the nested doublets 1 and 4, while the blue line 
represents the sum of the (unresolved) doublets 2 and 3. The decomposition of the spectrum into 
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four doublets is supported by the Fourier transform treated spectrum shown in Figure 2-4. Such 
treatments 
122-124
 increase the resolution of the spectrum by removing the line width contribution 
of the 
57
Co radiation source, a procedure that sharpens the absorption lines by roughly a factor 
two.  In Figure 2-4 the presence of three doublets is quite apparent, and it is also apparent that one 
of the three doublets is broader and more intense and thus must be composed of two similar 
subspecies. The observation of four doublets shows that the oxidized enzyme can stabilize at least 
two cluster forms in which the two irons of each cluster type reside in different environments.  
The 4.2 K Mössbauer spectra obtained at pH 6.5 and 7.5 are not related to that of the pH 9.0 form 
by a simple redistribution of the intensities of doublet pairs. Following the doublet pattern to 
lower pH did not yield the desired pairings, as EQ changes were observed that affect a single site 
in a cluster (as might be expected for a carboxylate changing from monodentate to bidentate 
coordination, or protonation of a monodentate carboxylate) as well as changes affecting both iron 
sites of a cluster (such as a change involving a bridging ligand).  
In Table 2-1 the doublets are enumerated in order of descending quadrupole splittings, 
EQ. There is no ambiguity in the assignment of the lines of doublets 1 and 4, as combining lines 
assigned to these doublets with those of doublets 2 and 3 would yield unreasonable pairs of δ 
values. Observation of iron clusters with similar isomer shifts but different quadrupole splitting 
suggests that while the two irons belong to the same cluster, they experience different local 
environments. In contrast to the pairing of doublets 1 and 4, combining the four lines of the 
similar doublets 2 and 3 into a non-nested pair would yield two doublets with parameters similar 
to doublets 2 and 3. Presently, we do not see an obvious way of combining the four doublets 
uniquely into two cluster types. Cluster form 1, comprising doublets 1 and 4, represents ca. 44% 
of the Fe in the sample, whereas cluster form 2 accounts for 56%.  Interestingly, the pH 7.5 
spectrum of CmlI resembles the pH 7.5 spectrum of AurF reported by Krebs and coworkers 
(overlay shown in Figure 2-5). 
53
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Figure 2-3: 4.2K Mössbauer spectra of (A) as-isolated CmlI and (B) dithionite reduced CmlI.  Spectra 
were obtained in the absence of an applied magnetic field (B = 0). Samples were prepared in Bicine buffer 
at pH 9.0. Solid black line in (A) is a spectral simulation assuming four quadrupole doublets of essentially 
equal intensity; parameters are listed in Table 1. The red line shows subspectra of nested doublets 1 and 4, 
while the blue line represents the superposition of the (similar) doublets 2 and 3. The sum of the red and 
blue lines yields the black curve.  (B) The solid black line drawn through the experimental data of diferrous 
CmlI is a spectral simulation for two similar doublets using the parameters listed in Table 2-1.    
 
 
Figure 2-3B shows a zero-field Mössbauer spectrum of dithionite-reduced CmlI. The spectrum 
consists of a doublet with parameters typical of high-spin Fe
II
. Spectral simulations indicate that 
the spectrum is a superposition of two overlapping doublets with EQ(1) = 3.13 mm/s, δ(1) = 1.25 
mm/s and EQ(2) = 2.80 mm/s,  δ(2) = 1.23 mm/s, parameters quite similar to the  EQ = 3.06 
mm/s,  δ(2) = 1.24 mm/s reported for diferrous AurF.53 Our simulations require a Lorentzian line 
width of 0.30 mm/s full width at half maximum (attempts to simulate the spectrum with one 
doublet while using different widths for the high-and low-energy features did not produce good 
matches in the wings of the high-energy line). The above choice of parameters results when the 
nested combination of the two doublets is chosen; the non-nested combination would yield the 
less plausible parameter set with δ(1) = 1.16 mm/s δ(2) = 1.33 mm/s. In contrast to the diferric 
state, only one cluster form, with two slightly inequivalent sites, seems to be present in the 
diferrous state. The presence of only one cluster form in the reduced state of the protein, rather 
than two as observed in the oxidized state,  would not be surprising as diiron clusters generally 
experience considerable ligand changes and rearrangements upon reduction, such as loss of an 
oxo bridge and carboxylate shifts.
125-128
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Table 2-1. Quadrupole Splittings and Isomer Shifts for as-Purified (CmlI
ox
), Dithionite-Reduced (CmlI
red
), 
and Oxygenated Forms of CmlI.   
 δ 
(mm/sec) 
ΔEQ 
(mm/sec) 
Area 
(%) 
CmlI
ox
 Cluster Form 1
a 
Doublet 1 0.55 
0.50 
2.02 
0.64 
44 
Doublet 4 
Cluster Form 2
a 
Doublet 2 0.50 
0.52 
1.48 
1.40 
56 
Doublet 3 
CmlI
red
  Site 1 1.25 
1.23 
3.13 
2.80 
50 
50 Site 2 
Oxygenated  Site a 0.62 
0.54 
-0.23
b 
-0.68
b
 
50
c 
50
c
 Site b 
a
 We have assigned doublets 1 and 4, somewhat arbitrarily, to one cluster form and doublets 2 and 3 to a 
second cluster form. Given the uncertainties in line shapes, which affect the percentages, other pair 
combinations are possible.   
b Signs of ΔEQ were determined from 4.2 K spectrum taken at B = 75 kG.  
c
 Represents spectral contribution after removing  22% of oxidized pH 9 CmlI from the spectrum. 
 
 
 
  
Figure 2-4: Mössbauer spectra of CmlI. Left: Fourier Transform treated Mössbauer spectrum of diferric 
CmlI at pH 9.0. A Mössbauer spectrum is the convolution of the spectrum of the absorber with the 
spectrum emitted by the 57Co Mössbauer source.  In the Fourier transform treatment, the experimental 
spectrum is transformed into the time-domain. The known source contribution to the linewidth is then 
removed in the time domain. The figure shows the back-transformed spectrum. The red line indicates the 
nested doublets 1 and 4. Doublets 2 and 3 contribute to the most intense peaks.  Figure S3: Comparison of 
the 4.2 K Mössbauer spectra of diferric CmlI prepared at different pH values.  (A): Spectra recorded at pH 
9 (black) and pH 7.5 (red). (B): pH 7.5 spectrum (red) is shown together with the pH 6.5 spectrum (blue). 
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Figure 2-5: Comparison of the pH 7.5 Mössbauer spectra of CmlI (black) and AurF (red). The AurF 
spectrum is our simulation based on inspection of Figure S1 of Li et al.
85
 
 
A Long-Lived Intermediate is Formed Upon Exposure of Reduced CmlI to 
Dioxygen.  The addition of excess dioxygen to the dithionite-reduced, anaerobic enzyme results 
in the appearance of a broad new optical absorption band at approximately 500 nm (≈ 500 M-1 
cm
-1
 per diiron cluster) (Figure 2-6, red trace).  The spectrum of this species is similar to that 
reported for the proposed peroxo intermediate of AurF.
53
 Extended incubation of this likely CmlI-
peroxo species (this assignment is made directly below) leads to the slow restoration of a 
spectrum indistinguishable from that of the resting diferric enzyme.  The stability of the 500 nm 
absorbing species was determined in transient kinetic experiments over a range of temperatures. 
The time course for its decay could be fit by a single exponential expression at all temperatures 
examined (Figure 2-8A). The oxygenated form of CmlI demonstrates extraordinary stability, with 
measured half-lives of 20 minutes and 3 hours at 25 °C and 4 °C, respectively.  The stability of 
this intermediate in CmlI is substantially greater than that of the similar intermediate observed for 
AurF, (t1/2 ≈ 7 min at 20 °C),
53
 which facilitates studies of its reactivity and structure. 
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Figure 2-6: Reaction of CmlI-Peroxo with NH2-CAM. CmlI-Peroxo (red trace) was formed by exposure of 
stoichiometrically reduced diferrous CmlI to O2. Aliquots of NH2-CAM (~0.05 equivalents) were added 
and the spectrum scanned (gray traces, only selected traces are shown for clarity). At the end of the 
titration, the spectrum of the resting diferric enzyme is restored (black trace). Buffer: 50 mM Bicine, pH 9, 
4 °C.  Inset: Fraction of CmlI-Peroxo remaining at each point during the titration plotted as a function of 
NH2-CAM equivalents added.  
    
Reactivity of the CmlI-Peroxo Intermediate. Addition of the chloramphenicol precursor D-
threo-1-(4-aminophenyl)-2-dichloroacetylamino-1,3-propanediol (NH2-CAM) to the CmlI-peroxo 
(P) species resulted in a rapid loss of the optical features of the intermediate (Figure 2-8B).  The 
acceleration of the decay of the intermediate, at 4 °C, is approximately 100,000-fold when using 
1 mM NH2-CAM.  Titration of P species with aliquots of NH2-CAM resulted in the restoration of 
the spectrum of the resting enzyme (Figure 2-6, gray traces leading to the black trace). Extraction 
of the reaction solution and analysis by HPLC and extracted ion mass spec showed that the 
product of the reaction is chloramphenicol (Figure 2-7).  Chloramphenicol was also shown to be 
the product from this substrate in previous continuous turnover reactions of CmlI. 
19
  A plot of the 
disappearance of P vs. the NH2-CAM equivalents added (Figure 2-6, inset) shows that 
approximately 3 P complexes are consumed for each NH2-CAM consumed, although titrations 
show a range of stoichiometries from 2-5 P species per NH2-CAM consumed. A similar 
stoichiometry was reported for the conversion para-aminobenzoate (pABA) to p-nitrobenzoate 
(pNB) by AurF, although a later study cast doubt on this stoichiometry.
53, 85
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Figure 2-7: Product from the reaction of 1 mM CmlI-peroxo with 10 mM NH2-CAM. Top: (A) HPLC 
traces of the extracted reaction mixture at the end of the titration in comparison to an authentic 
chloramphenicol standard. Bottom: Extracted ion chromatograms at m/z = 321 for the reaction product (B) 
and a chloramphenicol standard (C). Buffer: 50 mM Bicine, pH 9.0. 
 
CmlI-Peroxo Appears to React Directly with Substrates. The exceptionally long lifetime 
of the P allows the formation of the intermediate before transfer to a stopped-flow syringe, so that 
the reaction with NH2-CAM and a variety of adventitious substrates can be easily observed 
(Figure 2-8B, C). The decay time course is fit well by a single exponential for each substrate, 
consistent with a single-step reaction or a rate-limiting reaction followed by much more rapid 
reactions to form product.  The reciprocal relaxation time (RRT) for the decay of the CmlI-peroxo 
depends on both the concentration and type of substrate provided as shown in Figure 2-8C.  It is 
interesting that the plot of the RRT versus the substrate concentration is linear extrapolating to 
zero for each substrate when the substrates are supplied in large excess. This suggests that the 
reaction is irreversible, and thus, the observed RRT is the pseudo first-order rate constant for the 
reaction.  The linear dependence of the pseudo first-order rate constant is surprising, as it implies 
that the reaction of P with amine substrates occurs as a second order process without formation of 
a kinetically significant enzyme-substrate complex. To our knowledge, the only diiron enzyme 
intermediate that behaves kinetically in this way is the MMO bis--oxo FeIVFeIV intermediate 
Compound Q.
94
  However, slow, soluble alternative substrates for Compound Q reactions showed 
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hyperbolic substrate concentration dependence, suggesting that a high Km complex is, in fact, 
formed.
129
  In the case of CmlI, no deviation from linearity was observed at concentrations up to 
50 mM for the most soluble substrates tested (Figure 2-9). Apparent second order rate constants 
for P reaction with arylamine substrates are shown in Figure 2-8C, inset.  Interestingly, the 
chloramphenicol precursor L-para amino phenylalanine (L-pAPA), is not a substrate when bound 
to the NRPS for the system, CmlP, truncated to the adenylation and thiolation domains.   
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Figure 2-8: Single turnover reaction of CmlI-Peroxo with aryl-amine substrates.  A: Autodecay time 
course (filled ovals) for reaction of 600 μM pre-formed CmlI-peroxo at 4 or 25 °C.  A single exponential fit 
(red) is shown superimposed on the data.  B: Single turnover time course for reaction of 50 μM pre-formed 
CmlI-peroxo with 1 mM of the substrate shown (black). A single-exponential fit (red) is shown 
superimposed on the data.  C: Plot of the apparent first order CmlI-peroxo decay rate constant for the 
reaction of 50 μM diferrous CmlI with 850 μM O2 and the concentration of the substrate shown (all 
concentrations after mixing). Inset: Apparent second order rate constants calculated from the slopes of the 
plots in the main figure. Buffer: 50 mM Bicine at pH 9.0, 4 °C except where noted.  
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Figure 2-9: Linear dependence of CmlI-Peroxo decay rate. Reaction with L-pAPA (squares) and pABA 
(circles).  In these experiments, the CmlI-Peroxo was pre-formed and loaded into a stopped flow syringe.  
The substrates were mixed in large excess over the enzyme from the second syringe.  This method results 
in a single observed exponential kinetic phase which can be fit with nonlinear regression to give the 
observed rate constants. 
  
Only Reaction with Native Substrate NH2-CAM Yields the Complete Six-Electron 
Oxidation Product. P is shown to react with a variety of para-amino moiety containing 
substrates, including the native substrate NH2-CAM, p-aminophenol, p-aminobenzoate, p-
aminophenylalanine, and p-nitroaniline (Figure 2-8). However, analysis of reaction products by 
HPLC revealed that only the reaction with NH2-CAM results in a significant amount of the full 
six-electron oxidized product with a nitro moiety (Table 2-2). The reaction with p-
aminophenylalanine yields a small amount of p-nitrophenylalanine. The other substrates results in 
the two- or four-electron oxidized species, the hydroxylamine and nitroso derivatives, 
respectively. This finding suggests that the chloroacetyl, the hydroxyl, and/or the methyl 
hydroxyl groups play an essential protein binding role to ensure full oxidation.      
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Table 2-2: Products of the reaction of CmlI-P with aryl-amino substrates. 
 
Substrate 
 
Product(s) 
 
 
NH2-CAM 
 
 
- NO2 
- NO 
 
 
pAP 
 
 
- NO 
 
 
pABA 
 
- NO 
- NHOH 
 
 
L-pAPA 
 
 
- NO2  
- NO 
 
 
pNA 
 
 
- NO 
 
 
Characterization of the Oxygenated Intermediate by Mössbauer Spectroscopy. The 
exceptional stability of the oxygenated CmlI intermediate enables its spectroscopic interrogation 
at enzyme and O2 concentrations that surpass those normally obtained in rapid mixing 
experiments, as the intermediate can be prepared quite simply through the gradual addition of 
gaseous O2 to the reduced enzyme at 4 °C. A 2 mM solution of dithionite-reduced CmlI, at pH 
9.0, was gently oxygenated with a stream of O2 gas at 4 °C for 10 minutes and subsequently 
frozen in liquid nitrogen.    
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As shown in Figure 2-10A, the 4.2 K zero-field Mössbauer spectrum of this sample is 
quite different from those of the resting and dithionite-reduced enzyme. The majority component, 
assigned to P, comprises two nested doublets of equal intensity that account ca. 80% of the iron 
in the sample. Doublet a (simulated blue curve) has ΔEQ (a) = -0.23(1) mm/s, δ (a) = 0.62(1) 
mm/s, while doublet b (green line) has ΔEQ (b) = -0.68(2) mm/s, δ (b) = 0.54(1) mm/s.  The two 
doublets are superimposed on a minority species that contributes the shoulders at + 1.5 mm/s and 
-0.5 mm/s Doppler velocity. This spectral component seems to comprise the four doublets 
observed for the diferric pH 9.0 CmlI, and it accounts for 20% of the iron in the sample.  Given 
the observed rate constant of 0.005 min-1 for the decay of the P, at 4 °C, about 10% diferric 
CmlI is expected at the time the sample was frozen.  The remainder, if any, probably derives from 
incomplete reduction. Subtracting the diferric species (indicated by the red line) results in the 
removal of the shoulders and yields two doublets a and b.   
The EQ and δ parameters listed in Table 2-3 were obtained by assigning the four lines to 
two nested doublets; the non-nested choice would yield ΔEQ(a’) = -0.37 mm/s, δ (a’) = 0.69 mm/s 
and ΔEQ (b’) = -0.54 mm/s,  δ (b’) = 0.46 mm/s, a combination with less plausible δ values in our 
opinion.  Krebs and coworkers have observed a very similar species for AurF-peroxo (see Table 
2-3, Figure 2-2, and caption of 
85
). It is worth noting that the two doublets of Fe
III
Fe
III
 CmlI-
peroxo (and AurF-peroxo) have quite different δ values, a situation similar to that reported by 
Chavez et al. for the intermediate obtained by exposing the diiron(II) "paddlewheel" complexes 
of sterically hindered ArCO2
−
 ligands to O2. 
130
 We address this observation below.  
The Fe
III
Fe
III
 CmlI-peroxo complex exhibits quadrupole doublets at 4.2 K, which 
suggests an exchange coupled, high-spin diferric system for which the local spins S1= S2 =5/2 are 
antiferromagnetically aligned. The 7.5 T spectrum of Figure 2-10B can be simulated under the 
assumption that the 
57
Fe nuclei experience only the applied field, i.e. the ground state of Fe
III
Fe
III
 
P has a cluster spin S = 0.  By recording applied field Mössbauer spectra between 20 K and 100 K 
one can often measure the exchange coupling constant J. This technique works well for J  120 
cm
-1
 provided the electronic spin relaxes either fast or slow compared to the nuclear precession 
frequencies. At intermediate relaxation rates, however, the spectra are broad, and an analysis of 
such spectra, to our knowledge, has not yet been reported for a diferric system. Unfortunately, 
this situation applies to the Fe
III
Fe
III
 peroxo species of CmlI.  The exchange Hamiltonian H = J 
S1•S2 produces a spin ladder S = 0, 1... 5 for which the first excited state, the S = 1 multiplet, has 
energy J. For J  20 cm-1 a field of 7.5 T would mix the MS =  1 sublevels of the S = 1 multiplet 
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into the ground state, and this mixing would readily be detected in the 4.2 K spectrum. As there is 
no evidence for such mixing in the spectrum of Figure 5B, we conclude that Jperoxo > 20 cm
-1
.  
 
 
Figure 2-10: 4.2K Mössbauer spectra of oxygenated CmlI. (A) Zero field spectrum. The green and blue 
curves are spectral simulations for sites a and b of the major (>80%) peroxo species).  The red curves 
outline the 20% contribution of a diferric contaminant, assumed to be the pH 9 species of Figure 2A. (B) 
Spectrum of the same sample recorded in a parallel applied field of 7.5 T. The blue and green lines are 
spectral simulations of the diiron(III) peroxo components. The remaining (red) simulated spectrum, 
accounting for roughly 20% of the experimental spectrum, was well approximated with δ and ΔEQ 
parameters of pH 9 as-isolated diferric CmlI. 
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Table 2-3: Spectroscopic parameters of peroxodiiron(III) intermediates observed in dinuclear iron enzymes. 
O2 Adducts of diiron(II) 
enzymes 
max (nm) 
ε (M-1 cm-1) 
 (mm/s) EQ (mm/s) J (cm
-1
) (O-O) (cm-1) 
(16O-18O) 
Peroxo binding 
mode 
Refs. 
hDOHH 630 (1500) 0.55, 0.58
a
  1.16, 0.88  50-70 855 (44) -OH--1:1 
89
 
MMOH 725 (1800) 0.69 1.55   -1:1 
96, 124, 131
 
D84E R2 700 (1500) 0.63 1.58 50 868 (46) -1:1 
40, 92, 98, 100, 132
 
Frog M Ferritin 650 (1000) 0.62 1.08 70 851 (-51) -1:1 
109, 132-133
 
Stearoyl-ACP 9 
Desaturase 
700 (1100) 0.68,0.64 1.90, 1.06  898 (-54) -1:1 
99, 101
 
ToMO 
 
no visible 
band 
0.55 0.67    
38
 
W48A/Y122F R2 500 (1500) 0.52, 0.45 0.55, 1.53    - 
106
 
ADO
 
450 (1200) 0.48, 0.49 0.55, 1.23   - 
46
 
AurF
 
500 (500) 0.61, 0.55 0.35, 0.74
b
   - 
53
 
CmlI
 
500 (500) 0.62, 0.54 -0.23, -0.68
b
  20 791 (43) -1:2 This work 
a Alternatively, the Mössbauer data can be assigned, less plausibly, as a non-nested pair of doublets with parameters  = 0.49, 0.63 mm/s and EQ = 1.05, 0.99 mm/s 
b Values for assumption of nested doublets; signs of EQ unknown. 
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Resonance Raman Spectroscopy of the CmlI Oxygenated Intermediate. Resonance 
Raman spectroscopy can be used to demonstrate the presence of a peroxo ligand bound to the 
diiron(III) site and provides a means to evaluate the cluster structure of the intermediate 
absorbing at 500 nm.  Figure 2-11 shows the resonance Raman spectra obtained by 488 nm 
excitation of P samples prepared with different oxygen isotopes, as well as the spectrum of a 
sample in which the intermediate was allowed to decay. The spectrum of the 
16
O2 adduct (trace 
A) exhibits a peak at 791 cm
-1
 that slowly decays over 7 hours at 0 °C (trace D), matching the 
observed kinetics at 500 nm described above.  The spectrum of the 
18
O2 adduct (97 % 
enrichment) (trace B) shows a downshift of the 791 cm
-1
 peak to 747 cm
-1
.  The observed 44 cm
-1
 
downshift of the 791 cm
-1
 peak almost matches the value calculated by Hooke’s law for a 
diatomic O-O oscillator (-45 cm
-1
). A mixed-isotope labeling experiment (trace C) shows the 
appearance of a peak at 768 cm
-1
, halfway between those of the 
16
O2- and the 
18
O2-derived 
samples, demonstrating a vibrational mode that must involve both atoms of the added O2 and 
cannot arise from other possible band assignments such as ν(Fe=O) or νasym(Fe–O–Fe) modes, 
which involve only one oxygen atom. Taken together, these observations confirm that this ~800-
cm
-1
 feature arises from a peroxo moiety. (No 
18
O2-sensitive vibration was observed in the 500 
cm
-1
 region where the (Fe-O) mode would typically be found.) A perusal of Table 2-3 shows 
that CmlI-peroxo exhibits a (O-O) feature that is at least 60 cm-1 lower in frequency than 
observed for any other enzyme peroxodiiron(III) intermediate reported to date.  Taken together, 
the Mössbauer and resonance Raman results point to an as yet unobserved structure for a peroxo 
intermediate of a nonheme diiron enzyme.  
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Figure 2-11: Resonance Raman spectra of oxygenated CmlI, pH 9.0. Prepared with: (A) 
16
O2, (B) 
18
O2, (C) 
mixed-labeled O2, and (D) a sample after prolonged incubation. Spectra were obtained with 200 – 300 mW 
laser power and subjected to two-point baseline subtraction. No smoothing was required. Spectra were 
aligned and normalized using the sharp peak at 1005 cm
-1
 that arises from phenylalanine residues of the 
protein. Dashed lines represent Gaussian fits to the peaks of interest. 
 
Discussion 
Summary of Findings. It is shown here that P converts the arylamine precursor to 
chloramphenicol to the nitroaryl group of the active antibiotic. The metal center of CmlI is 
characterized as a diiron cluster that stabilizes an exceptionally long-lived peroxo intermediate.  
This intermediate appears to react directly with its substrate at physiologically relevant 
concentrations, suggesting that it is the reactive intermediate in the CmlI reaction cycle. It is 
noteworthy that P does not carry out the aliphatic or aromatic hydroxylations reactions reported 
for other diiron enzymes, and the latter enzymes do not carry out arylamine oxygenation. 
21, 38, 53, 
85, 91, 93-94
  The factors affecting stability of the diiron-peroxo intermediates and their substrate 
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reactivity are largely unknown.  Our kinetic and spectroscopic studies of P suggest that the 
unusual stability and substrate reactivity may result from formation of a previously 
uncharacterized peroxo structure.  The bases for this conclusion are discussed here.  
 
Nature of the CmlI-Peroxo Intermediate.  The Mössbauer spectra of the diferric states of 
CmlI show that at least two cluster forms are present at each pH studied, and that each cluster 
form has inequivalent Fe
III
 sites to yield four quadrupole doublets. These various forms occur in 
different ratios depending on conditions such as pH; at pH 9 two cluster forms in an approximate 
1:1 ratio are present. The pH 9 Mössbauer spectrum of diferrous CmlI exhibits two similar, but 
unresolved, quadrupole doublets with EQ = 3.13 and 2.80 mm/s.  For the closely related 
diferrous form of AurF (measured at pH 7.5) one broad quadrupole doublet was observed, with a 
EQ (= 3.06 mm/s) that is in between the EQ values determined here.  These observations seem 
to suggest that the reduced enzymes contain just one cluster form, with indistinguishable sites in 
AurF and slightly different sites in CmlI, although what is known about the diiron cluster 
structure (two His ligands bound to one iron and one to the other, see Figure 2-13) suggests that 
strict equivalence is ruled out.  
In contrast, the peroxo adducts of both CmlI and AurF exhibit a Mössbauer spectrum 
containing two equally intense quadrupole doublets, suggesting the presence of one cluster type 
with inequivalent Fe
III
 sites. An interpretation that the two doublets represent two cluster forms, 
each with equivalent sites, seems contrived as each cluster would be required to have equivalent 
ferric sites that differ in isomer shift from those in the other cluster. As pointed out above, the 
CmlI-peroxo cluster contains two antiferromagnetically coupled Fe
III
 sites; analysis of the 7.5 T 
spectrum of Figure 2-10 shows that J > 20 cm
-1
 (in the Hexch  = J S1•S2 convention).    
The unusually low (O-O) frequency associated with the P intermediate suggests a 
peroxo binding mode not yet recognized within the family of dioxygen activating diiron enzymes. 
The four other peroxo intermediates of diiron enzymes characterized thus far by resonance 
Raman spectroscopy (Table 2-3) exhibit (O-O) frequencies in the range of 851 – 898 cm-1 and 
have been assigned to have -1:1 binding modes.  The (O-O) frequencies of these complexes 
are at least 60 cm
-1
 higher than the 791 cm
-1
 value for CmlI-peroxo. Indeed, most synthetic 
diiron(III)-peroxo complexes described to date have -1:1 binding modes and exhibit the 
higher frequencies as well (Table 2-4).
54, 56-57, 103-104, 110
 The only potential exception to this 
generalization among diiron(III)-peroxo complexes is the O2 adduct reported by Chavez et al.,
130
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which has a (O-O) frequency at 822 cm-1. This synthetic adduct also has a diferric cluster with 
relatively weak antiferromagnetic coupling (J ~ 30 cm
-1
) and exhibits two doublets with distinct 
isomer shift values that are similar to those found for CmlI-peroxo. Unfortunately, there is no 
structural information available for this adduct.    
Lower (O-O) frequencies are more typically observed for mononuclear (2-
peroxo)iron(III)
 
complexes (812-827 cm
-1
; see Table 3). Even lower (O-O) frequencies (746 - 
813 cm
-1
) are found for a small subset of heterodinuclear complexes that consist of an (2-
peroxo)iron(III)
 
center having a second metal ion bound to the peroxo ligand to give rise to either 
a -2:2- or a -1:2-peroxo bridge.  The first examples of such complexes featured a CuII as 
the second metal ion,
134-135
 so the decrease in (O-O) could be attributed to an effect of the redox-
active Cu
II
, as previously observed in Cu
II
2(-
2
:2-peroxo) complexes.136 However, more 
recently reported examples with redox-inactive Sc
III
 or Y
III 
as the second metal ion
137-138
 also have 
lower (O-O) frequencies (but not as low as the dicopper complexes), so electron transfer from 
the second metal ion to the bound peroxo ligand is not required to lower the frequency of the 
side-on bound peroxo ligand. The fact that the (O-O) of CmlI-peroxo is observed at 791 cm-1 
raises the strong possibility that its peroxo ligand may be bound in either the -2:2 or -1:2 
bridging mode. Of these two modes, we favor the -1:2 bridging for the following reason: Site 
a has a substantially larger isomer shift ( = 0.62(1) mm/s) than site b ( = 0.54(1) mm/s), the 
latter value being associated with a more typical of high-spin ferric center.  Mononuclear 
complexes with side-on bound peroxo groups generally have  values between 0.58 and 0.67 
mm/s (see Table 2-4), which suggests that site a of CmlI-peroxo could have a side-on peroxo 
ligand. 
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Table 2-4: Spectroscopic parameters of synthetic nonheme high-spin iron-peroxo complexes. 
 
  a Abbreviations used: dxlCO2 = 2,6-bis(2’,6’-dimethylbenzyl)-4-tert-butylbenzoate anion; py = pyridine; TMC, 1,4,8,11-tetramethylcyclam; Tp
iPr2
 = 
hydridotris(3,5-diisopropylpyrazolyl)borate anion.     
 
 
 
 
 
Complex
a max  
(nm) 
  
(M
-1
cm
-1
) 
ν (O–O)  
(cm
-1
) 
J
(cm
-1
)
EQ)  
(mm s
-1
) 
ref 
[(TMC)Fe
III
(1-OOH)]2 500 (sh) 450 870  0.51 (0.2) 113 
[Fe2(Tp
iPr2
)2(O2CR)2(-
1
:1-O2)] 694 2650 888 66 0.66 (1.40) 
103
 
Fe
III
(-O)(-1:1-O2
=
)Fe
III 
 577-650 1200-1500 830-853 ≥110 
0.53-0.55 
(1.43-1.68) 
104, 110, 139-141
 
Fe
III
(-OR)(-1:1-O2
=
)Fe
III
 588-730 1500-3000 884-908 60-80 0.50-0.57 (0.96-1.35) 
104, 111, 141
 
[(py)2Fe
II
2(dxlCO2)4(O2)] 500-550 1100 822 ≈30(5) 0.65 (1.27)  0.52 (0.71) 
130
 
nonheme Fe
III
(2-O2
=
) 520-835 500-650 816–827  0.58-0.67 (0.6-1.4) 
113, 137-138, 
142-143
 
(TMC)Fe
III
(-2:2-O2
=
)(Sc
III 
) 525 780 807/799  0.47 (0.50) 
137-138
 
(heme)Fe
III
(-2:1-O2)Cu
II
   788–808   
134, 144
 
(heme)Fe
III
(-2:2-O2)Cu
II
   747–767   
134, 144
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Figure 2-13 illustrates the proposed -1:2-peroxo binding mode for the CmlI active 
site, which was modeled by introducing an O-atom to the oxo bridge between the iron atoms in 
the crystal structure of AurF-product complex (3CHT). It is not clear what factors cause this 
diiron active site to form an O2-adduct distinct from the other four diiron enzyme O2-adducts that 
have been characterized by resonance Raman spectroscopy. Perhaps the presumed third His 
ligand, deduced by comparison with the sequence of the structurally characterized AurF, 
promotes the shift in peroxo binding geometry from -1:1 to -1:2.  
 
 
Figure 2-13: Proposed structure of CmlI-Peroxo built from the active site coordinates of oxidized AurF–
para-nitrobenzoate complex (3CHT). An oxygen atom was introduced to convert the oxo bridge into a -
η1:η2-peroxo bridge. Fe, O, C, N, and H atoms are shown in orange, red, dark grey, blue, and light grey, 
respectively. 
  
What advantage might this difference in peroxo binding mode provide CmlI, and by 
inference, AurF? Reactivity data suggest that the decay of both peroxo intermediates is affected 
by the nature of the amine substrate, with more electron-rich substrates affording faster rates of 
decay (Figure 2-8C, inset).
145
 It is thus plausible for CmlI and AurF to initiate the oxidation of 
their arylamine substrates by simple electron transfer to the peroxo intermediate (Scheme 2-1), 
thereby avoiding having to form oxidants more powerful than required for the reaction and 
affording the active site better control of the reaction coordinate. Accordingly, this mechanism 
may account for the inability of CmlI to catalyze either aliphatic or aromatic hydroxylation 
reactions despite the fact that its active site can accommodate a wide range of substrates. 
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Scheme 2-1: Proposed mechanism for the first step in aryl-amine oxygenation by CmlI. 
 
The mechanism shown in Scheme 2-1 would be a logical first step in the oxygenation of 
the arylamine substrate to the nitroaryl product. However, we have not detected the potential 
intermediate products, namely, the hydroxylamino- or nitroso-adducts of the NH2-CAM 
substrate, during the reaction.  Minor amounts of these intermediates were reported for reactions 
of both AurF and CmlI with their respective substrates in multiple turnover studies by Zhou and 
coworkers.
19, 78
 The single exponential time course for the reaction of NH2-CAM with CmlI-
peroxo suggests that, if these discrete intermediates are formed, their subsequent conversion to 
chloramphenicol is very fast.  Recently, Krebs, Bollinger and coworkers proposed that the AurF-
peroxo adduct can react with the hydroxylamino-derivative of pAB by an interesting mechanism 
in which hydroxylation to form a dihydroxylamino-adduct is followed by 2-electron, 2-proton 
transfer to yield pNB and regenerate the AurF diferrous cluster.
85
  Oxygen binding to the 
diferrous cluster would re-form the AurF-peroxo adduct so that the hydroxylamino adduct is 
catalytically converted to the nitro adduct without net utilization of the peroxo adduct.  While it  
is possible that CmlI follows this same mechanism, our results (Figure 3, inset) show that 
approximately three CmlI-peroxo complexes are required for each chloramphenicol produced 
from NH2-CAM, favoring the stepwise oxidation mechanism. 
A proposal for an unsymmetrically bound peroxo intermediate absorbing at 450 nm 
reminiscent of CmlI-peroxo was recently advanced for the enzyme aldehyde deformylating 
oxygenase (ADO) based on dissimilar Mössbauer parameters for the two ferric ions in the 
complex. 46  As we propose here for CmlI, the authors postulated that ADO-peroxo is the reactive 
species that directly attacks its long chain fatty aldehyde substrate.  However, it was also 
proposed that the O-O bond cleavage reaction following formation of the initial hemiacetal 
species is promoted by transfer of one electron from an external donor.
146-147
  No similar role for 
an external donor is evident in the efficient single turnover reaction of CmlI (Figure 4). Instead, 
electron transfer from the amine function of the substrate may serve this role of promoting O-O 
bond cleavage as illustrated in Scheme 2-1.  An alternative mechanism for ADO was suggested 
by our recent study in which it was observed that the enzyme can hydroxylate the  terminal 
54 
 
methyl of the long-chain hydrocarbon formed as a product of long-chain aldehyde 
deformylation.
21
  This implies that a high-valent species at the Fe
IV
Fe
IV
 oxidation state of MMO-
Q is formed as a consequence of the O-O bond breaking reaction during deformylation. If this is 
the case, then an extra electron cannot be transferred to the peroxo intermediate in the ADO case.  
Similarly, electron transfer is not involved in the formation of MMO-Q prior to its reaction with 
methane.
94
  This observation is in accord with the proposal made above in Scheme 2-1 that the 
difference in the type of substrate bond that can be oxygenated is a consequence of the 
availability of electrons to the peroxo intermediate.   
 
Role of CmlI in Chloramphenicol Biosynthesis. Oxygenases in NRPS pathways have been 
shown to oxidize amino acid substrates in several modes, including: (a) prior to loading onto the 
peptidyl carrier protein (PCP) domain, (b) while the amino acid is tethered onto the PCP domain 
as a thioester, or (c) as a late-stage modification following release from the PCP.
148
  We have 
shown in previous studies that L-pAPA beta-hydroxylation during chloramphenicol biosynthesis 
catalyzed by the diiron monooxygenase CmlA proceeds exclusively by the second route.
88
  The 
reactivity of CmlI-peroxo was interrogated in the current study using the free precursor substrate 
L-pAPA, L-pAPA appended onto the chloramphenicol NRPS CmlP PCP domain, NH2-CAM, 
and other benzylamine substrates (Figure 2-8C, inset).  The L-pAPA-loaded NRPS T-domain did 
not result in an appreciable enhancement of the peroxo decay rate, indicating that, unlike CmlA, 
CmlI does not perform oxidation chemistry on the S-acylated amino acid.  The ability of CmlI-
peroxo to fully convert NH2-CAM to chloramphenicol was demonstrated by LC-MS studies 
(Figure 2-7) and is consistent with steady state and whole cell turnover studies.
19
  Thus, this 
reaction shows efficient six-electron oxidation of amine to a corresponding nitro derivative. The 
rate constant for CmlI-peroxo decay was significantly larger (~3x) for NH2-CAM when compared 
to that of free L-pAPA, indicating that the installation of a nitro-group is enhanced by reduction 
of the L-pAPA carboxylate (which occurs during reductive cleavage from the NRPS) or 
installation of the dichloroacetyl group, or both. However, the efficient metabolism of NH2-CAM 
observed here, considered together with earlier isotope feeding experiments used to order the 
modifications of CAM biosynthesis, 
149-150
 strongly suggest that CmlI functions as the last stage 
of CAM maturation as illustrated in Figure 2-13. 
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Figure 2-13: Role of CmlI in chloramphenicol biosynthesis. 
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Chapter 3  
 
Spectroscopic Characterization of Intermediates in the         
Six-Electron Conversion of an Aryl-amine to an Aryl-nitro 
Product by CmlI 
 
 
 
 
Portions of this chapter are reprinted (adapted) with permission from: Anna J. Komor, Brent S. 
Rivard, Ruixi Fan, Yisong Guo, Lawrence Que, Jr., and John D. Lipscomb. “Mechanism for Six-
Electron Aryl-N-Oxygenation by the Non-Heme Diiron Enzyme CmlI” J. Am. Chem. Soc., 2016, 
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Introduction  
  The enzyme-catalyzed six-electron oxidation of aryl-amines to aryl-nitro moieties is a 
process for which mechanistic consensus has not been reached. There are only three characterized 
enzymes known to perform this conversion: CmlI and AurF, both of which are non-heme 
dinuclear iron-cluster-containing enzymes, and PrnD, a Rieske-type non-heme iron oxygenase.
19, 
66-67, 69, 75, 84
 The cofactors of both of these enzyme classes are only capable of at most 2-electron 
redox chemistry.  Thus, the observed 6-electron aryl-amine (NH2-Ar) oxidation reaction of these 
enzymes presents a mechanistic puzzle.  
The proposals for the mechanism of NH2-Ar to aryl-nitro (NO2-Ar) oxidation by diiron 
enzymes can be grouped into two general hypotheses. In the sequential three-oxidation 
hypothesis, (Scheme 3-1, pathway I), the diiron cluster utilizes external electrons to activate O2 in 
three separate events. Each activated oxygen species, likely a diiron peroxo intermediate (see 
below), effects a 2-electron oxidation of the substrate or an intermediate. A single turnover thus 
requires six exogenous electrons.  The NH2-Ar substrate is converted to an aryl-hydroxylamine 
(NH(OH)-Ar) by the first oxidation, to aryl-nitroso (NO-Ar) or aryl-dihydroxylamine (N(OH)2-
Ar) by the second oxidation and to the NO2-AR product by the final oxidation. The diiron cluster 
returns to the diferric resting state at the end of the cycle. This mechanism was originally 
proposed by Hertweck and Winkler, based on work done on whole cells over-expressing AurF,
83
 
and expanded by Zhao and coworkers based on work on purified AurF and CmlI.
66, 75
 This type of 
mechanism requires either release of intermediates with subsequent rebinding at another activated 
metal center or a system to internally transfer the remaining required oxidizing equivalents 
between active sites in different subunits. The latter possibility seems unlikely given that 
structural studies show that AurF is only a homodimer, and three sets of oxidizing equivalents, or 
a homotrimer, would be required to complete the reaction in this case.
78
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Scheme 3-1: Two mechanistic hypotheses for aryl-amine oxygenation mediated by diiron cluster enzymes. 
(I) Sequential three-oxidation mechanism requiring six external electrons (2 for each peroxo-intermediate) 
per turnover and (II) substrate-mediated reduction mechanism requiring a net of two external electrons per 
turnover because the diferrous cluster is regenerated at the end of the turnover cycle. 
 
The second mechanistic hypothesis, introduced by Bollinger, Krebs and colleagues, 
invokes a substrate-based reduction step (Scheme 3-1, pathway II).
85
 Like the three-step oxidation 
mechanism, the substrate-based reduction mechanism begins with two 2-electron oxidations to 
form first NH(OH)-Ar, and then N(OH)2-Ar, intermediates. Using stopped-flow UV-Vis 
absorbance and Mössbauer spectroscopies, it was reported that N(OH)2-Ar intermediate can act 
as a reductant, reducing the diferric diiron cluster to diferrous while itself being oxidized to the 
final NO2-Ar product. The overall reaction utilizes only two diiron-peroxo species and results in a 
diferrous cluster at the end of the reaction cycle. As a result, only four exogenous electrons are 
required for O2 activation in a single turnover, and the final diferrous diiron cluster can be used to 
activate O2 for the next cycle. Consequently, when considered over multiple cycles, only two 
external electrons are required per cycle to sustain turnover.  
CmlI is an ideal enzyme with which to evaluate these two mechanistic hypotheses for 
aryl-amine oxidation. We have shown previously that the chemically competent intermediate of 
the reaction cycle, a diferric peroxo species, CmlI-peroxo (P), can be formed in high yield and 
has a distinguishable chromophore that can be followed by UV-Vis absorption spectroscopy at 
500 nm. P is remarkably stable (t1/2 = 3 h at pH 9 and 4 °C)
52
 in contrast to the peroxo 
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intermediates of AurF and other diiron oxygenases.
33, 49, 53
  This stability allows the key 
intermediate to be formed, degassed, transferred to and from an anaerobic chamber, transferred to 
stopped-flow or freeze-quench instruments, and reacted with the NH2-CAM substrate or one of 
the other pathway intermediates. Here it is shown that aryl-amine oxygenation proceeds by a third 
mechanism in which the reaction cycle ends with the diiron cluster in the diferric state. An 
N(OH)2-Ar derivative is not a required intermediate. However, diiron cluster reduction by another 
pathway intermediate serves to increase efficiency and reduce the need for external reducing 
equivalents in a single turnover. This new mechanism requires only two exogenous electrons, 
supplied at the beginning of the reaction cycle. 
Results 
Tracking Oxygen Atom Incorporation into Chloramphenicol Product. To determine 
the source of the oxygen atoms in the nitro-function of CAM, P was formed under either an 
16
O2 
or 
18
O2 atmosphere and then reacted with NH2-CAM. Reactions were carried out at 4 °C with 0.3 
equivalent of substrate, allowed to run for 10 min and then acid quenched as described in Chapter 
5. Equivalents of substrate here and in future experiments are calculated vs. concentration of P 
unless otherwise stated. When 
18
O2-P was reacted with NH2-CAM in an 
18
O2 environment, the 
resulting CAM product was 93 ± 2% doubly labeled with 
18
O (Table 3-1). NO-CAM, observed as 
a minor product, was >95% singly labeled with 
18
O. Based on the isotopic purity of the 
18
O2 
source, we could expect a maximum of 98% incorporation. Additional 
16
O incorporated during 
the reaction is likely to be due to contamination from atmospheric O2 during experimental 
manipulations. Thus, it appears that both of the O atoms of the CAM product derive from P (and 
therefore from O2), and not from H2O. To confirm this, reduced CmlI (CmlI
red
) was exchanged 
into H2
18
O buffer and then supplied with 
16
O2 to form 
16
O2-P. Reaction with NH2-CAM yielded 
only 
16
O-containing product (Table 1).  
When the reaction of 
18
O2-P with NH2-CAM was carried out in an 
16
O2 atmosphere, 
approximately 50% of the CAM produced was doubly labeled, while the remainder was either 
singly labeled (~40%) or had no 
18
O incorporation (10%) (Table 3-1). NO-CAM product labeling 
fell slightly, but remained >90%. No significant difference in oxygen incorporation was observed 
when 1.0 equivalent of substrate was used instead of 0.3.  
Three possible explanations were considered for why the aerobic reactions of 
18
O2-P with 
NH2-CAM incorporate a significant amount of 
16
O: (1) P exchanges with water, converting 
18
O2-
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P to 
18
O/
16
O-P and/or 
16
O2-P, (2) P exchanges with the atmospheric O2, converting 
18
O2-P to 
16
O2-P, (3) P re-forms with 
16
O2 from the aerobic atmosphere after the P-decay species, diferric 
CmlI (CmlI
ox
), is re-reduced by a pathway intermediate. 
 
Table 3-1: Oxygen incorporation into CAM products in the reaction of P with NH2-CAM.
a 
  oxygen isotope: atmosphere / P / solvent 
product oxygen 
incorporation 
18
O2/
18
O2 /H2
16
O 
% 
16
O2/
18
O2/H2
16
O 
% 
16
O2/
16
O2 /H2
18
O 
% 
 
CAM 
16
O, 
16
O 0.4 ± 0.2 10 ± 1 100 
16
O, 
18
O 7 ± 2 44 ± 1 0 
18
O, 
18
O 93  ± 2 47 ± 2 0 
NO-CAM 
16
O
 
4 ± 1 8 ± 6 98 ± 2 
18
O
 
96 ± 1 92 ± 6 3 ± 2 
a
 
16
O2-P or 
18
O2-P was reacted with 0.3 equivalents NH2-CAM under different atmosphere and 
solvent conditions shown.  Resultant products were analyzed by LCMS as described in the Experimental 
Procedures. All reactions done in buffer: 50 mM Bicine, pH 9, 4 °C. 
 
It was shown above that the reaction of 
16
O2-P in H2
18
O yields only 
16
O product, 
indicating that neither the peroxo species nor products exchange with water.  This finding rules 
out the first possible explanation. To test the second possibility and determine whether P can 
exchange with atmospheric O2, a stock of 
18
O2-P was made and then placed under a steady stream 
of 
16
O2. At time points between 1 and 100 min, an aliquot of P was removed and reacted with 
NH2-CAM for 10 minutes. No time dependent change in the 
18
O incorporation pattern was 
observed (Figure 3-1), showing that P does not exchange with ambient O2. In the absence of 
alternative explanations, the reduction of the enzyme by a substrate-based intermediate to allow 
re-formation of P with atmospheric 
16
O2 as part of the reactive cycle is strongly supported. The 
fact that >90% of the NO-CAM remained 
18
O-labeled also supports the hypothesis that the first 
oxygen atom is added by an 
18
O2-P and the second by a 
16
O2-P. The reducing agent required to re-
form P is identified below.  
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Figure 3-1: CmlI-Peroxo exchange test. Product isotope ratios when 
18
O2-P was incubated under a steady 
stream of 
16
O2. Time indicates the length of time 
18
O2-P had been incubating when it was removed from the 
reaction vessel and reacted with NH2-CAM. The reaction with substrate was allowed to proceed for 10 min 
before acid quench. Buffer: 50 mM Bicine, pH 9, 4 °C. 
 
Although the fraction of CAM with a mixed oxygen-labeled nitro group clearly increases 
in an 
16
O2 atmosphere, a significant portion of the product remains doubly labeled with 
18
O. A 
possible explanation for this observation is that a pathway intermediate prior to CAM escapes the 
active site and subsequently reacts with unreacted 
18
O2-P. This possibility is explored below.      
Reaction of CmlI with NO-CAM and Determination of NO-CAM as a Substrate-Based 
Intermediate. The detection of NO-CAM by LCMS during turnover of NH2-CAM suggests the 
possibility that NO-CAM is an intermediate in the reaction pathway. To test this possibility, NO-
CAM was synthesized from CAM using a zinc reduction method previously reported.
151
 An 
anaerobic solution containing 1 eq. of NO-CAM and diferrous CmlI (CmlI
red
) was rapidly mixed 
with O2-saturated buffer at 4 °C ( Scheme 3-2 and Figure 3-2) to yield Sample A. 
 
CmlI
red
 + NO-CAM  → CmlIred–[NO-CAM] 
CmlI
red–[NO-CAM] + O2 → P–[NO-CAM] 
P–[NO-CAM] → Sample A 
Scheme 3-2: Production of sample A from the reaction of CmlI
red
, O2, and NO-CAM. 
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Figure 3-2: Reaction of CmlI
red
 with NO-CAM. (A) 100 μM NO-CAM added anaerobically to 100 μM 
CmlI
red
, forming the nearly stoichiometric ES complex CmlI
red
-[NO-CAM] (black trace) that was rapidly 
mixed with O2 saturated buffer (~1.8 mM) to yield Sample A (blue trace). Inset: HPLC analysis of CmlI
red
-
[NO-CAM] yielded mostly NO-CAM (black HPLC trace) as expected, while analysis of Sample A shows 
that the NO-CAM was converted into CAM product (blue HPLC trace). (B) Stopped-flow time course of 
the reaction described in (A). The time course (black) fits to a triple summed exponential (red, residuals in 
blue).  1/τ1 = 24 ± 1 s
-1, 1/τ2 = 0.6 ± 0.1 s
-1
 and 1/τ3 = 0.05 ± 0.01 s
-1
. Buffer: 50 mM Bicine, pH 9, 4 °C. 
 
The time course of the reaction monitored at 500 nm by stopped-flow spectroscopy is fit 
well by the sum of three exponential expressions with reciprocal relaxation times of 24 ± 1, 0.6 ± 
0.1 and 0.05 ± 0.01 s
-1
, respectively (Figure 3-2B).  Given the previously observed rapid, 
irreversible formation of P, and the direction and magnitude of the spectral change,
52
 it is likely 
that the fastest of the values correlates with the rate constant for P formation.  However, it 
remains unclear whether the slower two phases arise from a two-step reaction or two parallel 
pathways leading to loss of P.  In either case, these reciprocal relaxation times imply that the 
reaction steps occur with rate constants 100-1000 fold faster than the rate constant for P 
autodecay (~0.0006 s
-1
). It is evident that the increase in rate constant for P decay was caused by 
a reaction(s) that leads to formation of CAM because analysis of Sample A by HPLC showed 
only this product (Figure 3-2A, inset). The yield of CAM was ~50% in these experiments.  Less 
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than stoichiometric yields were consistently observed for reactions utilizing NH2-CAM and, to a 
lesser extent, NO-CAM as substrates. The low yields may result from uncoupling of the reaction 
at the high enzyme and substrate concentrations used in single turnover experiments (see 
discussion). A control reaction of diferric CmlI and NO-CAM yielded no CAM product or 
spectral changes either in the presence or absence of O2, demonstrating that NO-CAM reacts 
exclusively with the P form of CmlI. 
Reaction of NH(OH)-CAM with CmlI and Determination of NHOH-CAM as a 
Substrate-Based Intermediate and Catalytically Relevant Reducing Agent. NH(OH)-
CAM was synthesized from NO-CAM by reaction with reduced glutathione.
151
 NH(OH)-CAM 
was reacted separately with P and CmlI
ox
, under aerobic conditions followed by acid quench. 
Remarkably, both reactions yielded CAM as the primary product, with a small amount of NO-
CAM as either a product or a side product of acid-mediated decay of NH(OH)-CAM. NH(OH)-
CAM is a relatively unstable compound which could potentially yield CAM in a non-specific 
reaction.  To explore this possibility, it was acid quenched in buffer. This
 
control yielded only 
NO-CAM product, likely resulting from the acid-mediated decay of NH(OH)-CAM in the quench 
procedure. These results indicate that the observed CAM production was mediated by CmlI 
(Figure 3-3).  
When reacted aerobically with a 10-fold excess of NH(OH)-CAM, P and CmlI
ox
 
produced 5.9 ± 0.6 and 5.7 ± 0.1 equivalents of CAM product, respectively, under the conditions 
of Figure 3-3. The remaining NH(OH) -CAM was converted to NO-CAM in the acid quench. 
Thus, both reactions are catalytic with no requirement for external reducing equivalents.  This 
result suggests that NH(OH)-CAM can provide the reducing equivalents required to reduce 
CmlI
ox
 and prime it to produce P in the presence of O2.  
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Figure 3-3: Reaction of P and CmlI
ox
 with NH(OH)-CAM. The aerobic reaction of 300 μM P or CmlIox 
with one equivalent NH(OH)-CAM yields primarily CAM product. Control incubation with buffer (50 mM 
Bicine, pH 9) yields primarily NO-CAM, formed during the acid quench of the reaction.  The apparent 
yield of NO-CAM is decreased about 50% by dimerization of the NO-CAM species into azoxy-CAM.
83, 86, 
152
  Buffer: 50 mM Bicine, pH 9, 4 °C. 
 
The reaction between CmlI
ox
 and NH(OH)-CAM was followed by UV-vis spectroscopy 
to characterize pathway intermediates. The addition of NH(OH)-CAM directly to CmlI
ox
 (Figure 
3-4 and Scheme 3-3) in an anaerobic environment resulted in the formation of a diferrous CmlI 
Sample B. An aliquot of Sample B removed and quenched anaerobically yielded an HPLC peak 
with the same retention time as NO-CAM. Oxygen was then added to sample B, forming 
primarily CmlI
ox
, Sample C. HPLC analysis of Sample C showed that the NO-CAM species had 
disappeared and CAM was formed in its place. Total CAM yield was ~70% versus initial P 
concentration.  
 
CmlI
ox
 + NH(OH)-CAM → Sample B 
Sample B + O2 → Sample C 
Scheme 3-3: Production of samples B and C from the reaction of CmlI
ox
 and NH(OH)-CAM. 
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Figure 3-4: Stepwise characterization of the reaction of CmlI
ox
 with NH(OH)-CAM by UV-vis and HPLC. 
Optical absorbance spectra and product analysis in the reaction of 560 μM NH(OH)-CAM with 560 μM 
anaerobic CmlI
ox
 (red spectrum), which yields Sample B (black spectrum) which contains NO-CAM 
product (black HPLC trace). Addition of O2 yields Sample C (blue spectrum) which contains primarily 
CmlI
ox
 and CAM product (blue HPLC trace). Buffer: 50 mM Bicine, pH 9, 4 °C. 
 
The oxidation state of the diiron cluster at each stage of the reaction was directly 
determined in a parallel Mössbauer experiment as shown in Table 3-2 and Figure 3-5. The 
anaerobic addition of approximately one equivalent of NH(OH)-CAM to CmlI
ox
 generates 
Sample B, the major component, representing 65% of the total iron in the sample, was assigned to 
a diferrous cluster. The remaining species were assigned to diferric clusters (~30%) and a small 
amount of unassigned mononuclear ferric material (~7%). Addition of O2 to this sample formed 
Sample C, which by UV-Vis appeared as primarily CmlI
ox
 and accordingly exhibited the 
Mössbauer parameters of the diferric enzyme, which represents ~ 90% of the total iron in the 
sample. The different Mössbauer parameters of the CmlI
ox
 before and after the reaction with 
NH(OH)-CAM could be due to the perturbation of the diiron centers by substrate/product binding 
or a change in the pH of the cluster environment; further studies are needed to resolve the detailed 
mechanisms resulting in such a difference. 
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Figure 3-5: Stepwise characterization of the diiron center during NH(OH)-CAM oxidation by CmlI
ox 
by 
Mössbauer spectroscopy. Left: Mössbauer spectrum measured under 0.45 kG and 4.2 K of various samples 
indicated in the figure; Purple: the simulation for diferric species (CmlI
ox
) in the sample; Green: the 
simulation for diferrous species (CmlI
red
) in the sample Right: the corresponding Mössbauer spectra 
recorded under 7.0 T and 4.2 K. Red: experimental spectra; Black: spectral simulation curves; Purple: the 
simulation for diferric species (CmlI
ox
) in the sample; Green: the simulation for diferrous species (CmlI
red
) 
in the sample. For the spectra in the right panel, the mono-ferric species represents ~0%, ~7% and ~ 9% of 
the total iron in the sample from top to bottom.  
 
 
 
 
Table 3-2: Mössbauer quantification of CmlI forms during single turnover reactions 
 Sample
a
 
Species
b
 (%) B C D
c
 E F
d
 G 
CmlI
ox
 30 ± 3 90 ± 3 17 ± 3 85 ± 3 35 ± 3 75 ± 5 
CmlI
red
 65 ± 3 0 68 ± 2 0 30 ± 3 0 
Unassigned 
mononuclear 
ferric species 
7 ± 3 9 ± 3 14 ± 3 14 ± 3 30 ± 5 23 ± 5 
a
Mössbauer spectra and parameters of the species found in each sample are presented in Supporting 
Information Figures S2-S5. 
 b
Species are identified by the oxidation state of the diiron cluster. They may 
also have intermediate products bound in some cases. An ~10% conversion to diferric is expected in the 
Mössbauer samples vs the optical time course experiments due to autodecay of P during addition time 
required to prepare these high concentration samples. The presented quantifications do not include P, see 
Supporting Information for details.   
c
Starting sample of P prior to degassing contained 72% P, 24% 
CmlI
ox
, and 4% unassigned ferric species. 
d
Starting sample of P prior to degassing contained 60% P, 36% 
CmlI
ox
, and 4% unassigned ferric species.
 
67 
 
Addition of approximately one equivalent of NH(OH)-CAM to P resulted in Sample D 
(Scheme 3-4), which has a UV-Vis spectrum that reflects a mixture of diferric and diferrous 
species (Figure 3-6, black trace). Analysis of Sample D by HPLC shows generation of CAM 
product in ~45% yield vs. initial NH(OH)-CAM concentration (Figure 3-6, inset, black). Addition 
of O2 to Sample D produced Sample E (Figure 3-6, red trace) and an increase in CAM product, 
presumably arising from unreacted NH(OH)-CAM (Figure 3-6, inset, red). The spectrum of 
Sample E is best fit by summing the spectra of approximately 80% CmlI
ox
 and 20% P. 
  
CmlI
red
 + O2 → P 
P + NH(OH)-CAM → Sample D 
Sample D + O2 → Sample E 
Scheme 3-4: Production of samples D and E from the reaction of CmlI
red
, O2, and NH(OH)-CAM. 
 
 
 
Figure 3-6: Stepwise characterization of the reaction of P with NH(OH)-CAM. Absorbance spectra and 
product analysis in the anaerobic reaction of 300 μM NH(OH)-CAM with 300 μM P (orange trace), which 
yields Sample D (black spectrum). Addition of O2 forms Sample E (red trace). Inset: HPLC analysis of 
CAM and NO-CAM products from Sample D (black trace) and Sample E (red trace). Buffer: 50 mM 
Bicine, pH 9, 4 °C. 
       
Mössbauer analysis of parallel samples (Figure 3-7) is generally consistent with the 
results observed by UV-Vis spectroscopy. In the Mössbauer experiment, P was formed in 72% 
yield and then degassed, leaving ~ 60% P and ~36% diferric CmlI (plus 4% mono-ferric 
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material).  After anaerobic addition of one equivalent of NH(OH)-CAM versus total active site 
concentration and a 5 minute incubation, the resulting Sample D was ~68% CmlI
red
 and ~17% 
diferric clusters (Table 3-2). The observation of CmlI
red
 and CAM (Figure 5) suggests that this 
reaction proceeds at least in part by the route proposed by Bollinger, Krebs and coworkers for 
reaction of NH(OH)-Ar with the peroxo intermediate of AurF. The latter reaction yields NO2-Ar 
and diferrous AurF (see Scheme 2, pathway II). 
85
 The generation of 68% CmlI
red
 was 
accompanied in this experiment by production of 62% CAM (product yield differences were 
observed between the optical and Mössbauer experiments, but the trends remained the same). 
These values support the reduction of CmlI
ox
 by N(OH)2-CAM to yield roughly equal amounts of 
CAM and CmlI
red
.  A small amount of NO-CAM is also observed suggesting that the CmlI
ox
 
fraction also reacts with NH(OH)-CAM to yield CmlI
red
 and NO-CAM.  Consequently, only part 
of the observed CmlI
red
 derives from pathway II, thereby slightly decreasing the relative yield of 
CAM.  
 
 
Figure 3-7: Stepwise characterization of diiron center during the NH(OH)-CAM oxidation by P. Left: 
Mössbauer spectrum measured under 0.45 kG and 4.2 K of various samples indicated in the figure; Right: 
the corresponding Mössbauer spectra recorded under 7.0 T and 4.2 K. Red: experimental spectra; Black: 
spectral simulation curves; Purple: the simulation for the  diferric species (CmlI
ox
) in the sample; Green: the 
simulation for the diferrous species (CmlI
red
) in the sample. For the spectra in the right panel, the mono-
ferric species represents ~14% of the total iron in the sample in both spectra. The detailed relative iron 
concentrations of different species in each spectrum are listed in Table 2 of the main text. 
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Addition of excess O2 to Sample D formed Sample E, which Mössbauer spectra show to 
contain ~85% CmlI
ox
. This value is similar to the approximately 80% CmlI
ox
 and 20% P observed 
by UV-Vis spectroscopy.  The difference in the percentages derived from UV-Vis and Mössbauer 
data can be attributed to some P decay during the extended Mössbauer sample preparation 
process. Formation of Sample E is accompanied by formation of an additional 10% CAM 
product, which probably arises from the re-formation of P and its reaction with residual NH(OH)-
CAM. It is unclear why the remaining unreacted CmlI
red
 is converted to CmlI
ox
 rather than P but 
we demonstrate above that the process of forming P is less than stoichiometric, resulting in a 
significant amount of adventitious CmlI
ox
 formation.   
 
Reaction of CmlI
red
, O2, and NH2-CAM Confirms NH(OH)-CAM and NO-CAM as 
Intermediates.  It is shown above that P reacts individually with NH2-CAM, NH(OH)-CAM 
and NO-CAM to produce chloramphenicol; however it is also important to demonstrate the 
reaction of NH2-CAM beginning with CmlI
red
 also proceeds through the NH(OH)-CAM and NO-
CAM intermediates. Accordingly, the reaction between NH2-CAM, CmlI
red
, and O2 was 
monitored in a stepwise fashion using UV-Vis spectroscopy (Figure 3-8 and Scheme 3-5). The 
addition of O2 to CmlI
red
 formed P, which was made anaerobic and then reacted with one 
equivalent of NH2-CAM. The resulting species, Sample F, lacks the strong absorbance band at 
375 nm that is characteristic of CmlI
ox
 and the band at 500 nm characteristic of P. Sample F looks 
similar to CmlI
red
 save for an additional shoulder at ~ 400 nm, which may be attributable to the 
presence of a substrate or product. NO-CAM has significant absorbance at 400 nm, and so a 
sample of CmlI
red
 combined with NO-CAM was prepared for comparison. Sample F exhibits a 
spectrum similar to that of the comparison sample, supporting its assignment as CmlI
red
 bound to 
one equivalent of NO-CAM. Differences between Sample F and authentic diferrous CmlI-NO-
CAM can be attributed to an estimated 10% O2 contamination introduced during handling of the 
P sample, leading to oxidation of the diferrous cluster after the CmlI
red
-NO-CAM complex is 
formed. When oxygen was added to Sample F, a species which exhibits a spectrum that overlays 
with an independently prepared sample of decayed P (i.e. CmlI
ox
) was observed (Sample G).  
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CmlI
red 
+ O2 → P 
P + NH2-CAM → Sample F 
Sample F + O2 → Sample G 
Scheme 3-5: Production of samples F and G via the reaction of CmlI
red
, O2, and NH2-CAM. 
 
 
 
Figure 3-8: Spectroscopic snapshots of the CmlI catalytic cycle and HPLC analysis of associated products. 
The reaction began with 600 μM CmlIred (grey trace), to which O2 was added to form P (orange trace). 
Anaerobic addition of 600 μM NH2-CAM yields Sample F (solid black trace), proposed to be CmlI
red
-NO-
CAM by comparison to independently prepared 600 μM CmlIred-NO-CAM (dotted black trace). The 
addition of O2 to Sample F yields Sample G (solid blue trace), which nearly overlays with an independently 
prepared 600 μM decayed P sample (dotted blue trace). Inset: HPLC analysis of products in Sample F 
(black trace) and Sample G (blue trace). Sample F yields NO-CAM as the primary product and Sample G 
shows that NO-CAM has been consumed and CAM produced. Buffer: 50 mM Bicine, pH 9, 4 °C 
 
Aliquots of Sample F and G were analyzed by HPLC. Sample F was found to contain 
primarily NO-CAM in an acid quench experiment.  Repeating this experiment using a spin 
quench method gave the same results, eliminating the possibility that the sample contained 
NH(OH)-CAM which was then converted to NO-CAM under acidic conditions. A small amount 
of CAM was also present corroborating the 10% O2 contamination during handling of P proposed 
above. An aliquot of the reaction end point Sample G contained no NO-CAM, presumably 
because it had been converted to CAM, which was detected as the sole product. These results 
suggest that CmlI is re-reduced concomitantly with the production of NO-CAM, and that the 
addition of O2 converts the new CmlI
red
 to CmlI
ox
 (presumably with P as an intermediate) while 
NO-CAM is converted to CAM. The yield of CAM from a single turnover reaction using NH2-
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CAM as the substrate is ≤ 30%, in contrast to the nearly stoichiometric yields observed when 
using NH(OH)-CAM as the substrate in a single turnover experiment.   
Corroborating evidence for the proposed oxidation states was provided by analyzing a 
parallel experiment by Mössbauer spectroscopy (Table 3-2 and Figure 3-9). P was formed in 
~60% yield as CmlI
red
 reacted with O2. The remaining iron was 36% unreacted CmlI
ox
 and 4% of 
a paramagnetic component that can be attributed to adventitious mononuclear iron sites in the 
enzyme. Formation of Sample F by addition of NH2-CAM to P in the absence of excess O2 causes 
the disappearance of >90% of P and the emergence of CmlI
red
. Interestingly, only ~55% of P 
decays to CmlI
red
 in Sample F; the rest decays to one or more unidentified mononuclear ferric 
species, representing ~ 30% of the total iron in the sample. Addition of O2 to yield sample G 
regenerates ~75% diferric enzyme in the sample, the rest of the sample is still the mononuclear 
ferric species (~ 23%). Therefore, the Mössbauer results suggest that P is prone to degradation by 
an unknown mechanism when reacting with NH2-CAM under the experimental conditions we 
applied, causing significant uncoupling of the reaction. Based on the amount of CmlI
red
 generated 
(35%) in the anaerobic reaction, it is understandable that the yield of CAM from a single turnover 
reaction using NH2-CAM as the substrate is sub-stoichiometric as observed in HPLC analysis.  
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Figure 3-9: Stepwise characterization of diiron center during  NH2-CAM oxidation by P by : Mössbauer 
spectroscopy. Left: Mössbauer spectrum measured under 0.45 kG and 4.2 K of various samples indicated in 
the figure; Right: the corresponding Mössbauer spectra recorded under 7.0 T and 4.2 K. Red: experimental 
spectra; Black: spectral simulation curves; Blue: the 36% diferric (CmlI
ox
) species in the sample containing 
P; Purple: the simulation for diferric species (CmlI
ox
) in the sample; Green: the simulation for diferrous 
species (CmlI
red
) in the sample. The spectra in the left panel were used for characterizing the different 
oxidation state of the diiron center; and the spectra in the right panel were used for quantifying the amount 
of mono-ferric species. For the spectra in the right panel, the mono-ferric species represents ~5%, ~30% 
and ~ 23% of the total iron in the sample from top to bottom. The detailed relative iron concentrations of 
different species in each spectrum are listed in Table 3-2.  
 
CmlI is in the Oxidized State After a Single Turnover.  It has been reported that the AurF 
single turnover ends with the enzyme in the diferrous state (Scheme 3-1, pathway II).
10
 Under 
conditions of stoichiometric NH(OH)-Ar substrate and excess O2, the AurF diferric peroxo 
species re-formed and was detected by its characteristic Mössbauer spectrum and absorbance at 
500 nm.
10
 It is shown here that the reactions of P with NH2-CAM and NO-CAM end with CAM 
production and CmlI in the diferric state. In addition, the reaction of P with NH(OH)-CAM yields 
an intermediate diferrous state and CAM prior to O2 addition. When assessed by its optical 
spectrum, a fraction of this sample is found as P at its completion.  The N(OH)2 reduction 
mechanism proposed by Bollinger and coworkers suggests that the reaction of P with a 
substoichiometric amount of NH2-Ar substrate should result in the decay and partial reformation 
of P. The conclusion that CmlI does not end up in the reduced state after a single turnover of the 
native substrate is confirmed by the time course of a reaction of P with a substoichiometric 
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concentration of NH2-CAM shown in Figure 3-10, red trace. Rapidly mixing P with 0.25 or 0.5 
equivalents of NH2-CAM in an oxygenated buffer at 4 °C led to only a rapid decay of P to 
CmlI
ox
. In contrast, the reaction with 1.0 equivalent NH(OH)-CAM showed decay and then 
partial reformation of P within two seconds (Figure 3-10, blue trace). The observation of re-
formed P suggests that the reaction of P with NH(OH)-CAM leads to substantial formation of the 
diferrous cluster, as reported for AurF-peroxo and NH(OH)-benzoate.
85
 Rates of P decay and 
reformation are sufficiently similar such that only a small percentage of decay is observed before 
the reformation process begins. Thus, using equivalents of NH(OH)-CAM below or above the 
stoichiometric amount masks the reformation process. 
 
 
Figure 3-10: Single turnover reaction of P with 0.5 x NH2-CAM (red trace) and 1.0 x NH(OH)-CAM (blue 
trace). Single wavelength (500 nm) stopped flow traces for the reaction of 260 μM P and 130 μM NH2-
CAM or 260 µM NH(OH)-CAM (post-mix concentrations) in the presence of excess O2. No P reformation 
is observed in the reaction with the native substrate NH2-CAM, suggesting that the in-vitro reaction ends in 
the diferric state. The reactions using the same concentrations of NH2-CAM and NH(OH)-CAM give the 
same results but the reformation of P in the case of the latter substrate is masked due to the rates of the 
decay and re-formation reactions.  Buffer: 50 mM Bicine, pH 9, 4 °C.    
    
Exchange of NO-CAM from the CmlI Active Site. In order to test whether NO-CAM can 
leave and reenter the active site during the reaction cycle, 
18
O2-P was degassed to remove excess 
O2, and equilibrated in an anaerobic chamber before 1 equiv. NH2-CAM was added.  After a 20 s 
incubation, 1 equiv. N
16
O-CAM was added. The sample was then quickly put under an 
18
O2 
headspace and allowed to react for 10 min. Samples were acid quenched and analyzed by LCMS. 
Control samples were made by adding buffer instead of NO-CAM. If the NO-CAM made during 
the reaction cannot leave the active site, then only CAM containing 
18
O in the nitro group should 
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be made. If, however, NO-CAM can leave and subsequently re-bind in the active site after 
16
O-P 
has formed, then there should be some CAM formed with both 
18
O and 
16
O in the nitro group. As 
shown in Figure 3-11 and Table 3-3, approximately 20% more 
16
O,
18
O CAM is formed compared 
to the control, suggesting that at least 20% of the NO-CAM dissociates during the course of the 
experiment. Unfortunately, the short lifetime of the NH(OH)-CAM intermediate prevented a 
similar evaluation of dissociation from the active site. 
 
Table 3-3: Exchange of NO-CAM from the CmlI active site during single turnover
a
 
isotopic composition 
in CAM nitro group  
18
O2-P + NH2-CAM 
% 
18
O2-P + NH2-CAM   
followed by N
16
O-CAM 
%  
16
O, 
16
O 2 ± 1 5 ± 3 
16
O, 
18
O 13 ± 2 28 ± 3 
18
O, 
18
O 85 ± 4 66 ± 6 
a
Reaction performed with one equivalent of each substrate as described in the text. 
 
 
 
Figure 3-11: NO-CAM exchange test. Reaction of 200 μM of NH2-CAM with 200 μM 
18
O2-P, followed  
20 s later by addition of buffer or NO-CAM under an 
18
O2 atmosphere. Presence of mixed labeled CAM in 
the reaction in which NO-CAM was added shows that NO-CAM can exchange from the active site given a 
20 s incubation period. Buffer: 50 mM Bicine, pH 9, 4 °C.    
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Discussion 
Summary of Findings. It is shown here that the CmlI reaction cycle intermediate P reacts with 
the native substrate NH2-CAM as well as the reaction pathway intermediates NH(OH)-CAM and 
NO-CAM to yield CAM.  Moreover, NH(OH)-CAM is found to reduce CmlI
ox
 to yield CmlI
red
, 
which can subsequently form P in the presence of O2. These observations provide the basis for 
the new single turnover mechanistic cycle shown in Scheme 3-6 in which re-reduction of CmlI
ox
 
by NH(OH)-CAM, formed during the reaction of P with NH2-CAM, allows formation of CAM 
with the input of only two non-substrate-derived electrons (supplied in vivo by an as yet 
unidentified reductase). This cycle is conceptually similar to a recent model proposed for AurF.
85
  
However, it differs in both the pathway intermediate that serves as the reductant and the state of 
the enzyme diiron cluster at the conclusion of a single turnover cycle. The mechanistic 
significance of these observations will be discussed here. 
 
 
Scheme 3-6: Proposed single turnover reaction pathway of CmlI. Reduction steps are shown in red. 
 
Comparison to a Model Requiring Three Successive Reactions with P. As shown in 
Scheme 2, pathway I, the original model for the 6-electron oxidation of NH2-Ar substrates 
envisioned three similar successive oxidation reactions, each utilizing a P-like intermediate (or a 
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high valent species derived from it).  This model was supported by the observation that a titration 
of P with NH2-CAM, or the equivalent titration for the AurF system, had approximately a 3:1 
stoichiometry.
52-53, 76, 83
  The current results show that the reaction of NH(OH)-CAM with either 
CmlI
ox
 or P approaches 1:1 stoichiometry and yields CAM as the major product.  These results 
suggest that the original mechanistic proposal is not correct and that at least one step of the 
reaction involves oxidation of a pathway intermediate coupled to reduction of CmlI
ox
.   
 Based on the stepwise study of the reaction shown in Figure 3-8, the reaction of NH2-
CAM with P (i.e. CmlI
red
 + O2) to produce CAM also proceeds by utilizing a pathway 
intermediate to re-reduce the diiron cluster.  The reductive pathway intermediate is again 
NH(OH)-CAM.  However, the overall yield of CAM from this reaction is typically 33% or less, 
due presumably to uncoupling.  We believe that this fortuitous fractional loss of yield led to the 
observed roughly 3:1 P to NH2-CAM ratio that supported the original mechanistic proposal. 
 
Comparison of the Mechanistic Models Employing a Pathway Intermediate as an 
Electron Source. The observation by Bollinger, Krebs, and coworkers that the reaction of 
NH(OH)-Ar with the AurF-peroxo intermediate led to NO2-Ar product plus diferrous AurF under 
anaerobic conditions initiated a new way to think about the amine oxygenase chemistry. 
85
  It was 
proposed that N(OH)2-Ar is formed as an intermediate and then acts as the reducing agent for 
diferric AurF as it itself is oxidized to NO2-Ar. However, despite the structural similarity and 
common reaction type of AurF and CmlI, we do not believe that CmlI follows this mechanistic 
pathway during its native cycle.  Scheme 3-7, pathways II and III, respectively, compare an 
AurF-type mechanism to that proposed here for CmlI for CAM formation.  We believe that 
pathway III better describes the native reaction for CmlI for five reasons: (1) NH(OH)-CAM is 
shown to act as an efficient reducing agent for CmlI
ox
, and it is the consensus first intermediate in 
both pathways II and III. (2) In general, hydroxylamines are efficient reducing agents for iron. 
The reduction of ferric to ferrous ion is well documented in the organic synthetic literature, and it 
is an essential step of colorimetric assays to determine iron concentration. 
151, 153-154
 In contrast, 
N(OH)2-Ar is more likely to hydrolyze quickly to the NO-CAM intermediate rather than act as a 
reducing agent. (3) The single turnover reaction of stoichiometric NH2-CAM and P proceeds 
through NO-CAM, and NO-CAM is independently shown to react with P to form CAM.  (4) 
After a single turnover of sub-stoichiometric NH2-CAM and P under aerobic conditions, CmlI
ox
 
rather than CmlI
red
 or P is observed.  This requires that the pathway reducing agent not act in the 
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final step of the pathway because doing so would generate a reduced diiron cluster after the final 
step. (5) As shown in Scheme 3-7, a single turnover reaction of 
18
O-P in an 
16
O2 atmosphere and 
H2
16
O would be expected to give mixed-labeled product by pathway III but not by pathway II. 
Mixed-labeled CAM product was, in fact, observed for the CmlI reaction (Table 1).  
 Although this data set strongly supports the reaction pictured in Scheme 3-6 and Scheme 
3-7, pathway III as the best fit for the CmlI cycle, it also reveals the complexity of the reaction. 
For example, in the reaction of NH2-CAM with 
18
O-P in an 
16
O2 atmosphere and H2
16
O, doubly 
18
O-labled product was observed in addition to the mixed-labeled CAM product predicted by 
Scheme 3-7, pathway III.  Two ways in which this might come about are: (1) partial dissociation 
of NO-CAM and subsequent reaction with unreacted 
18
O-P, or (2) partial dissociation of 
NH(OH)-CAM and subsequent reaction with 
18
O-P through pathway II.  We view the latter 
possibility as unlikely because CmlI
ox
 and NH(OH)-CAM are formed simultaneously in the 
active site where the observed redox reaction to form Cml
red
 and NO-CAM would be expected to 
occur efficiently. Approximately 50% of the NH(OH)-CAM would have to dissociate and react 
through pathway II in order to account for the amount of mixed-label CAM observed. However, 
very little CAM and no NH(OH)-CAM are observed in the stepwise reaction of NH2-CAM with 
P illustrated in Figure 3-8 prior to addition of O2. In contrast, generation of mixed-label CAM via 
the partial dissociation of NO-CAM is possible based on the exchange experiment illustrated in 
Figure 8. It is possible that these alternative pathways as well as the lower that stoichiometric 
yields in some cases described above result from performing the reaction under single turnover 
conditions without the native reductant.  Indeed, protein interactions are very important 
throughout the diiron oxygenase family but cannot be explored in the current case because the 
native reductase has not been identified for any amine oxygenase.
155-157
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Scheme 3-7: Comparison of oxygen incorporation into CAM via different pathways. 
 
   Although pathway III better describes the native CmlI pathway, the off-cycle or 
artificial reaction of P with NH(OH)-CAM was carried out to make a direct comparison to the 
analogous reaction in the AurF cycle. In accord with the results reported for the anaerobic 
reaction of the AurF-peroxo intermediate reaction with NH(OH)-Ar,
85
 we find that CmlI
red
 and 
CAM are produced when P is reacted with NH(OH)-CAM.  This reaction would not be on-
pathway for Scheme 3-7, pathway III, as only CmlI
ox
 and NH(OH)-CAM are found together in 
the active site, thereby allowing the redox reaction to occur. Consequently, the off-pathway 
reaction for CmlI might occur as proposed for AurF (Scheme 3-7, pathway II).  However, the 
subsequent addition of O2 was found to yield additional CAM and CmlI finishes in the mostly 
oxidized rather than reduced or P states expected based on the reported AurF reaction. 
85
  
Additional kinetic and spectroscopic studies will be required to fully characterize the off-pathway 
reaction of P with NH(OH)-CAM.    
 
Mechanistic Significance.  The reactivity of the various activated forms of O2 created by 
diiron clusters is of great current interest.
158-159
  In the past, there has been significant focus on the 
high-valent species that can transfer oxygen into very stable C-H bonds, such as in the reaction of 
sMMOH compound Q with methane.
8, 31, 91
  The potential reactivity of peroxo or superoxo 
intermediates has, by contrast, come to light only recently.
93, 159-160
  The activity, novel structure, 
and long lifetime of the CmlI peroxo intermediate P offer an opportunity to explore new aspects 
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of the formation and reaction of peroxo species in diiron-cluster containing enzymes.   Indeed, we 
find that P, proposed to have a µ-12 peroxo core,52 is quite reactive with both aromatic amine 
and aromatic nitroso substrates. The 
18
O2 incorporation studies reported here show that both of 
the nitro oxygens in the final product derive from O2, but it is clear that they are added in a 
stepwise fashion from different O2 molecules (via two successively formed P intermediates), 
because a mixed-isotope product is obtained when 
18
O-P is reacted with NH2-CAM in an 
16
O 
atmosphere. Thus, CmlI is a monooxygenase where the reactive oxygen species is formed prior to 
O-O bond cleavage, quite distinct from the high-valent strategy used by sMMOH-type diiron 
monooxygenases.
8
 The use of a diferric peroxo species may allow the enzyme to catalyze a wide 
range of N-oxygenation reactions.  Over the course of the amine to nitro conversion, the substrate 
becomes increasingly electron deficient. Thus P must be ambiphilic, able to shift from acting as 
an electrophilic species for the oxygenation of NH2-CAM to a more nucleophilic oxidant for 
oxygenation of NO-CAM. It is significant that, despite the monooxygenase reactivity of CmlI, it 
cannot oxygenate C-H bonds of aromatic or aliphatic hydrocarbons.
52
  While this may be 
attributed to several causes including the relative bond stability of these substrates, it may also 
reflect the unique structure of the CmlI P intermediate and its environment.  For example, this 
environment may restrict access to the protons thought to play a role in the generation of the 
high-valent oxo or bis µ-oxo intermediates of hydrocarbon monooxygenases.
33, 91
   
 
Conclusions  
Aromatic amine oxygenation deviates from the paradigm of diiron oxygenation chemistry in 
several ways.  While cluster reduction and formation of a peroxo intermediate is shared among 
oxygen-activating diiron oxygenases, the structure of the peroxo intermediate P of the CmlI 
aromatic amine oxygenase is unique.
52
  This specialized peroxo intermediate is highly reactive 
with NH2-CAM and the other amine oxidation pathway intermediates, while the peroxo 
intermediates of other oxygenases serve primarily as unreactive stepping stones to reactive high 
valent intermediates.    Another remarkable aspect of the diiron cluster of the aromatic amine 
oxygenases CmlI and AurF is their ability to use intermediate products as mid-pathway diiron 
cluster reductants in place of the reductase used by all other diiron oxygenases.  This means that a 
6-electron oxidation of the NH2-Ar substrate could occur without dissociation of the intermediate 
products, thereby avoiding release of hydroxylamino- and nitroso-intermediates that might be 
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damaging to the cell. While the results presented here show that dissociation is possible at the 
NO-Ar stage, the time scale for release versus the rate of normal catalysis appears to be slow. The 
versatility of the P intermediate allows it to react with intermediate products that it would not 
normally encounter in the native pathway to CAM formation.  In particular, the P reaction with 
NH(OH)-CAM would not normally occur because they are not present at the same time in the 
cycle.  Nevertheless, this reaction can occur with high efficiency when these reactants are 
separately prepared and mixed, and it leads to the same CAM product, albeit through an 
alternative reaction pathway. 
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Chapter 4  
 
Kinetic Characterization of P Formation and the CmlI 
Mechanism  
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Introduction 
Diiron-cofactor-containing aryl-amine oxygenases are unusual in that they catalyze a six-
electron substrate oxidation using an oxidant that can transfer, at most, two electrons at a time. 
Initial hypotheses suggested a logical mechanism in which the two-electron oxidant was formed 
thrice in an identical manner, requiring the injection of six external electrons in order to generate 
the activated form of oxygen that serves as the oxidant.
75, 83
 Recent work has provided evidence 
for a second, more efficient, mechanism that requires the injection of only two exogenous 
electrons.
85, 161
 One iteration of this mechanism has been described for the diiron cluster N-
oxygenase CmlI, and proceeds as follows (Figure 4-1): the diiron cluster accepts two electrons 
and binds O2 to form a diferric peroxo species (P) that oxygenates the aryl-amine substrate to an 
aryl-hydroxylamine substrate. P is converted to a diferric resting state after performing this 
oxygenation. The hydroxylamine substrate then reduces the diferric cluster to a diferrous state, 
priming it to re-form P upon the addition of O2. The aryl-hydroxylamine substrate is itself 
oxidized to the nitroso intermediate. Finally, the second P species oxygenates the aryl-nitroso 
intermediate to the aryl-nitro final product. The only exogenous electrons required are those to 
convert the resting state diferric CmlI to diferrous, so that P can be formed to initiate the 
oxidation of another substrate molecule.   
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Figure 4-1: Proposed mechanistic cycle for N-oxygenation by CmlI. Reduction steps are shown with red 
arrows. Color coding of the oxygen atoms highlights the fact that oxygen atoms from two different O2 
molecules are incorporated into the final product.  
 
The proposed intermediates on this cycle, both enzyme- and substrate-based, have been 
trapped and characterized by spectroscopic and analytical methods. Much of the previous work 
was done by analyzing intermediates with a freeze-frame approach, artificially pausing the 
reaction at different points, or by analyzing products at the end of the reaction cycle. We would 
like to verify the proposed reaction cycle in real time using transient kinetic analysis.   
In this work, the kinetic constants describing various steps of the proposed CmlI single 
turnover reaction are described. The experimental approach was to isolate steps of the reaction 
cycle as much as possible in order to minimize the number of processes monitored at one time. 
Kinetic constants and trends were measured for individual steps of the cycle and compared to 
those of the overall cycle. An encompassing kinetic mechanism was constructed using rate 
constants derived from the experimental data and from simulations of the experimental data. This 
approach allowed assessment of the model proposed by the mechanism in which the aryl-
hydroxylamine serves as the reducing agent, as well as reveals new aspects of the enzyme cycle 
and its regulation.  
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Results 
Kinetic Parameters of P Formation. The diferric peroxo species of CmlI (P) forms within 
seconds when chemically reduced diferrous CmlI (CmlI
red
) is combined with O2.  P is highly 
stable in the absence of substrate, exhibiting a t1/2 ~ 3 h at 4 °C and pH 9, and thus the formation 
reaction is expected to be irreversible. To determine the rate constant(s) for P formation, 
anaerobic CmlI
red
 was mixed with 5-36 equivalents of O2 on a stopped-flow UV-vis instrument. 
The formation of P was followed at 300 nm, the wavelength where optical changes due to P 
formation are maximized. The resulting traces are best fit by a three summed exponential 
expression (Figure 4-2 and Table 4-1) (complete description of analysis of transient kinetic data is 
found in Chapter 5, “Trace Fitting and Rate Constant Determination.”) Plotting the reciprocal 
relaxations times (RRTs) versus O2 concentration shows that all three phases have a linear 
dependence on O2 concentration (Figure 4-3). The magnitude of the total amplitude change stays 
the same over the range of O2 concentrations tested, and the three observed phases are 
approximately equal in amplitude. The contribution of phase three to the total change in 
amplitude increases from 30% to 50% over the range of O2 concentrations, while the first and 
second phase decrease equally and accordingly. This may be due to the fact that the third phase 
makes an increasing contribution to the portion of the time course observed as the O2 
concentration increases, thereby increasing the accuracy of the RRT values obtained.   
 
 
Figure 4-2: Optical changes correlated with the formation of species P. Single- (blue), double- (gray), and 
triple- (red) exponential fits of the P formation process shown by the black trace. Fit residuals are shown 
below the trace and highlight the need for a three exponential fit. 50 mM Bicine pH 9, 4 °C.  
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The presence of three phases linearly dependent on substrate is most easily accounted for by three 
parallel reactions to form P, rather than a single P formation process that employs three 
consecutive steps. Presently, we do not have evidence for more than one form of P and the 
Mössbauer spectrum of P shows only one type of cluster.
52
  If there are more forms of P that are 
not distinguishable by Mössbauer, they all appear to react rapidly with substrates, exhibiting the 
same rate constant (see below).  The multiple phase P formation behavior is likely to be the result 
of either or both of the following scenarios: (a) three different pathways for O2 to bind that all 
lead to the same P, or (b) CmlI
red
 exists in three different structural or protonation states that 
differentially affect P formation. Plots of all phases have a y-intercept close to zero, showing that 
the formation of P in the absence of substrate is nearly irreversible, as expected. This finding is 
also in accord with our previous demonstration that P does not exchange with head space O2 over 
the course of hours.
161
 
 
Figure 4-3: O2 dependence of P formation. 40 µM CmlI
red
 (final, post mix concentration) was mixed in a 
1:1 ratio with varying concentrations of O2 in buffer. RRT-1, -2, and -3 from multiexponential fitting of 
stopped-flow traces was plotted versus O2 concentration, all showing linear relationships. The second order 
rate constant (k1) for each process was determined from the slope of the linear fit to the data (solid line) and 
reported in Table 4-1. Reported error of each point is one standard deviation from the mean. 50 mM Bicine 
pH 9, 4 °C. 
 
Table 4-1: Rate constants and amplitudes for P formation.  
Phase 
k1 (s
-1
 mM
-1
)  Amplitude (%) 
 Eqv. O2 7 14 18 28 
1 58.1 ± 2.0  30 30 25 25 
2 19. 6 ± 0.4  40 30 35 25 
3 1.4 ± 0.1  30 40 40 50 
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Kinetic Parameters of P Formation with CAM Present. We hypothesized that the 
presence of a substrate might “streamline” the P formation to a single process by favoring one 
form of CmlI
red
. To simulate this reaction without using substrate, and thereby avoid complicating 
the kinetic traces with substrate-mediated decay, P was formed in the presence of the product 
CAM. The reaction of CmlI
red
 with a ten-fold excess of CAM and 3-30 equivalents of O2 results 
in the formation of a P species with comparable stability to that formed in the absence of CAM. 
This process was followed at 320 nm to avoid the significant absorbance of CAM at 300 nm.  
The resultant kinetic traces for P formation are fit best by a two-summed, rather than a 
three-summed, exponential expression (Figure 4-4A). When the two RRTs are plotted versus O2 
concentration, the best fits are by linear equations, as in the case without CAM (Figure 4-4B, C). 
The observation of only two phases suggests that there are only two ways to make P when a 
substrate-like molecule is present. The second order rate constants for P formation in the presence 
of CAM are listed in Table 4-2. The non-zero y-intercepts may be a result of experimental error 
or may be an indication that O2 binding is reversible in the presence of a substrate-like molecule. 
Because the concentration dependence of the kinetic parameters for O2 binding to form P changes 
dramatically when pseudo-first-order concentrations of CAM are present, it is likely that CAM 
binds before O2 under these conditions. These observations provide a clear indication that binding 
of product, and presumably substrate, has a significant effect on the P formation process.  
 
 
Figure 4-4: P formation in the presence of the product CAM. 40 µM CmlI
red
 (final, post mix 
concentration) was mixed in a 1:1 ratio with varying concentrations of O2 in buffer containing 400 µM 
CAM. A: P formation time course fits best to a two exponential equation (red trace), as shown by the fit 
and residuals. B: RRT-1 (black) and -2 (red) from multiexponential fitting of stopped-flow traces were 
plotted versus O2 concentration, both showing linear relationships. The extracted rate constants are found in 
Table 4-2. Reported error of each point is one standard deviation from the mean. 50 mM Bicine pH 9, 4 °C. 
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Table 4-2: Rate constants for P formation with CAM present. 
Phase kf (s
-1
 mM
-1
) kr (s
-1
) 
1 25.5 ± 2 1.6 ± 0.6 
2 0.8 ± 0.06 0.1 ± 0.02 
 
Kinetic Parameters of the Reaction of P with NH2-CAM. After P formation, the next 
step of the CmlI cycle that can be isolated is the reaction of P with NH2-CAM to form NH(OH)-
CAM and CmlI
ox
, followed by oxidation of NH(OH)-CAM to NO-CAM and reduction of the 
diferric cluster to form CmlI
red
. P was formed with 0.9 equivalent of O2 (to ensure no excess O2 in 
the reaction) and then loaded immediately on the stopped-flow instrument for reaction with 5-40 
equivalents of NH2-CAM dissolved in anaerobic buffer. Since P formation in the absence of 
substrate is nearly irreversible (see Figure 4-2), the kinetics of the reaction with substrate are 
simplified. When monitored at 480 nm, both P decay and the subsequent reduction of the diiron 
cluster appear as a decrease in absorbance. Both processes are first order or pseudo-first order, 
and the reaction halts after the last step, so summed exponential fitting is appropriate.   
The time courses are fit well by a two-summed exponential expression (Figure 4-6). Both 
exponentials have positive amplitudes (a positive amplitude sign correlates with decreasing 
absorbance), and the phase with larger RRTs contributes ~85% of the total absorbance change. 
Since the reactions involved are quasi-irreversible, and the phases differ substantially in RRT, it 
is possible to assign the two RRTs to rate constants for two steps of the reaction.  It would be 
convenient to assign one phase and its RRT to the conversion of P to CmlI
ox
, and the second to 
the reduction of CmlI
ox
 to CmlI
red
, but analysis of the absorbance changes invalidates this 
assignment.  
The extinction coefficients for CmlI-P, CmlI
ox
, and CmlI
red
 at 480 nm (Table 4-3) were 
used to calculate the expected absorbance of those species in this reaction based on the known 
CmlI concentration. There is negligible absorption due to any of the organic CAM substrates at 
480 nm. The starting species, 10% CmlI
red
 and 90% P, has Abs = 0.11. A spectrum of 90% 
CmlI
ox
/10% CmlI
red
 would give Abs = 0.072 and a pure CmlI
red
 spectrum would give Abs = 
0.046. The extrapolated P decay ends at ~0.053, indicating that the final species is a mixture of 
38% CmlI
ox
 and 62% CmlI
red 
(Figure 4-5). Accounting for a maximum of 10% P decay over the 
course of the experiment would shift those percentages by up to 10%, so the mixture in the 
absence of P auto decay is expected to be 28% CmlI
ox
 and 72% CmlI
red
. This amount of reduction 
is consistent with that seen by Mössbauer when the same reaction was done under similar 
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conditions.
161
 The two steps (P to CmlI
ox
, CmlI
ox
 to CmlI
red
) should be approximately equal in the 
absorbance change they each contribute, thus the phase with 85% of the absorbance change must 
refer to more than one step.  
 
Table 4-3: Extinction coefficients for CmlI-P, CmlI
ox
 and CmlI
red
 at four wavelengths. 
 Extinction coefficient (cm
-1
 M
-1
) 
CmlI Species 300 nm 390 nm 480 nm 500 nm 
CmlI
red
 8000 520 230 190 
CmlI
ox
 11,000 1300 375 300 
P 12,000 1350 580 500 
 
 
 
Figure 4-5: Reaction of a ten-fold excess of NH2-CAM with 200 µM P, showing P decay. Dashed lines 
indicate the calculated absorbance of 180 µM P + 20 µM CmlI
red
, 180 µM CmlI
ox
 + 20 µM CmlI
red
, and 
200 µM CmlI
red
.  
   
One interpretation is that there are two reduction processes starting from two different 
CmlI
ox
. The first reduction is quite fast, and thus the rate constant is averaged into the rate 
constant observed for the P to CmlI
ox
, and so the dominant phase is reflective of both P decay and 
the fast reduction. The second phase would then describe a slow reduction with kf = 1 s
-1 
mM
-1
. 
The observation of more than one form of CmlI
ox
 by Mössbauer supports the two reduction 
mechanism hypothesis, modeled in Scheme 4-1 I.
52
 Another interpretation is that a portion of the 
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NH(OH)-CAM dissociates and rebinds relatively slowly before performing the reduction, giving 
the slow reduction rate (Scheme 4-1 II). The rate for NH(OH)-CAM dissociation from E
ox
 has 
not been independently determined but must be > 1 s
-1
 to account for the proposed flux from the 
active site. The assignment of the slower phase as a reduction reaction is consistent with the 
observed rate constants in the reaction of NH(OH)-CAM and CmlI
ox
 described in the next 
section. 
 
 
Scheme 4-1: Proposed schemes for the reaction of P with NH2-CAM. Rate constants are derived from the 
plots in Figure 4-7. For simplicity CmlI
ox
 and CmlI
red
 are abbreviated as E
ox
 and E
red
, respectively.  
 
RRTs from each exponential were plotted versus [NH2-CAM] to give hyperbolic fits 
(Figure 4-7). If, as argued above, the faster phase is correlated with the P to CmlI
ox
 conversion 
followed by a comparably fast conversion of CmlI
ox
 to CmlI
red
, the hyperbolic curve suggests that 
a fast second-order process precedes P decay, presumably NH2-CAM binding.  Consequently, the 
observed concentration-dependent fast phase is closely correlated with the step in which P reacts 
with NH2-CAM.  It has rate constants of kf = 79.1 ± 6 s
-1
 and kr = 3.9 ± 0.2 s
-1
.  It is unlikely that 
this step is actually reversible, given that it involves the cleavage of an O-O bond and insertion of 
an O atom into a N-H bond. The apparent KD of the hyperbolic curve gives KD for the NH2-CAM 
binding to P, KD = 11.9 ± 1.7 mM.  This third step has rate constants of kf = 0.9 ± 0.1 s
-1 
and kr ≈ 
0, based on a hyperbolic fit of the RRT concentration dependence (Figure 4-9 B).  
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Figure 4-6: Optical changes at 480 nm correlated with the reaction of 200 µM P with 2 mM NH2-CAM. A, 
single- (blue trace) and double- (red trace) exponential fits of the substrate-mediated P decay process are 
shown by the black trace. Fit residuals are shown below the trace and highlight the need for a two-
exponential fit. B, fit with a single exponential plus slope. 50 mM Bicine pH 9, 4 °C. 
 
 
Figure 4-7: NH2-CAM concentration dependence of the RRTs for the reaction of P with NH2-CAM. 
Extracted RRTs plotted versus [NH2-CAM] for the reaction of P (200 µM, final post-mix concentration) 
with varying concentrations of NH2-CAM in anaerobic buffer. A: RRT-1, hyperbolic fit gives KD = 11.9 ± 
1.7 mM, kf = 79.1 ± 6 s
-1
, and kr = 3.9 ± 0.2 s
-1
. B: RRT-2, hyperbolic fit gives kf = 0.9 ± 0.1 s
-1
, kr = -0.02 ± 
0.12 (≈ 0) s-1, KD = 4.0 ± 2.7 mM
-1
. 50 mM Bicine pH 9, 4 °C. 
 
Kinetic Parameters of the Reaction of CmlI
ox
 with NH(OH)-CAM. The 
reaction of CmlI
ox
 by NH(OH)-CAM can also be monitored by simply mixing these two reactants 
anaerobically.  Careful scrubbing of O2 from the reaction buffers and the stopped-flow instrument 
ensures that the reaction stops after the reduction process and does not proceed to re-form P for 
the final oxidation step. In these reactions, CmlI
ox
 was made anaerobic and then mixed in a 1:1 
ratio with anaerobic buffer containing varying concentrations of NH(OH)-CAM, all of which 
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were appropriate to establish pseudo first order conditions. The resulting optical change at 390 
nm was a decrease in absorbance; the trace fit to a double exponential equation (Figure 4-8). The 
monitoring wavelength was chosen to maximize optical change while minimizing the 
contribution of the NH(OH)-CAM that occurs at lower wavelengths. The net absorbance change 
is ~0.03, which matches the expected absorbance change for the conversion of 40 μM CmlIox to 
CmlI
red
. 
 
 
Figure 4-8: Optical change at 390 nm upon the anaerobic mix of 40 µM CmlI
ox
 and 2 mM NH(OH)-CAM 
(final, post-mix concentrations). The trace fits best to a two exponential equation, as shown by the colored 
fit lines and the residuals for 1- (blue) and 2- (red) exponential fits shown below the trace. 50 mM Bicine 
pH 9, 4 °C.  
 
The plots of RRT-1 and RRT-2 versus NH(OH)-CAM concentration are both hyperbolic 
(Figure 4-9 A and B), suggesting that a relatively fast step, possibly NH(OH)-CAM binding, 
precedes the CmlI reduction occurring in the observable steps. The rate constants extracted from 
these plots are all very slow compared with the rate of reduction of the diiron cluster observed 
when starting the reaction with NH2-CAM as described above (RRT-1: kf = 1.3 ± 0.1 s
-1
 and kr = 0 
and RRT-2: kf =0.2 ± 0.03 s
-1
, kr ≈ 0). The slower phase disappears at high concentration of 
NH(OH)-CAM (Figure 4-9 C). The KD values for NH(OH)-CAM binding (RRT-1: 1.1 ± 0.05 
mM, RRT-2: 1.2 ± 0.3 mM) for the plots are approximately equal and indicate higher affinity that 
P exhibits for NH2-CAM.  The similar KD values suggests that the two phases describe parallel, 
not sequential, processes, which seems likely given that both result in reduction of CmlI
ox
. The 
disappearance of one phase at high substrate concentrations indicates a more complex interaction 
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with NH(OH)-CAM than simple binding in the active site.  For instance, binding at a secondary 
site might cause a conformational change that affects the reduction rate constant. 
 
 
Figure 4-9: NH(OH)-CAM concentration dependence of the RRTs for the reaction of 40 µM CmlI
ox
 (final, 
post mix-concentration) and varying concentrations of NH(OH)-CAM in anaerobic buffer. A: Hyperbolic 
fits of RRT-1s extracted from the traces of the reaction, giving KD = 1.1 ± 0.05 mM and kf = 1.3 ± 0.1 s
-1
. 
B: Hyperbolic fits of RRT-2s extracted from the traces of the reaction, giving KD = 1.2 ± 0.3 mM and kf = 
0.23 ± 0.03 s
-1
. C: Plot of the fractional contribution of RRT-1 to the total amplitude change, showing that 
at high [NH(OH)-CAM], RRT-1 becomes increasingly dominant until it is responsible for 100% of the 
amplitude change at 11 mM/ 300 equivalents of NH(OH)-CAM. 50 mM Bicine pH 9, 4 °C. 
 
 The rate constant extracted from the asymptotic maximum of the plot of the faster phase 
RRT (kf  ~ 1 s
-1
) is similar to that of the difficult to assign slowest phase of the P reaction NH2-
CAM, as are the KD values, within error (KD = 1.2 ± 0.3 mM
-1 
vs. KD = 4.0 ± 2.7 mM
-1
), 
supporting the hypothesis that these are the same process and represent CmlI
ox
 reduction.  
However, the slow rate constant in each case is not consistent with the overall flux in the CAM 
biosynthetic pathway (see below), suggesting that there is a difference between the process of 
reduction when NH(OH)-CAM is generated adjacent to the diferrous cluster in the active site by 
P reaction with NH2-CAM and when NH(OH)-CAM is added from solution. Indeed, the slowest 
rate constant in the reaction of P with CmlI
ox
 may represent the case in which NH(OH)-CAM 
escapes the active site before reduction can occur, forcing it to rebind to complete the process. 
Presumably, the rebinding and subsequent reduction would proceed with the kinetics observed 
here for the reaction of NH(OH)-CAM in solution with CmlI
ox
. 
 
Reaction of P with NO-CAM. Anaerobic P was formed as described above and mixed with NO-
CAM dissolved in anaerobic buffer.  Surprisingly, no reaction was observed when monitored at 
480 nm. This is consistent with an earlier observation that the reaction of P and NO-CAM does 
not yield CAM product. Alternative ways to approach this reaction allow the kinetic time course 
to be monitored and yield product as described below. 
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Kinetic Parameters of the Reaction Pathway where NO-CAM and O2 React with 
CmlI
red
. The final steps in the reaction in which NO-CAM is converted to CAM can be 
examined by mixing CmlI
red
 with a buffer solution containing 5-150 fold excess of NO-CAM and 
a 5-fold excess O2 (a saturated solution) (Figure 4-10 A).  At 480 nm, one would expect to 
observe an increase in absorbance as P is formed and then a decrease as the NO-CAM is 
converted to CAM with the formation of CmlI
ox
. Conducting the reaction in this way gave time 
courses that are fit reasonably well by a three-summed exponential equation. The resulting RRTs 
were plotted versus NO-CAM concentration as shown in Figure 4-10. The faster two phases show 
a hyperbolic dependence on NO-CAM concentration, while the slower phase shows no 
dependence. In this case, the amplitudes of the two faster phases have opposite sign, making it 
unlikely that they arise from parallel reactions. The hyperbolic dependences indicate that there is 
a fast reversible step that precedes the observable reaction, which must consist of at least 3 steps 
in accord with the three-exponential fit.  
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Figure 4-10: Reaction of CmlI
red
 and NO-CAM in O2-saturated buffer, 50 mM Bicine pH 9, 4 °C. A, 
Optical changes at 480 nm upon the mixture of 200 µM CmlI
red
 and buffer containing 2 mM NO-CAM and 
0.9 mM O2 (all post mix, final concentrations), showing fit to two- (blue line) and three- (red line) 
exponential equations. B-D, Fits of the RRTs extracted from the optical absorption changes, showing NO-
CAM concentration dependence of the RRTs for the reaction of NO-CAM-O2 and CmlI
red
. B, kf = 136.4 ± 
8.8 s
-1
, kr = 19.4 ± 2 s
-1
, KD = 8.6 ± 1 mM. C, kf = 37.7  ± 10 s
-1
, kr ~ 0 s
-1
. D, dotted line drawn in to 
estimate concentration-independent rate constant, kf = 5.2 ± 0.01 s
-1
. 
 
Scheme 4-2 shows one interpretation of the reaction of CmlI
red
 with O2 and NO-CAM. In 
this model, NO-CAM binding is the fast reversible step that precedes the optically observable 
steps. O2 binding in the following step to form P with kf = 136.4 s
-1 
and kr = 19.4 s
-1
 (calculated 
from the maximum and y-intercept the plot shown in Figure 4B). In the subsequent step, P reacts 
with NO-CAM irreversibly with kf = 37.7 s
-1
 (maximum of the plot in Figure 4C). The 
irreversible nature of this step uncouples one of the RRTs from NO-CAM concentration, so the 
final concentration-independent step with kf = 5.2 s
-1
 may be product release and represent the rate 
constant for substrate flux through the cycle. At high NO-CAM concentrations, the faster RRT 
95 
 
reaches values that far exceed the expected values based on the rate constant for P formation in 
the absence of NO-CAM (see above).  This suggests that in the NO-CAM complex, O2 binding is 
facilitated, allowing much faster P formation. A small amount of P may form prior to NO-CAM 
binding; this results in essentially a dead end complex as P cannot react with NO-CAM.    
 
 
Scheme 4-2: Proposed scheme for the reaction of CmlI
red
 with NO-CAM. Rate constants are derived from 
the plots in Figure 4-10. For simplicity CmlI
ox
 and CmlI
red
 are abbreviated as E
ox
 and E
red
, respectively. 
 
 
Scheme 4-3: Proposed scheme for the reaction of CmlI
red
 with NO-CAM and O2, with rate constants 
derived from numerical integration. For simplicity CmlI
ox
 and CmlI
red
 are abbreviated as E
ox
 and E
red
, 
respectively. 
 
The time course of the reaction shows that the maximum amount of P increases with NO-
CAM concentration (Figure 4-11).  Numerical integration fits to the Scheme 4-2 reaction 
adequately model the reaction time course as a function of NO-CAM concentration (Figure 4-12 
A and Figure 4-13). Rate constants from the numerical integration are reported in the caption of 
Figure 4-13. The steps for which we know the rate constants by direct observation, which are the 
reaction of E
red
 or E
red
-NO-CAM with O2 to form P-NO-CAM, and the decay of that species to 
E
ox
-NO2-CAM, provide rate constants in the model with reasonably small margins of error. The 
rate constants for the first step, rapid binding of NO-CAM to E
red
, have high variability because 
this step is not trackable at 480 nm, and may be too fast to monitor at any wavelength. The rate 
constants for product release, the proposed last step in this sequence, are also not adequately 
monitored at this wavelength.  
Simulation revealed several important aspects of this reaction. One, the trends in the 
traces are reproduced by using the rate constants given by analysis of the RRTs and shown in 
Scheme 4-2. This is not to imply that Scheme 4-2 is the only solution, but it does represents a 
viable model of the reaction. Two, to obtain the correct shape of the traces, binding of NO-CAM 
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to CmlI
red
 is required to have fast kf and kr rates and the simulation predicts that NO-CAM release 
is 5-10 times faster than NO-CAM binding. This is consistent with our earlier observation that 
NO-CAM can exchange from the CmlI
red
 active site, although the rate of exchange predicted by 
the rate constants from the simulation is higher than the rate that would be predicted based on the 
observed flux of NO-CAM from the active site.
161
 The previous experiment showed that about 
15% of the NO-CAM was released from the active site over the course of five minutes, whereas 
the simulation-generated rate constants are sufficiently high to predict complete (100%) release. 
Thus, it is likely that the ratio of the exchange rates is accurate but not the absolute magnitudes. 
Third, accurate fits require a significantly higher rate constant for O2 binding for the CmlI
red
-NO-
CAM complex than observed for P formation in the absence of substrate (165 s
-1
 vs. 1, 15, or 50 
s
-1
 at 0.9 mM O2). This increase in rate constant accounts for the observed increase in the 
maximum amount of P formed as a function of increased NO-CAM concentration. In this 
scheme, the increased maximum amount of P is due to the increased formation of the CmlI
red
-
NO-CAM complex, rapid O2 binding to form P-NO-CAM, and relatively slow reaction of P-NO-
CAM to yield CAM. Finally, O2 binding is reversible when NO-CAM is present, which is 
surprising given that in the absence of substrate P formation is irreversible.  
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Figure 4-11: NO-CAM concentration dependence of trace shape, peak P time, and total P accumulation in 
the reaction of CmlI
red
 with pseudo-first order concentrations of O2 and NO-CAM. The traces follow the 
reaction of 200 µM CmlI
red
 and 1-30 mM NO-CAM in O2-saturated buffer, 50 mM Bicine pH 9, 4 °C. 
 
A simulation in which O2 could bind E
red
 before NO-CAM to form the dead end complex 
P was also tested, using the rate constant for P formation in the absence of substrate from Table 
4-1 (Figure 4-12 B). At low concentrations of NO-CAM, a significant amount of P would form 
and persist, thus the endpoint absorbance would be expected to be quite high. The end point 
absorbance would also be expected to decrease as NO-CAM concentrations increased, as NO-
CAM would become more likely to bind E
red
 first and thus less P (E
red
 + O2) would form and 
persist. The simulation reflects these predictions and does not match the experimental data, 
suggesting that O2 is in some way prevented from binding E
red
 before NO-CAM binds.    
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Figure 4-12: Comparison of two models for the reaction of E
red
 with NO-CAM and O2. A, simulation of a 
model in which NO-CAM must bind first to E
red
, as shown in Scheme 4-3 above. B, simulation of a model 
in which either O2 or NO-CAM can bind first.  
 
 
 
Figure 4-13: Optical changes in the reaction of CmlI
red
 with varying NO-CAM concentrations and fivefold 
excess of O2. Solid lines show the experimental data and dotted lines show the fit to the model shown in 
Scheme 4-3. Rate constants extracted from the fit are: k1 = 722 ± 291 s
-1
 mM
-1
, k-1 = 5333 ± 2220 s
-1
, k2 = 
165 ± 1 s-1 mM-1, k-2 = 8.1 ± 0.5 s
-1
, k3 = 22.5 ± 0.2 s
-1
, k-3 = 0 s
-1
, k4 = 0.1 s
-1
, k-4 = 1.1 ± 0.1 s
-1
 mM
-1
  
 
Verification of P as the Active Oxidant that Acts on NO-CAM. It was assumed, though never 
verified, that the active oxidant P that reacts directly with NH2-CAM is the same active oxidant 
that reacts with NO-CAM to perform the final oxidation of the cycle. UV-vis spectroscopic data 
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showed that a species with absorbance at 480 nm formed and decayed when CmlI
red
 was reacted 
with NO-CAM and O2 (Figure 4-14).  To further verify the identity of the active oxidant in this 
step, short time point samples of the reaction of CmlI
red
 with an excess of NO-CAM and O2 were 
prepared by a rapid-freeze quench procedure and analyzed by Mössbauer spectroscopy (Figure 
4-15).  
 
 
Figure 4-14: Time points chosen for Mössbauer analysis of the reaction of 200 µM CmlI
red
 with 0.9 mM 
O2 and 2 mM NO-CAM (final, post mix concentrations). 50 mM Bicine pH 9, 4 °C.  
  
Mössbauer analysis showed a decrease in CmlI
red
 over the course of the reaction, 
concomitant with an increase in P, for which the Mössbauer parameters have been previously 
determined (Table 4-4). At long time (30 s), < 5% P is present and the sample is predominantly 
diferric, suggesting that P has decayed via reaction with NO-CAM. The data supports the 
hypothesis that the same P is the active oxidant in the oxygenation of both NH2-CAM and NO-
CAM.   
 
Table 4-4: Percentage of P and CmlI
red 
at various time points in the reaction of CmlI
red 
with NO-CAM and 
O2, as determined by Mössbauer spectroscopy. 
Quench time point P CmlI
red
 
20 ms 40% 30% 
80 ms 59% 20% 
250 ms 57% 10% 
30 s < 5% < 1% 
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Figure 4-15: Mössbauer spectra of the 20 ms, 80 ms, 250 ms, and endpoint (30 s) time point samples of the 
reaction of 200 µM CmlI
red
 with 0.9 mM O2 and 2 mM NO-CAM. The black line is the experimental data 
and the colored lines are fits to various species: diferrous (blue), diferric peroxo (red) and resting state 
diferric (green). See Table 4-4 for percentages of each individual species.   
 
Kinetic Parameters of the Complete Reaction Pathway.  The complete biosynthetic pathway 
was examined by pre-equilibrating NH2-CAM anaerobically with CmlI
red
 to allow the complex to 
reach equilibrium and then initiating the reaction by mixing with O2-saturated buffer. All optical 
changes were observed by stopped-flow UV-vis spectroscopy at 480 nm and 4 °C, pH 9. This 
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wavelength was chosen because it gives the maximum optical change for both the P formation 
and P decay processes. Using a shorter wavelength gives a greater optical change for P 
formation, but P decay is masked by reappearance of the Fe-O-Fe charge transfer band of diferric 
CmlI, which has a shoulder at ~375 nm. Initiating the reaction in this way allows both P 
formation and substrate-mediated P decay to be observed (Figure 4-16). The maximum amount of 
P formed is shown in Figure 4-16 to decrease and occur earlier in the time course as the 
concentration of NH2-CAM increases.   
After P forms and decays, the resulting CmlI
ox
 is reduced by the NH(OH)-CAM product 
of the first reaction to give a further decrease in absorbance. This reduction is followed by 
binding of O2 to re-form P, resulting in an increase in absorbance. Finally, P decays as CAM is 
formed to give a decrease in absorbance.  Both NH2-CAM and O2 are supplied in high enough 
concentrations that all of the reactions can be considered first order or pseudo first order.  Also, 
the reaction halts and becomes irreversible when CAM is ultimately formed, so summed 
exponential fitting of the time course is appropriate.  The time course can be adequately fit using 
a three summed exponential equation in the time range monitored, and the resulting plots of RRT 
versus NH2-CAM concentration are shown in Figure 4-17.   
  
 
Figure 4-16: NH2-CAM concentration dependence of P formation and decay. A: Optical changes at 480 
nm from the reaction of CmlI
red
 (200 µM) and 1-6 mM NH2-CAM (final, post mix concentrations) with O2-
saturated buffer. Post-mix [O2] ~ 0.9 mM at 4 °C. 50 mM Bicine pH 9, 4 °C. B: Simulation of experimental 
data in A.   
 
 One way to analyze these plots is to assume that the linear plot seen for the fastest RRT 
gives information about the kf (slope), kr (y-intercept) and KD (y-intercept/slope) for NH2-CAM 
binding to CmlI
red
 (monitored by rapid subsequent binding of O2 to form P), and the nearly 
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hyperbolic plot of the second fastest RRT gives information about the kf (RRT observed 
approaches kf + kr) and kr (y-intercept) reaction of P with bound NH2-CAM. This type of analysis 
was used in the previous reaction iterations and is appropriate if the reverse rate constant for the 
first reaction (24.1 s
-1
) is fast relative to the forward rate constant for the second reaction         
(21.6 s
-1
), which is not the case for the fits shown in Figure 4-17. Another check is that the KD 
computed from the linear plot (3.5 mM) should equal the KD from the fit to the hyperbolic plot 
(1.34 mM), which is also not correct. A more precise method to analyze the data using the slopes 
and intercepts of the sums and products of the RRTs plotted versus NH2-CAM concentration 
(Figure 4-18, Scheme 4-4). However, this approach yields a value of the KD for NH2-CAM 
binding which is ten-fold lower than the value estimated from the reaction of NH2-CAM with P 
described above.  Two additional problems with this simple approach to analysis are: (1) a 
reaction scenario that requires formation of the CmlI
red
-NH2-CAM complex prior to formation of 
P in a reactive state would be expected to show increasing maximum concentrations of P as the 
NH2-CAM concentration increases, which is opposite of what is observed, and (2) if the rapid 
formation of P that follows NH2-CAM binding is irreversible like the formation of P in the 
absence of substrate, then the concentration dependence of the slow phase would be lost. 
 
 
Figure 4-17: NH2-CAM concentration dependence of RRTs for the reaction of CmlI
red
-NH2-CAM and O2. 
Extracted RRTs plotted versus [NH2-CAM] for the reaction of CmlI
red
 (200 µM, final post-mix 
concentration) premixed with varying concentrations of NH2-CAM and O2-saturated buffer (~0.9 mM at 
4°C). A, kf = 6.9 ± 1.4 s
-1 
mM
-1
, kr= 24.1 ± 2.7 s
-1
, KD = 3.5 mM. B, kf = 21.6  ± 1.7 s
-1
 mM
-1
, kr~ 0 
s
-1
. C, kf = ~ 0.7 s
-1
. 50 mM Bicine pH 9, 4 °C.    
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Figure 4-18: NH2-CAM concentration dependence of RRTs for the reaction of CmlI
red
-NH2-CAM and O2. 
Linear fit of sum of extracted RRTs (black line) and product of extracted RRTs (red line) plotted versus 
[NH2-CAM] for the reaction of CmlI
red
 (200 µM, final post mix concentration) premixed with varying 
concentrations of NH2-CAM and O2-saturated buffer (~0.9 mM at 4 °C). 50 mM Bicine pH 9, 4 °C.    
 
 
Scheme 4-4: Proposed scheme for the reaction of CmlI
red
 with O2 and NH2-CAM to form NH(OH)-CAM 
with rates derived from Figure 4-18. 
 
An alternative way to consider the reaction is suggested by the experiments described 
above in which P can form rapidly in the absence of substrate and then react with NH2-CAM in a 
separate reaction. It is evident that the rate constant for oxidation of CmlI
red
 is maximized as the 
complex of CmlI
red
 with NH2-CAM saturates (Figure 4-16), a reaction that involves the 
intermediate P and product formation.  Shown in Scheme 4-5 is an alternative pathway in which 
the reaction can proceed through rapid initial reaction of either CmlI
red
 or CmlI
red
-NH2-CAM with 
O2 to form P or P-NH2-CAM, respectively.  The reaction ends with all of the CmlI in the diferric 
state, independent of the concentration of NH2-CAM used, so both forms of P must be reactive. 
Allowing P-NH2-CAM to form by either of the pathways shown would account for: (1) the 
failure of the less complex analytical approaches, (2) a possible route to the observed decrease in 
the maximum amount of P formed during the time course, and (3) the hyperbolic concentration 
dependence of the slow phase since reversible substrate binding occurs after the irreversible P 
formation step in one branch of the pathway.  
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Scheme 4-5: Proposed scheme for the reaction of CmlI
red
 with NH2-CAM and O2. For simplicity CmlI
ox
 
and CmlI
red
 are abbreviated as E
ox
 and E
red
, respectively. 
 
 As discussed above, an integrated rate equation for a complex scenario such as the 
reaction depicted by Scheme 4-5 can be derived; however, the number of reversible steps would 
make the resulting equation quite complex. Another approach is to fit the observed time courses 
by numerical integration using the rate constants derived from the individual steps described in 
the sections above to limit the number of unknown parameters.  The rate constants for the 
simulation (Figure 4-16 B) are shown in Scheme 4-6, below. However, the bounds of the 
simulated rate constants are quite large and not sufficient for accurately reporting such constants. 
Thus these rate constants describe a solution, but certainly not a unique one. It is likely that 
additional data points (i.e., additional concentrations of NH2-CAM) are required to accurately fit 
a scheme as complex as this one. The input rate constants for the simulation came from the plots 
in Figure 4-17.  
 
 
Scheme 4-6: Proposed scheme for the full cycle reaction of CmlI
red
 with NH2-CAM and O2, with rate 
constants from numerical integration of the model.  
 
To simplify analysis and prevent the final stage of the reaction shown in Figure 4-16, 
where multiple processes are occurring at the same time, the experiment was repeated using 
limiting O2. In this scenario, 400 µM CmlI
red
 was mixed in a 1:1 ratio with buffer containing 360 
µM O2 and a range of NH2-CAM in pseudo-first order concentrations. Unfortunately, under these 
conditions P did not form as quickly, and thus did not accumulate enough to allow fitting of two 
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or more separate phases. Figure 4-19 shows the difference between maximum P accumulation 
and the P accumulation that was observed under these conditions. 
  
 
Figure 4-19: Comparison of maximum P formation achieved by mixing 200 µM CmlI
red
 with 0.9 mM O2 
(red trace) versus P formation and decay when 200µM CmlI
red
 is mixed with 180 µM O2 and 2mM NH2-
CAM (black trace). All concentrations reported are final, post mix values. Optical changes monitored by 
stopped flow at 480 nm. 50 mM Bicine pH 9, 4°C. 
  
Discussion 
The CmlI cycle was described kinetically by monitoring absorbance changes resulting 
from different combinations of CmlI and the various substrates. Both the individual steps of the 
cycle and the cycle as a whole were monitored. The extracted rate constants and insight into 
binding order obtained from these experiments now allow us to construct a kinetic model of the 
CmlI cycle. 
 
Applying Kinetic Insight to Evaluate the Proposed Mechanism.  Elucidating the 
kinetics of the CmlI cycle required close analysis by UV-vis spectroscopy. All of the observed 
absorbance changes were consistent with the previously proposed mechanistic model, presented 
in Figure 4-1. As expected, the reaction of P and NH2-CAM in the absence of O2 resulted in 
CmlI
red
 due to the NH(OH)-CAM-mediated reduction step. The reaction of CmlI
red
, O2, and NH2-
CAM carries through the whole cycle due to excess O2, but the traces show a slight dip and rise 
after the initial P decay, again indicative of the substrate-mediate reduction step. Finally, NO-
CAM reacts with CmlI
red
 in the presence of O2 to form first P, which then rapidly decays to the 
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CmlI
ox
 resting state. This work also provides experimental evidence for the earlier supposition 
that P is the active oxidant in both oxygenation steps of the cycle, via Mössbauer analysis of the 
oxidant responsible for the conversion of NO-CAM to NO2-CAM.   
 
Evaluation of the Single Active Site Hypothesis. In our previous work we showed that the 
entire six-electron amine to nitro conversion could occur in a single CmlI active site. This work 
provides further evidence for the retention of the organic intermediates in the active site. Firstly, 
the cluster reduction mediated by NH(OH)-CAM occurs at a very fast rate (estimated > 100 s
-1
) 
when NH(OH)-CAM is generated in the active site by reaction of P and NH2-CAM, as shown by 
the analysis of Figure 4-5. The reduction rate is much slower, kf ~ 1 s
-1
, when NH(OH)-CAM is 
added to the system externally to diferric CmlI. This suggests that the NH(OH)-CAM likely does 
not leave the active site in which it was formed to bind at another active site during the native 
cycle. Secondly, NO-CAM only reacts with P when the substrate is already bound in the active 
site, and no reaction with P occurs if NO-CAM is added externally to P. Again, this suggests that 
NO-CAM stays in the active site to avoid decoupling of the reaction. Based on the relatively slow 
rebinding of the organic intermediates, enforcing a single site mechanism allows the reaction to 
happen more quickly. Equally importantly, this ensures that the relatively reactive organic 
intermediates are not allowed into the cell to neutralize each other through coupling reactions, or 
have deleterious effects by reaction with other cell components.          
 
The Formation of Intermediate P. We have shown previously that a stable P intermediate is 
formed when the diferrous enzyme is rapidly mixed with O2, and that P is reactive towards the 
native substrate to form the native product CAM. In an effort to understand the kinetics of P 
formation, CmlI
red
 was reacted with a range of pseudo-first-order concentrations of O2 and the 
resulting RRTs were plotted to obtain kinetic constants. In the absence of substrate, P forms via 
three parallel pathways, indicating that either O2 can bind the same active site in the three 
different fashions, or there are three different configurations of the active site present in the bulk 
enzyme. The latter explanation is supported by the fact that Mössbauer spectroscopy shows at 
least two different configurations of the diiron cluster active site in diferric state. We 
hypothesized that the presence of substrate might enforce a particular active site conformation 
that would subsequently enforce a single P formation process, so we did the same set of reactions 
in the presence of the product CAM. CAM is analogous to the substrate in shape, size, and 
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chemical makeup, but it is not reactive towards P. Introduction of CAM to the reaction mixture 
resulted in two linearly O2-dependent phases, compared with three such phases in the absence of 
CAM. Comparing the second order rate constants obtained from each scenario suggests that the 
presence of CAM eliminates the fastest P formation pathway.  
 Further evidence for the impact of substrate presence on P formation comes from the 
reactions of the diferrous enzyme with substrate (NH2-CAM or NO-CAM) and O2. In both cases 
the presence of substrate resulted in a single exponential phase with a negative amplitude, 
indicating that the number of P formation pathways is reduced to one, or one pathway becomes 
significantly dominant so that a second pathway cannot be detected. Simulations of the reaction 
of CmlI
red
 with O2 and NH2-CAM case gave P formation rate constants of 27.8 mM
-1
 s
-1
 and 22.6 
mM
-1
 s
-1
 (Scheme 4-6), comparable to the fastest P formation rate in the presence of CAM and a 
slight increase in the middle rate in the substrate-free P formation. When NO-CAM is added to 
the reaction of E
red
 with O2, the rate constant for P formation increases 3 - 130 fold compared to 
the case in which substrate is absent. This effect is visualized in Figure 4-11, where increasing 
NO-CAM causes P to form earlier (faster) and to accumulate more. Altogether, this data indicates 
that substrate has an impact on P formation, both by enforcing a single pathway and by 
accelerating O2 binding. Whether the effects are due to direct binding to the active site, or are 
hysteretic, remains unknown.     
 
Importance of Binding Order and Hysteretic Effects. This work reveals the importance 
of binding order when O2 and substrate are presented to an enzyme. Both NH2-CAM and NO-
CAM require O2 to react, so binding order is a consideration. Curiously, the two substrates have 
different binding order preferences versus O2. 
The reaction of CmlI
red
 with O2 and NH2-CAM results in formation of P and product 
regardless of which substrate binds first.  In addition to experimental data, simulation of the 
reaction of the three species (CmlI
red
, NH2-CAM, O2) showed that a two-pathway model is 
required to obtain a fit with the observed trends in the data. In contrast, the reaction with NO-
CAM shows a clear preference. P does not react with NO-CAM, as shown by spectroscopic and 
product analysis. One possible explanation for this contrast is that the peroxo species (P) that 
forms in the absence of substrate and reacts with NH2-CAM is not the same peroxo species that 
reacts with NO-CAM. However, Mössbauer analysis of the reactive species that forms in the 
presence of O2 and NO-CAM shows that it is P, or if it is different, the differences are small 
enough not to be resolvable by Mössbauer. Clearly, some other mechanism is at play such that the 
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enzyme is set up to react NO-CAM and P only if NO-CAM is bound first (i.e., already in the 
active site from the NH(OH)-CAM reduction). 
Unlike binding NH2-CAM, which necessarily is initiated when NH2-CAM enters from 
the exterior of the enzyme, there may be no efficient pathway for NO-CAM bind when 
introduced exterior to the enzyme. CmlI is designed to have this substrate already positioned 
correctly in the active site from the oxidation of NH(OH)-CAM. When NO-CAM is introduced 
mid-cycle, as in some of the experiments reported, it may exchange rapidly with a second site 
before binding the active site. This explanation would account for the rapid rate constants from 
NO-CAM binding predicted by the simulation of the reaction of CmlI
red 
with O2 and NO-CAM, 
but the experimentally observed relatively slow exchange of NO-CAM from the active site 
(discussed above).  
 An important observation from this body of work is that hysteretic effects of substrate 
binding are likely playing a role in enzyme regulation. One example of this is the convergence of 
the P formation pathways into one pathway in the presence of substrate. Another example is the 
fact that O2 binding is reversible in the presence of substrate but not in the absence. A third 
example is that O2 is seemingly not allowed to bind CmlI
red
 when NO-CAM is present but not 
bound. Taken together it appears that substrate binds to some site other than the active site to 
convert the enzyme to an active form prior to the binding of any small molecule or organic 
molecule.  
 
Overall Kinetic Model.  A kinetic model of the overall reaction was constructed using 
reactivity information and rate constants from all the reactions performed, as well as insight 
gained from the simulations. Scheme 4-7 shows the model that assembles all of the available 
information. The portions of the scheme printed in black represent the portions that are part of the 
native cycle, the portions in blue represent the off-pathway components that are accessible by 
experimental manipulation but are not thought to be part of the in-vivo cycle based on the current 
study.  
The reaction begins when CmlI
red
 is mixed with its substrates O2 and NH2-CAM. First, 
we recognize that the organic substrate presence has a hysteretic effect on O2 binding. Thus, the 
first step of the reaction is rapid binding of NH2-CAM to some location on the enzyme other than 
the active site, to convert the enzyme into a different form. The substrates bind to E
red
 to form P-
NH2-CAM via one of two pathways; currently there is no evidence to indicate whether only one, 
or both, of these pathways is valid in-vivo. We know from previous work that CmlI
red
 can react 
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with O2 to form a stable P species that can react with substrate in a subsequent step.
52
 The rate 
constant for P formation is taken from the plots in Figure 4-3; justification for choosing the 
middle rate was explained earlier and is supported by the simulation-generated rates in Scheme 
4-5. The rate for subsequent P reaction with NH2-CAM is based on the KD in Figure 4-7 A and on 
the simulation-generated rates. Second, we showed that pre-equilibration of CmlI
red
 with NH2-
CAM followed by exposure to O2 also results in P formation and subsequent generation of 
product. For this second pathway, the rate constant for CmlI
red
 binding NH2-CAM is taken from 
Figure 4-17 and for subsequent O2 binding the rate constant is that for O2 binding to an ES 
complex (Figure 4-4).     
P-NH2-CAM rapidly reacts to form CmlI
ox
-NH(OH)-CAM (Figure 4-7) and the 
subsequent oxidation of NH(OH)-CAM to NO-CAM is fast. If NH(OH)-CAM escapes the active 
site before the reaction can occur, then the reduction occurs at a much slower rate, probably due 
to slow rebinding or incorrect binding followed by a necessary reorganization in the active site 
(Scheme 4-1). NO-CAM appears to be loosely bound in the active site when CmlI is in the 
diferrous form, and based on spectroscopic and product analysis, no reaction ensues if O2 binds 
when NO-CAM is not present. However, NO-CAM dissociation from the active site is prevented 
by rapid binding of O2 in vivo. O2 binds rapidly but reversibly to the E
red
-NO-CAM complex to 
form P-NO-CAM, which reacts to form the NO2-CAM product and the resting state CmlI. An 
observed concentration- independent step with kf = 5.2 s
-1
 may be product release from the active 
site (rate constants from Figure 4-10). 
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Scheme 4-7: Proposed scheme for the reaction of CmlI
red
 with NH2-CAM and O2 to form NO2-CAM. For simplicity CmlI
ox
 and CmlI
red
 are abbreviated as E
ox
 
and E
red
, respectively. Black text represents components of the native cycle, blue components are experimentally accessible but not thought to be part of the 
native cycle. The steps in which NO-CAM and NH(OH)-CAM bind from the exterior may be multiple steps, i.e., initially binding to region other than the site or 
to the active site in the incorrect orientation, followed by reorganization.  
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Future Work 
This work provides support for the substrate-mediated reduction model of N-oxygenation by 
diiron-cluster containing enzymes. A couple of additional pieces of data would help to 
corroborate the conclusions stated in this work. First, additional data points in the reaction 
investigating NH2-CAM concentration dependence on the reaction of CmlI
red
, O2, and NH2-CAM  
(as seen in Figure 4-15) would likely provide a better platform for numerical integration of the 
proposed reaction model. Second, photo-diode array (300 – 800 nm) absorbance data of the 
reactions monitored here by single wavelength may provide additional information about rapid 
substrate binding, as is proposed in many steps. This may lead to the ability to monitor substrate 
binding and determine rate constants therein at different wavelengths than the reactions were 
initially monitored, or at least inform on any expected optical changes when substrate binds. 
Mössbauer analysis of enzyme-substrate complexes may confirm that the binding of substrate, to 
the active site or otherwise, changes the electronics of the CmlI active site. Finally, a method of 
evaluating overall flux in the cycle would inform on which rate constants are part of the 
productive cycle and which correspond to decoupled side reactions. This additional information 
about substrate interaction with the enzyme will help finalize the model presented in Scheme 4-7. 
This model, combined with previous analytical and spectroscopic work, supports the hypothesis 
that the full six-electron conversion of an aryl-amine to an aryl-nitro product can occur in a single 
enzyme active site, requiring neither dissociation of the organic intermediates, nor mid-cycle 
injection of external electrons.     
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Chapter 5  
 
Experimental methods 
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Summary 
 
This chapter describes all of the reagents and methods used to perform the experiments reported 
in the previous three chapters. An effort was made to be informative without overwhelming with 
detail or repetitiveness. To that end, the reader is recommended to use this chapter in conjunction 
with the text of the experiment in the appropriate previous chapter to provide a complete picture 
of how an experiment was completed.  
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Reagents 
 
General Reagents. Water used in all experiments was purified with a Millipore Super-Q 
system. 
57
Fe (95.5 %) was purchased from Cambridge Isotope Laboratories (Andover, MA). 
Amino-chloramphenicol (D-threo-1-(4-aminophenyl)-2-dichloroacetylamino-1,3-propanediol 
hydrochloride) (NH2-CAM) was purchased from Toronto Research Chemicals, Inc. p-
aminophenol (pAP), p-aminobenzoate (pABA), and L-p-aminophenylalanine (L-pAPA) were 
purchased from Sigma-Aldrich.  Bicine and other standard reagents used were purchased from 
Fisher. 
18
O2 gas (98 atom %) was purchased from Icon Isotopes, Summit, NJ.    
 
Synthesis and Characterization of NO-CAM and NH(OH)-CAM. The nitroso and 
hydroxylamine derivatives of chloramphenicol (NO-CAM and NH(OH)-CAM, respectively) 
were synthesized according to published methods.
151
 The reported final purification of NO-CAM 
with Sephadex LH20 was not performed. Instead, normal phase chromatography (SiO2, ethyl 
acetate) was used as a final purification step for both compounds. The final purity, estimated via 
integration of the 
1
H-NMR, was 90% for NO-CAM and 80% for NH(OH)-CAM. Residual 
proteated solvent (δ 3.31) was the reference compound for 1H-NMR. These products were 
characterized and found to have the spectral characteristics listed below.  
2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitroso)propan-2-yl]acetamide (NO-CAM). 
Green solid: λmax = 316 nm (aqueous 0.1% formic acid). Rf = 0.40 (SiO2, ethyl acetate). 
1
H NMR 
(500 MHz, CD3OD): δH  7.85 (2H, d, J1 = 8 Hz), 7.71 (2H, d, J1 = 8 Hz), 6.24 (1H, s), 5.14 (1H, d, 
J1 = 3 Hz), 4.18-4.08 (1H, m), 3.82 (1H, dd, J1 = 7 Hz, J2 = 11 Hz), 3.62 (1H, dd, J1 = 6 Hz, J2 = 
11 Hz). 
2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-hydroxylamine)propan-2-yl]acetamide 
(NH(OH)-CAM-). λmax = 237 nm (aqueous 0.1% formic acid).Pale yellow gum: 
1
H NMR (500 
MHz, CD3OD): δH  7.25 (2H, d, J1 = 8Hz), 6.94 (2H, d, J1 = 9Hz), 6.930 (1H, s), 4.90 (1H, d, J1 = 
4Hz),  4.05-4.02 (1H, m), 3.72 (1H, dd, J1 = 6Hz, J2 = 11Hz), 3.50 (1H, dd, J1 = 6Hz, J2 = 11Hz). 
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Preparation of Wild Type CmlI and 
57
Fe CmlI 
 
Cloning and Heterologous Expression of CmlI. CmlI was cloned from genomic DNA 
isolated from Streptomyces venezuelae mycelia.  The primers used for PCR amplification of CmlI 
are shown with restriction sites underlined:  
Forward:  CCATATGGCGATCGCCCGTGACCACACGGACGAGAAA 
Reverse:  CCATATGGTTTAAACTCATCGGGTCACCGTCGTGCC 
 
PCR products were digested with AsiSI and PmeI and ligated to similarly digested 
pVP91A, obtained from the DNASU plasmid repository, to produce the N-terminal His8 tagged 
enzyme.  The final CmlI-containing plasmid was verified by sequencing at the University of 
Minnesota Biomedical Genomics Center. Plasmid stocks are maintained by regeneration ~ every 
six months using the QIAprep Spin Miniprep Kit (Qiagen).  
 
Expression of CmlI.  Expression of CmlI was performed in E. coli BL21(DE3) in M9 minimal 
medium in the presence of 100 g/mL ampicillin.  Cells were grown to an OD ~ 1.0 and induced 
with 150 M IPTG and 50 M FeCl3 at which point the temperature was lowered to 20 °C, and 
growth was allowed to continue for an additional 15 h.  Cells were harvested by centrifugation 
and stored at -70 °C until further use.  
57
Fe enriched CmlI was prepared similarly from cells 
grown in M9 media with the addition 
57
Fe metal dissolved in a minimal volume of aqua regia to 
a final concentration of 25 M.   
 
Purification of CmlI. To purify CmlI, cells were resuspended in 50 mM potassium phosphate 
pH 7.4, 300 mM NaCl, 10 mM imidazole, lysed via sonication, and centrifuged.  The resulting 
supernatant was loaded onto a Ni nitrilotriacetic acid column (Qiagen) equilibrated in the same 
buffer.  After loading, the protein was eluted using an imidazole gradient. Protein-containing 
fractions were pooled and dialyzed against 25 mM Bicine pH 9 and stored at -80 °C until further 
use. CmlI concentrations were determined by calculated extinction coefficient checked against 
denatured protein (ε280 = 50 mM-1 cm-1).  To assess metal content, CmlI quantified by 280 nm 
absorbance was treated in 4 M nitric acid for 2 hours. The denatured sample was centrifuged at 
25,000 x g for 20 min and the supernatant transferred to a volumetric flask for dilution to 5 ml 
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with dH2O. The metals present in the sample were quantitated using inductively-coupled plasma 
mass-spectrometry (ICP-MS) at the UMN Earth Sciences Department. 
 
Generation of Diferrous and Peroxo-Diferric CmlI 
 
Preparation of CmlI Diferrous Intermediate (CmlI
red
). As isolated diferric CmlI (0.5 – 
1.5 mM) was reduced under anaerobic conditions with an excess amount of dithionite in the 
presence of 0.05 - 0.1 equivalent of methylviologen. Excess reductant and methylviologen were 
removed using a PD-10 desalting column (G-25, GE Healthcare) in an anaerobic chamber. If high 
concentrations were required (i.e., for spectroscopic samples), protein was concentrated using a 
centrifuge located in the anaerobic chamber and 10 or 30 kDa cutoff filters (Amicon Ultra-0.5 ml 
centrifugal filters).   
 
Preparation of CmlI Diferric Peroxo Intermediate (P). Aliquots of reduced CmlI were 
exposed to either 
16
O2 or 
18
O2
 
at ~ 4 °C for several min. P concentration was determined by 
absorbance at 500 nm (ε = 500 M-1 cm-1) under the assumption of nearly stoichiometric formation 
of the intermediate.  
 
Preparation of P in D2O or H2
18
O. P in D2O was generated as described above, except that 
the enzyme was passed through a PD-10 size exclusion column equilibrated with buffer prepared 
with D2O (50 mM Bicine, pD 9) after the reduction step. Concentration and re-dilution with D2O 
buffer a minimum of two times ensured nearly complete isotope exchange. H2
18
O were prepared 
in the same manner as their corresponding standard water samples, with the addition of several 
concentration and dilution cycles to exchange the H2
16
O-containing buffer with the H2
18
O-
containing buffer. In P preparation, the exchange was performed on the diferrous enzyme in an 
anaerobic chamber. To prepare H2
18
O-containing buffer, 2 mL of standard buffer (50 mM Bicine, 
pH 9) was lyophilized for 24 h. The resulting salts were then dissolved in 2 mL H2
18
O water in 
the anaerobic chamber. 
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Analytical Methods 
 
Metabolite Analysis. To analyze products in the reaction of CmlI with substrate, 150 μL 
aliquots of P diluted to 100-300 μM were promptly transferred to pre-cooled Reacti-Vials with 
stir bars at 4 °C. The indicated equivalents of substrate were added to the stirring P. (Substrate 
stocks were 2-20 mM in 10% MeOH, 90% water, kept at 4 °C. Normal substrate addition was 1-
15 μL, so the amount of MeOH added to the reaction was minimal). Substrate equivalents were 
calculated vs. concentration of P unless otherwise stated. The reactions were run for 10 min 
unless otherwise indicated, at which point they were quenched with 150 μL 5% TFA or 75 μL   
10 M HCl/50 μL 7.5 M HCOONa/50 μL 10 M NaOH. The reaction mixture was centrifuged at 4 
°C at maximum speed for 20 min to pellet the protein precipitate, and then the supernatant was 
transferred to a clean Eppendorf  microcentrifuge tube and either stored at -80 °C or analyzed by 
HPLC immediately.  
Under the highly acidic conditions of the quench procedure, NH(OH)-CAM converts to 
NO-CAM which may subsequently dimerize.
83
 To control for this non-enzymatic conversion, 
some reactions were spin-quenched instead of acid-quenched by centrifuging an aliquot for 20 
min in an Amicon Ultra-0.5 mL 10K (Millipore), washing the retentate with 150 μL of buffer, 
and centrifuging again for another 20 min. Some experimental procedures required an acid 
quench. After surveying several acid quench procedures, the 5.0% TFA acid quench was found to 
be the least damaging, with retention of >95% of CAM product and ~70% of the NO-CAM 
product. 
 
HPLC. HPLC analysis was performed using a Waters 1525 binary HPLC pump and Waters 
2487 dual λ absorbance detector with an Agilent Zorbax SB-C18 column. Products were 
monitored in dual wavelength mode at 280 nm and 316 nm. The method was isocratic 75% buffer 
A (water with 0.1% v/v formic acid) and 25% buffer B (MeOH with 0.1% v/v formic acid) for 15 
min followed by a 5 min wash with buffer B at a flow rate of 2.5 mL/min. By this method, NH2-
CAM elutes at 1.2 min, NO-CAM at 11.2 min and CAM at 10 min.     
 
UPLC/MSe and Analysis. Instrumentation for UPLC/MSe analysis was a Waters Acquity 
UPLC with a Waters HSS T3 C18 2.1 mm x 100 mm column (1.7 m diameter particles) coupled 
to a Waters Synapt G2 HDMS quadrupole orthogonal acceleration time of flight mass 
118 
 
spectrometer (Waters Corp., Milford, MA USA). A 15 min linear gradient separation was run at a 
flow rate of 0.400 mL/min at 35 C using A: water containing 0.1% v/v formic acid and B: 
acetonitrile containing 0.1% v/v formic acid: 3% B, 0 min to 1 min; 3% B to 97% B, 1 min to 9 
min; 97% B, 9 min to 11 min; 97% B to 3% B, 11 min to 12 min; 3% B 12 min to 15 min. 
Spectra were collected in negative mode. 
Determination of 
18
O incorporation into product was complicated by the fact that the 
substrate and product both contain two Cl atoms, for which two common isotopes, 
35
Cl and 
37
Cl, 
are two mass units apart just as 
16
O and 
18
O. To establish a baseline for the isotope patterns, the 
reaction of P and NH2-CAM was performed under an 
16
O2 atmosphere in quadruplicate and the 
natural abundance at each m/z was noted. These were loaded into an excel spreadsheet to be 
iteratively subtracted from the value obtained from reactions with 
18
O2. Under the these 
conditions, the retention time for CAM and NO-CAM was 4.5 min and the retention time for 
NH2-CAM was 1.3 min. The m/z values for NH2-CAM are 291.03, 293.03 and 295.03, for NO-
CAM are 305.01, 307.01, 309.01 and 311.01, and for CAM are 321.01, 323.01, 325.01, 327.01 
and 329.01.     
 
Spectroscopic Methods 
 
UV-visible Spectroscopy. Absorbance spectra were taken on an Agilent Cary 60 UV-Vis 
spectrophotometer at room temperature. For the titration of P with NH2-CAM, P was prepared as 
described above at 500 µM concentration and stored in a quartz cuvette on ice.  Small aliquots of 
a 1 mM NH2-CAM solution in 50 mM Bicine buffer, pH 9 were added each representing 
approximately 0.05 equivalents relative to the starting CmlI-peroxo concentration.  The optical 
spectrum was scanned and used to construct plots. About 3 % of the P decays spontaneously 
during the experiment. No correction was made for this loss. The end point of the reaction was 
analyzed by reverse phase HPLC and an authentic standard of CAM was run by the same HPLC 
method to confirm that the UV-Vis titration was producing CAM. 
   
UV-Vis Stopped-Flow. Stopped-flow experiments were performed using an Applied 
Photophysics model SX.18MV stopped-flow device.  Specific experiments and fitting procedures 
are described in the Kinetic Methods section.  
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Resonance Raman Studies. CmlI (2 mM) was reduced under anaerobic conditions with an 
excess amount of dithionite in the presence of 0.1 equivalent of methylviologen. Excess reductant 
and methylviologen were removed using a PD-10 desalting column (G-25, GE Healthcare) in an 
anaerobic chamber.  The removal of methylviologen is essential as it can be photoreduced by the 
laser, which results in the reduction of the peroxo species and thus loss of rRaman signal.  
Aliquots of reduced CmlI from the same batch were exposed to either 
16
O2 or 
18
O2
 
at ~ 4 °C for 
several minutes. The samples were then flash-frozen with liquid nitrogen and kept at 77 K for 
future experiments. 
16
O2 and 
18
O2 samples were repeated three times. Multiple measurements 
were carried out for each sample. For each measurement, a ~ 70 L aliquot of  samples was 
thawed and transferred to flat-bottomed NMR quartz tubes and maintained at a temperature range 
of -10 °C to 10 °C. For the isotopically labeled samples, the tubes were sealed with septa and 
equilibrated with argon prior to sample transfer to minimize the exchange of the peroxo ligand 
with atmospheric dioxygen (this step was later determined to be unnecessary as the O2 ligand 
does not exchange in the absence of substrate). 
Resonance Raman experiments were performed on an Acton AM-506 spectrophotometer 
(1,200-groove grating) with a Princeton Instruments LN_CCD-1100-PB_UVAR detector cooled 
to -120 °C with liquid nitrogen. The 488 nm excitation line at 100 – 600 mW power was provided 
by a Spectra-Physics BeamLok 2060-KR-RS Argon ion laser, which is filtered out by a Kaiser 
Optical holographic super notch filter. Spectra were collected in 90° scattering geometry at 
resolution of 4 cm
-1
, and referenced to indene. Multiple spectra were continuously collected over 
10 or 20 minutes with each spectrum obtained from a 15-second exposure. Spectra within desired 
time range were added to improve the signal-to-noise ratio. Multiple measurements were 
performed for each CmlI-peroxo sample. GRAMS/AI (Thermo Galactic, Salem, NH) was utilized 
data processing. 
 
EPR sample preparation and analysis. EPR spectra were collected using a Bruker Elexsys 
E-500 spectrometer equipped with a Bruker dual mode cavity and an Oxford ESR 910 liquid 
helium cryostat.  Mixed valent CmlI was prepared via photoreduction of the diferric enzyme (1 
mM) at 4 °C with 50 µM 5-deazaflavin in the presence of 10 mM phenazine methosulfate using a 
standard 100 W lamp.  Mössbauer spectroscopy was performed as previously described.
88
  
Spectra were analyzed using the software WMOSS (SEE Co., Edina, MN). 
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Mössbauer sample preparation and analysis. Samples for Mössbauer analysis were 
removed at various points of the catalytic cycle in which 
57
Fe-enriched CmlI replaced natural 
abundance enzyme. Samples include diferric (as-isolated), P and diferrous, all described 
previously, and samples from the catalytic walks, as described in the next section. To freeze the 
anaerobic samples, the Mössbauer cup containing the sample was placed in a large Reacti-Vial 
(Thermo Scientific) while still inside the anaerobic chamber and sealed. After removal from the 
chamber, the entire vial was promptly frozen in liquid nitrogen. The vial was unsealed for 
spectral studies. 
Mössbauer spectra were recorded with home-built spectrometers using Janis Research 
Super-Varitemp dewars, which allowed studies in the temperature range from 1.5 to 200 K and 
applied magnetic fields up to 8.0 T. Mössbauer spectral simulations were performed using the 
WMOSS software package (SEE Co., Edina, MN). Isomer shifts are quoted relative to Fe metal 
at 298 K. All Mössbauer figures were prepared using SpinCount software.
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Obtaining Snapshots of the CmlI Catalytic Cycle  
 
NH2-CAM Catalytic Walk. All samples were kept at ~4 °C unless otherwise stated and all 
experiments were performed in 50 mM Bicine buffer pH 9.  A sample of P (600 μM) was 
prepared as described above. A 200 μL aliquot was removed and an absorbance spectrum was 
taken. This sample was then left on the benchtop to decay; a spectrum was later taken to serve as 
the P decay control. The remaining P was degassed to remove excess O2, first by purging with Ar 
gas for 20 min, and then by transferring to the anaerobic chamber and stirring for 10 min in the 
anaerobic atmosphere. After excess O2 was removed, one equivalent of NH2-CAM (freshly 
prepared in the anaerobic chamber, 10% MeOH, 90% water) was added and allowed to stir for 5 
min. A 100 μL aliquot of this sample was removed and quenched in the anaerobic chamber with 
100 μL 5% TFA for HPLC analysis. The remaining enzyme substrate mixture was transferred 
into a sealable cuvette and brought out of the anaerobic chamber. An absorbance spectrum was 
taken, after which the sample was exposed to a stream of O2 for 2 min. The spectrum of the 
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resulting sample was taken and an aliquot was removed and quenched in equal volume 5% TFA 
for HPLC analysis.  
 
NH(OH)-CAM and NO-CAM Catalytic Walks. Diferric resting state CmlI (560 μM) or P 
(300 μM, prepared as described above) was degassed first by purging with Ar gas for 20 min, and 
then by transferring to the anaerobic chamber and stirring for 10 min in the anaerobic atmosphere. 
After excess O2 was removed, one equivalent of NH(OH)-CAM or NO-CAM (freshly prepared in 
the anaerobic chamber, 10% MeOH, 90% water) was added and allowed to stir for 5 min. A 100 
μL aliquot of this sample was removed and quenched in the anaerobic chamber with 100 μL 5% 
TFA for HPLC analysis. The remaining enzyme substrate mixture was transferred into a sealable 
cuvette and brought out of the anaerobic chamber. An absorbance spectrum was taken, after 
which the sample was exposed to a stream of O2 for 2 min. The spectrum of the resulting sample 
was taken and an aliquot was removed and quenched in equal volume 5% TFA for HPLC 
analysis. 
 
Capturing the Oxidant in the Reaction of CmlI
red
 with NO-CAM. Reduced CmlI (400 
µM) was mixed 1:1 with reaction buffer (50 mM Bicine, pH 9) saturated with O2 (1.8 mM at       
4 °C) containing NO-CAM (4 mM). Rapid quenches used an Update 715 Ram Syringe Controller 
to mix and dispense the reactants at time points < 30 sec. The reaction mixture was dispensed 
onto rapidly spinning LN2-cooled metal wheels of a home-built instrument. Contact with the 
cooled wheels causes the reaction solution to freeze instantly into a powder. The powder is then 
scrapped off into a LN2 bath and packed into Mössbauer cups for analysis. Samples at time points 
> 30 seconds are mixed by a magnetic sir bar in a reaction vial and then frozen by hand. Reaction 
time points are chosen by inspecting the UV-vis trace of the formation and decay of the 
intermediate in question.  
      
Determining Kinetic Trends and Constants  
 
General Procedures. All stopped flow experiments were performed in 50 mM Bicine pH 9 at 
4 °C. In reactions of the diferrous enzyme with O2 and aryl-amine-derived substrates (including 
NH2-CAM, NH(OH)-CAM and NO-CAM), CmlI was reduced as described above and then 
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loaded anaerobically using a Hamilton syringe to the stopped-flow device which had been 
previously scrubbed with dithionite and anaerobic buffer.  Reactions of the pre-formed CmlI-
peroxo complex with aryl-amine substrates were performed similarly, with the diferrous enzyme 
extensively oxygenated prior to loading the stopped flow syringe. The resultant traces were fit as 
described below.   
 
Trace Fitting and Rate Constant Determination. The kinetic data were analyzed to extract 
reciprocal relaxation times (RRTs) using the nonlinear regression function of the Applied 
Photophysics ProData Viewer program. Each reaction time course was fit to a summed 
exponential expression, Eq. 1, which is appropriate for a series of first order or pseudo-first order 
reactions.
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  In this equation, Abst is the observed absorbance at time t, Ampi is the observed 
amplitude for exponential phase i, τi is the relaxation time for phase i, and Absinf  is the final 
absorbance at the end of the reaction.  For a linear series of n reaction steps, n phases are required 
for the fit.  Fitting statistics were reported by the fitting program, and each reaction was repeated 
at least 10 times to determine the average fitting parameters and errors. 
  
𝐴𝑏𝑠𝑡  = (∑  
𝑛
𝑖=1 𝐴𝑚𝑝𝑖 𝑒
−
𝑡
𝜏𝑖) +  𝐴𝑏𝑠𝑖𝑛𝑓      (Eq. 1) 
 
 For a two-step reaction where the first step is fast reversible binding, a hyperbolic 
dependence of the 1/obs on substrate or O2 concentration may apply if the observable step that 
follows is comparatively slow: 
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E + ligand
𝑘1
⇄
𝑘−1
E∙ligand
𝑘2
⇄
𝑘−2
E-ligand'  (Eq. 2) 
 
Plots of 1/obs versus either substrate or oxygen concentration were fit to the hyperbolic function 
below using Origin: 
 
1
𝜏𝑜𝑏𝑠
=
𝑘2[ligand]
(
𝑘−1
𝑘1
)+[ligand]
+ 𝑘−2  (Eq. 3) 
 
The parameters of the equation yield the apparent KD for the binding reaction (k-1/k1) and forward 
and reverse rate constants for observable conversion which follows binding.  The accuracy of the 
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Kd value depends upon how closely the binding reaction approaches rapid equilibrium, and 
specifically, whether k-1 is >> than k2.  
 
Extraction of the rate constants from the sum and product plots of the RRTs (as in 
Chapter 4, Figure 4-18) was performed using previously described methods.
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 Three 
relaxations are observed in the transient reaction implying that there are at least three steps in the 
reaction. The first two phases have a clear dependence on substrate concentration. The nonlinear 
dependence on substrate concentration of the second relaxation is consistent with a sequential 
rather than parallel sequence of steps. Moreover, a nonlinear substrate dependence on one phase 
would only be observed if the first step in the reaction in which substrate binds is reversible. The 
final step is unlikely to be reversible because the reaction observed involves the cleavage of an O-
O bond and the subsequent insertion of an O atom into an N-H bond. This leads to the following 
initial model for the reaction with O2 and substrate: 
𝐸𝑟𝑒𝑑 + 𝑂2 
𝑘1
⇄
𝑘−1
𝑷 + 𝑁𝐻2 − 𝐶𝐴𝑀
𝑘2
⇄
𝑘−2
𝐸𝑜𝑥 +  𝑁𝐻(𝑂𝐻) − 𝐶𝐴𝑀  (Eq. 4) 
The rate constants for the individual steps cannot be determined directly from the exponential fits 
due to mixing of the relaxations through the reversible step(s). Under the assumption that the final 
irreversible step is slow, the analysis can be performed by solving a series of differential rate 
equations describing the first two steps of the reaction. This analysis shows that the first and 
second RRTs correspond to the negative roots of a quadratic equation given by Equations 5 and 
6, where S is any substrate: 
 
 𝜆2 + (𝑘2[𝑆] + 𝑘−2 + 𝑘1 + 𝑘−1)𝜆 +  (𝑘2[𝑆](𝑘1 + 𝑘−1) + 𝑘−2𝑘−1)  (Eq. 5) 
  
1
𝜏1
,
1
𝜏2
=
1
2
{(𝑘2[𝑆] + 𝑘−2 + 𝑘1 + 𝑘−1) ± √[(𝑘2[𝑆] + 𝑘−2 + 𝑘1 + 𝑘−1)
2 − 4 + (𝑘2[𝑆](𝑘1 +
𝑘−1) + 𝑘−2𝑘−1)]}   (Eq. 6) 
 
The rate constants may thus be extracted using the following relationships: 
 
1
𝜏1
+
1
𝜏2
= 𝑘2[𝑆] + 𝑘−2 + 𝑘1 + 𝑘−1  (Eq. 7) 
1
𝜏1𝜏2
= 𝑘−2(𝑘1 + 𝑘−1)[𝑆] + 𝑘1𝑘2  (Eq. 8) 
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The slopes and intercepts in the plots of the sum or product of the RRT vs. [S] can then be used to 
calculate the rate constants.  
 
Numerical Integration and Simulation of Kinetic Data. KinTek Explorer (KinTek 
Corporation, Snow Shoe, PA) was used to simulate reactions. A model for the reaction course is 
built based on the number of phases observed in optical data for a particular reaction and on 
previously established information regarding the proposed steps. Optical absorption traces and 
experimentally determined rate constants are imported and fit to the model to test the model, 
provide refined rate constants, and determine how changing rate constants changes the shape and 
trend of the traces. 
 
Reactions to Monitor P Formation. These reactions were monitored at 300 nm (no CAM 
present) or 320 nm (CAM present) with ~ 40 µM CmlI. (All concentrations are final, post-mix 
concentrations. Thus, in this case the syringe contained ~80 µM CmlI, which was diluted to ~ 40 
µM when mixed 1:1 by the stopped-flow instrument). One syringe was loaded with diferrous 
CmlI and the second with buffer containing 3-30 equivalents O2 (pseudo-first order conditions, 
~100 – 900 µM). The reactions with CAM used 10 equivalents (400 µM) CAM in the O2 syringe.  
 
Reactions with NH2-CAM. All reactions with NH2-CAM were monitored at 480 nm with ~ 
200 µM CmlI. In reactions in which both P formation and decay were monitored, one syringe 
was loaded with diferrous CmlI and the second with buffer containing either ~900 µM O2 
(pseudo-first order conditions) or ~200 µM O2 (stoichiometric conditions). In reactions where 
only P decay was monitored, P was formed in-syringe by loading 800 µM diferrous CmlI into a 
gas tight syringe, removing it from the anaerobic chamber and cooling it to 4 °C on ice (~ 5 min). 
An equal volume of O2-saturated buffer was then introduced into the syringe to dilute the enzyme 
to 400 µM, the syringe was inverted several times to mix, and then loaded onto the stopped-flow 
instrument. This method maximized P formation and minimized pre-reaction P decay.  Substrate 
(5- 40 equivalents or 1-8 mM) was loaded either anaerobically into the enzyme syringe, or into 
the O2 syringe, as the experiment dictated.  
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Reactions with NH(OH)-CAM. All reactions with NH(OH)-CAM were monitored at 390 nm 
with ~ 40 µM CmlI. One syringe contained anaerobic diferric CmlI and the second contained 5-
300 equivalents NH(OH)-CAM in anaerobic buffer.  
 
Reactions with NO-CAM. All reactions with NO-CAM were monitored at 480 nm with ~ 200 
µM CmlI. Methods are the same as for reaction with NH2-CAM (above).  
 
Oxygen Isotope Tracing Methods 
 
Oxygen Isotope Incorporation Experiments.  P was prepared as above, with appropriate 
O2 isotope. For the reactions in H2
18
O, labeled water was introduced when the enzyme was in the 
diferrous state by three cycles of anaerobic concentration and dilution with 50 mM Bicine buffer, 
pH 9, prepared in H2
18
O. For the reactions with 
18
O-P, the vial containing the intermediate was 
brought into an anaerobic chamber and substrate was added. The sealed vial with P-substrate 
complex was brought out of the chamber and kept under a positive pressure of 
18
O2. Reactions 
were run for 10 min at 4 °C and then acid-quenched. After centrifugation to remove protein 
precipitate, the supernatant was transferred to an LCMS vial. Reactions of 
16
O-P were performed 
similarly expect that the substrate was introduced on the benchtop. 
  
Experiment to Evaluate Exchange of CmlI-Peroxo with Atmospheric O2. 1 mL of 
18
O-
P (200 μM) was prepared as above and stirred on ice for the duration of the experiment. A stream 
of 
16
O2 was applied over the sample. 100 μL aliquots were removed at time points from 1 to 90 
min and reacted with 0.3 equivalents of NH2-CAM. Reactions were run for 10 min and then 
quenched and prepared for LCMS analysis as described above.  
 
Exchange of Products from the Active Site. 18O2-P (200 μM) was prepared as above, 
degassed to remove excess O2, and equilibrated in an anaerobic chamber before 1x NH2-CAM 
(200 μM) was added.  After a 20 s incubation, one equivalent of N16O-CAM (200 μM) was 
added. The sample was then quickly put under an 
18
O2 headspace and allowed to react for 10 min. 
Samples were acid quenched and analyzed by LCMS. Control samples were made by adding 
buffer instead of NO-CAM. 
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